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Abstract 
 
Modified nucleotides are becoming increasingly attractive, e.g. to create supramolecular 
assemblies by using the Watson-Crick base pairing motif, or to incorporate various 
functionalities such as fluorophores or amino acid side chain mimics into the DNA itself. 
Here, we present a general synthetic route to porphyrinyl-nucleosides 31-38, where the 
substitution pattern and the metallation state of the porphyrin residue can be varied to 
introduce diversity. Based on the synthetic route, the corresponding phosphoramidites 39-42 
were synthesized.  
First, diphenylporphyrin dimers were synthesised both in solution (46a, 46b) and on 
solid support 47. The building block was then successfully incorporated into trimer 57, 
tetranucleotides 54-56 and 21-mer oligo-deoxynucleotides 64-70 on solid support via an 
automated DNA synthesiser. The 21-mer DNA contains one central modification, two 
porphyrins separated by one thymidine, three consecutive and five consecutive porphyrins. 
These strands were purified by hybridisation of the complementary strand on support solid or 
by fluorous affinity chromatography.  
First results on the interaction of the dimer, the tetramer, and the 21-mer with the 
complementary strands are discussed. The UV-Visible and fluorescence spectroscopy show 
an electronic interaction between the different porphyrins in the hetero-tetranucleotide 55. 
Similarly, in the 21-mer porphyrin DNA strands, an electronic coupling between the 
chromatophore is evident from the broadened UV-Vis absorbances (porphyrin B-band).  
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    Scheme 1: Solid phase synthesis of oligonucleotides. 
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Abbreviations 
 
A   adenine within structural formulas, adenosine within text 
Å   angstrom (1 Å = 10-10 m) 
aro.   aromatic 
Ac   acetyl 
AcOH   acetic acid 
Anh.   Anhydrous 
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Boc   tert-butoxycarbonyl 
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Calcd.   calculated 
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DCM/CH2Cl2  dichloroethane 
DMAP  N,N-dimethylamino pyridine 
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18  Abbreviations 
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HPLC   high performance liquid chromatography 
Hz   hertz 
J   coupling constant 
MALDI-TOF  matrix-assisted laser desorption ionization time-of-flight 
MeOH   methanol 
min   minute (s) 
m.p   melting point 
NMP   N-methyl-2-pyrrolidone 
NMR   nuclear magnetic resonance 
org.   organic 
PE   petrol ether 
ppm   parts per million 
quant.   quantitative 
Rf   retention factor (TLC) 
RP   reverse phase 
RT.   room temperature 
sat.   saturated 
T   thymine structural formulas, adenosine within text 
TBAF   Bu4NF 
TBDMS  t-BuMe2Si 
TEAA   tetraethylammonium acetate 
TEA   triethylamine 
TFA   trifluoroacetic acid 
TIS   triisopropylsilane 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
Tm   DNA melting point 
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Tris   tris(hydroxymethyl)aminomethane  
tBu   tert-butyl 
UV   ultra violet 
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1 Introduction 
1.1 Porphyrins 
1.1.1 Structure 
 
The porphyrins are a group of naturally occurring pigments and a typical example of zinc 
octaethylporphyrin[1] is shown in figure 1: 
 
N N
N N
Zn
 
 
Figure 1: Zinc octaethylporphyrin ZnOEP. 
 
A porphyrin is a heterocyclic macrocycle made from four pyrrole subunits linked on 
opposite sides (α position) through four methine bridges (=CH-). The macrocycle is fully 
oxidized and therefore more aromatic than the related chlorines (2,3-dihydroporphyrin) and 
bacteriochlorophylls (2,3,12,13-tetrahydroporphyrin). The extensive conjugated system 
makes the compound chromatic, hence the name porphyrin, from a Greek word for purple. 
The first porphyrin was synthesised by Fisher, more than one century ago. The porphyrin 
structure, with the different possible substitution position, is given in Figure 2. 
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Figure 2: Porphyrin structure.  
 
Porphyrins have already been complexed with nearly all metals in the central cavity. 
Best know are Iron-, magnesium-, zinc-, copper-, nickel-, and cobalt- containing porphyrins. 
A porphyrin, in which no metal is inserted in its cavity, is called a free base. Some iron-
containing porphyrins, hemes, and hemoproteins, are found extensively in biochemistry, e.g. 
haemoglobin, where iron is the actual transfer site for oxygen and can be preferentially bound 
with carbon monoxide, thus poisoning by asphyxiation can occur. Some shellfish, with green-
colored blood, have a copper-centered porphyrin. Porphyrin derivatives can also be found in 
nature, as in chlorophyll (Mg chlorine) and photosynthetic bacteria (bacteriochlorin). 
The porphyrin consists of a planar system with 22 π-electrons, 18 of which are in the 
conjugated system. As they follow Hückel's rule, porphyrins have aromatic properties. The 
delocalisation degrees through the π-system depend on the porphyrin being: (i) a free base, 
(ii) a di-anion, or (iii) a metallocomplexe (Figure 3).[2] The porphyrin is an amphoteric 
molecule. The pKa can varies from ~ 5.5 (H2P + H+ ↔ H3P+) to ~ 2 (H+ + H3P+ ↔ H4P2+) for 
the protonated form and from 10-15 for the pyrrol-proton (H2P ↔ HP- + H+; HP- ↔ P2- + H+).  
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Figure 3: Delocalisation of the porphyrin π–system: in (a) free base, (b) di-anion and (c) 
metallocomplexe. 
 
The di-anion structure can form a metallocomplexe with four equivalent coordinative 
donor-acceptor -bonds, through labile electrostatic interaction (e.g.: Na+, K+, Rb+, Cs+, Be2+, 
Sr2+, Mg2+, Ba2+, Ca2+) or through covalent bonds with cations whose vacant orbital is 
occupied or semi-occupied (e.g.: Fe2+, Fe3+, Co2+, Ni2+, Zn2+, Mn3+, Cr3+). The porphyrin 
central cavity is ~ 1.4 Å, which is an appropriate size for a 3d metal-ion. The spectroscopic 
characteristic of a porphyrin is due to the π-delocalisation. The UV-visible spectrum shows an 
intensive absorption at ~ 400-450 nm which is named “Soret-Band” or “B-Band”. Four other, 
smaller peaks, at 500-700 nm with lg(ε) ~ 4.5-5.5, are named “Q-Bands”, and vary with the 
solution, the pH, and the porphyrin structure. Figure 4 shows the UV-visible spectra of a 
typical porphyrin: H2DPP and ZnDPP(OAc)2.  
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Figure 4: UV-Vis. spectra of H2DPP and ZnDPP(OAc)2. 
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Figure 5: 1H NMR spectrum of the protected diphenylporphyrin 77. 
 
The NMR spectra of the protected diphenyl porphyrin (figure 5) show the pyrrol-NH 
signal at δ = -2 to -3 ppm, which disappears in the Zn-DPP. Generally, the signal of the two 
meso-H of the porphyrin is at 10 ppm, and the aromatic protons generate a multiplet from 7.5 
to 9 ppm. Due to the asymmetry of the porphyrin, the four methyl groups on the β-position 
give two singlets at 2.5 ppm. For a symmetrical porphyrin, these two singlets will be turned in 
one singlet. The signal of the first –CH2- on the alkyl chain appears at 4.5 ppm. 
 
Porphyrins are well-known pigments: they have been widely studied because of their 
electrochemical and photophysical properties, which can be tuned upon insertion of different 
metal ions and by changing the substituents on the porphyrin core. Metalloporphyrins 
undergo reversible redox processes at low potential values, to yield stable and nonfluorescent 
radical cations. Therefore, Porphyrins have been used extensively to investigate electron and 
energy-transfer processes. Nowadays, they are not only used in optical and electrochemical 
properties, but they cover a great variety of fields from photonic devices to light-harvesting 
antennae and molecular electronics. They offer new way to design molecular devices in the 
field of material chemistry. 
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Porphyrins can form conjugated oligomers, in which they possess some extraordinary 
electrical properties, due to their extended π-systems. They can also form giant 
supramolecular chromophores where the metal chelation of porphyrins allows considerable 
control of the redox properties of such systems. The relatively large size of the monomer unit, 
which is about 16 Å, offers another key advantage to use porphyrins as a molecular wire. For 
example, a linear tetramer has a length of ca. 56 Å, which is large enough to span a gap in an 
electrical circuit. 
 
 
1.1.2 Supramolecular multiporphyrin arrays 
 
In order to construct a supramolecular assembly, the mode of connectivity between the 
porphyrins and the ligand should be appropriate, otherwise the systems will not be stable in 
solution, and dissociation to yield the individual building block will be observed.   
 
 
1.1.2.1 Mode of connectivity : Coordination 
 
Porphyrins are widely used and highly versatile building blocks in supramolecular 
chemistry, especially the metalloporphyrins. Nearly every metal of the periodic table has been 
inserted into porphyrins. One application of metalloporphyrins is in catalysis, in which case 
the metal center is used as an active site[3]. The most common application of the 
metalloporphyrin is in the construction of various supramolecular assemblies via coordinative 
patterns. Generally, the supramolecular binding motif is represented by the axial coordination 
of the donor ligand to the metal center. Various Zn(II)- and Ru(II)- porphyrins complexes 
were used, as supramolecular building blocks that selectively associate with the nitrogen 
donor atoms, to form a supramolecular assembly via Zn-Npyr interaction. An example of a 
tris(meta-pyridyl)phosphine template used with a meso-substituted Zn- tetraphenylporphyrin 
to create a supramolecular encapsulated ligand assembly[4], is given in Scheme 2.  
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Scheme 2: Formation of supramolecular Phosphine Ligand via Zn(II)- Npyr interactions using 
Zn(II) porphyrin building blocks. 
 
 
 
 
Figure 6: X-ray crystallography of the supramolecular ligand. (Zn = green colour). 
 
In the solid state, the template-encapsulated structure formed do not have the expected 
1:3 ratio of building blocks, but instead a 2:5 stoichiometry was observed. One of the 
Zn(II)porphyrin units is part of two adjacent capsule assemblies as a result of a rather unusual 
hexacoordinated zinc metal. The structure can therefore be described as a fusion of two ‘1:3’ 
assemblies through the central Zn(II)porphyrin unit. The unique hexacoordinated Zn center 
bridges the two parts of the 2:5 assemblies via a double axial ligation of two pyridyl 
phosphines as shown in figure 6.  
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1.1.2.2 Mode of connectivity : Covalent 
 
NN
NN Zn HN
N
NNH NN NN Mg
Fe N
Fe N
B
Linear Gate
Optical
input
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ouput
Redox-switching unit
 
Figure 7: Linear gate.[5] 
 
The construction of supramolecular assemblies using covalent linkage was used in the 
design and the synthesis of optoelectronic gates.[6] The porphyrins connected via a 
diphenylethyne covalent linker were used in the construction of molecular wires, where their 
oxidation/reduction properties were used to control the excited-state energy-migration 
process. An example of a linear gate and a T gate is shown is figure 7. In the linear gate a 
BDPY-Zn porphyrin dyad was coupled with Fb porphyrin-Mg porphyrin dimer. The synthesis 
of the T gate used a Zn porphyrin bearing four different meso substituents. Attachment of the 
three different groups to the Zn porphyrin was accomplished using successive Pd-mediated 
coupling reactions in the following sequence: Fb porphyrin (output unit), BDPY dye (input 
unit), and Mg porphyrin (redox switching unit). Both the linear gate and T gate syntheses 
introduce the Mg porphyrin at the final step to minimize demetalation of the Mg porphyrin. 
Lindsey and co-workers have studied the dynamics of the energy transfer processes in the 
linear- and T-shaped optoelectronic gates and their component parts. They have elucidated the 
dynamics and mechanism of energy flow in the gates. They showed that the energy transfer 
occurs very rapidly (ktrans = (9 ps)-1) from a Zn porphyrin to a Mg porphyrin joined via a 
diphenylethyne linker and the majority of the energy in the T gate initially flows to the site of 
switching rather than to the output unit. The electronic communication in diphenylethyne-
linked multiporphyrin arrays can precede via superexchange among distant sites, such as from 
a Mg porphyrin to a Fb porphyrin in an array of Mg, Zn, and Fb porphyrins (i.e., like the T 
gate). Thus, in the T gate, the excited-state energy that initially reaches the Mg porphyrin then 
proceeds to the Fb porphyrin via superexchange. 
 
28  Introduction 
1.1.2.3 Mode of connectivity : combined Covalent-Coordination 
 
A combined covalent-coordination approach was used to realise multiporphyrin arrays 
by Sanders et al. A large heterometallic porphyrin array, assembled using a combination of 
Sn(IV) and Rh(III) porphyrin coordination chemistry [7], is shown in figure 8.  
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Figure 8: Heterometallic undecamer by Sanders using orthogonal binding mode. 
 
A Sn(IV) porphyrin acted as a core around which were coordinated two carboxylic 
acid functionalized porphyrins. Rh(III) porphyrins were coordinated to pyridyl groups at the 
periphery of these entities. In this way an eleven porphyrin array, with four different 
porphyrin metallation states, was assembled. The two-dimensional 1H NMR analysis proved 
the integrity of the eleven-porphyrin assembly. This example demonstrates that the 
composition of such multi-porphyrin arrays can be tuned by choosing the appropriate 
combination of substituted porphyrins-as-ligand together with the metalloporphyrins that act 
as ligand acceptor porphyrins. 
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1.1.3 Templated porphyrin assemblies 
 
In section 1.1.7, reasons will be given for constructing supramolecular assemblies with 
porphyrins and fullerenes. The construction of supramolecular porphyrin-fullerene complexes 
is achieved through the π-π stacking formed between porphyrins and fullerenes. 
Multiporphyrin arrays, which are based on an oligopeptide scaffold, can form clusters with 
C60 [8], which show enhanced activity in photoelectronic devices (figure 9). 
 
 
 
Figure 9: Illustration of a Supramolecular Assembly between 
Porphyrin-Peptide Oligomers and Fullerenes. 
 
The porphyrin-C60 complex forms linear arrays with an alternating porphyrin and 
fullerene composition. These arrays are preformed in solution (toluene-acetonitrile) and 
subsequently deposited on SnO2 electrodes. Such porphyrin oligomers are flexible enough to 
accommodate C60 between the porphyrin units. Compared to the monomer porphyrin, no 
quenching of the excited state of porphyrins occurs. The systems showed efficient 
photoresponse from the UV to the near-IR region. A high power conversion efficiency (ŋ) of 
1.3% and a maximum incident photon-to-photocurrent efficiency (IPCE) of 42% show that 
the formation of a molecular assembly between fullerene and multi-porphyrin arrays with a 
polypeptide backbone controls the electron transfer efficiency in the supramolecular complex, 
which is essential for the light-to-energy conversion (chapter 1.1.6). A recently emerging 
trend concerned with the association of porphyrins and fullerenes could lead to new materials 
in the future. 
 
30  Introduction 
 
 
Figure 10: Porphyrin-Modified Peptides. 
 
Another example of a supramolecular assembly,[9] that features long-range electronic 
coupling between porphyrins covalently attached to a designed peptide scaffold, is shown in 
figure 10. The resulting construct self-assembles to form extended organized aggregates in 
which porphyrins engage in exciton coupling. By this approach, Akerfeld et al. aim to control 
the structure and the electronic properties of the assembly by manipulation of the spacing 
between the porphyrins along the peptide chain. They report an example where a short 
diporphyrinlinked peptide sequence that self-assembles in a “Lego-like” fashion to yield 
extended porphyrin arrays. The properties can be controlled by concentration, temperature, 
and pH. By adjusting the temperature, the growth of the aggregate can be monitored over 
time. This system could be used in the construction of photonic nanodevices that mimic the 
photosynthetic light-harvesting complexes.  
 
A “classical” covalent synthesis is mostly used to obtain this multi-porphyrin 
supramolecular species[10-12] as seen above. The main reason for the predominance of the 
covalent synthesis over the noncovalent method is that the former allows finer control over 
the structure of the final species, intrinsic to the strength of the covalent bond. Noncovalent 
interactions are weaker and less addressable. Purrello et al.[10] give one possible way to partly 
overcome this limitation inherent in the noncovalent route by using a combined approach. 
They begin the synthesis with covalently synthesized multipart components (as porphyrin 
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conjugates) and then self-assemble these with the other components (or multiparts) to obtain 
the final species as shown in figure 11. This assembly formed by the interaction between 
multi-anionic and multicationic components take advantage in terms of thermodynamic 
stability and/or kinetic inertness. Some of these ”purely” noncovalent species have good 
control in aqueous solution. This self-assembly is driven by the templating action of an octa-
anionic calixarene on a tetracationic porphyrin and/or its metal derivatives. They started from 
a central 1:4 porphyrin/calixarene species; they show the possibility to pile, in a stepwise 
fashion, up to six porphyrins above and below the central porphyrin to form a final 7:4 array. 
Interestingly, the stoichiometric ratio of the complex corresponds to the ratio of the 
components in solution. 
 
 
Figure 11: Porphyrins and Calixarenes complexes. 
 
The top of the figure shows a host–guest interactions in the unit, formed by the central 
tetracationic porphyrin and four calixarenes as extracted from the structure of the complexes 
indicated in the lower part of this figure. Each calixarene hosts a sodium ion (violet circles) in 
the lower rim. On the side view, they are tri- (left) and penta-porphyrin (right) supramolecular 
complexes where the two calixarenes interacting with the central porphyrin above and below 
the figure plane have been omitted for clarity. 
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1.1.4 Photoinduced electron transfer 
 
The design of “smart” molecular arrays, able to perform useful acts upon external 
stimuli, are used for the construction of nanostructures in a “bottom up” approach. The 
present example addresses the effect of using excitation with UV light in a series of dyads and 
triads (figure 12) based on porphyrins and bis-terpyridine complexes. In the models 
elaborated by Sauvage and co-workers, a free-base or zinc(II) porphyrin is used as 
chromophore and primary electron donor, while a Au(III)-metalated porphyrin serves as 
electron acceptor. These electro-active components are assembled around an octahedral 
transition metal complex of the Ir(III) terpyridine type, which can act as electron relay 
between two porphyrins. The construction of linear dyads and triads are fixed by 
intercomponent distances. The Iridium-(III) polyimine complexes was selected for its 
photophysical and electrochemical properties, its high energetic excited states which avoid the 
risk of energy transfer from a porphyrinic component, and its good ability to accept electrons. 
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Figure 12: Arrays and related models.[13] 
 
Excitation of these arrays by light in the visible range excites only the porphyrins. A 
selective excitation of the free base porphyrin in acetonitrile solutions of the arrays PH2-Ir 
and PH2-Ir-PAu dyads results in an electron-transfer process from the excited state of the 
free base porphyrin to the metal complex, leading to a charge separated (CS) state 
characterized by a reduced metal complex and an oxidized free-base porphyrin. In the triad a 
further electrontransfer step to the gold porphyrin moiety can compete with the back electron 
transfer and gives PH2+-Ir-PAu-. Compared to the zinc metalated homologues, the excitation 
of the zinc porphyrin unit in the triad PZn-Ir-PAu in toluene produced two consecutive 
electron-transfer steps leading to the CS state PZn+-Ir-PAu-. (The corresponding PZn-Ir and 
PAu-Ir dyads could not be studied in the same solvent.) Excitation at 350-355 nm, of the 
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dyads PAu-Ir, PH2-Ir and of the triads PH2-Ir-PAu and PZn-Ir-PAu, produces to a 
predominant extent the excited state of the metal complex identified as a ligand centered state. 
The excitation of this unit leads to an energy transfer process, in contrast with the electron-
transfer process observed for excitation of the porphyrin free-base photosensitizer. Switching 
of the type of process from electron-to energy-transfer by changing the excitation wavelength, 
does not occur in PZn-Ir-PAu, which exhibits electron-transfer irrespective of the unit which 
is excited.  
These results reveal that in PH2-Ir dyads and PH2-Ir-PAu triads arrays, it is possible to 
switch the nature of the photoinduced process between energy and electron transfer by 
selective excitation of the different component units. The excitation of the Ir complex unit in 
the ultraviolet leads to energy transfer and sensitization of the triplets of the porphyrins 
whereas excitation of the free-base porphyrin in the visible wavelength range leads to electron 
transfer which yields a charge separated state. 
 
 
1.1.5 Electron transfer: electronic wires 
 
The field of single-molecule electronics has become a promising design concept for 
miniaturisation in electronics. Molecular wires are the crucial components of such electronic 
devices, and several types of molecules have been suggested that have the potential for charge 
transfer, including conjugated hydrocarbon, carbon nanotubes, porphyrins oligomers and 
DNA strands. All have the same key requirements, namely they have to be electron or hole 
conducting in order to carry a current through the circuit. Rate measurements of the electron 
transfer along the wires are studied by spectroscopic techniques and STM in order to obtain 
current-voltage characterisation. Porphyrins are one of the most attractive building blocks due 
to their desirable characteristics such as rigid planar geometry, high electronic stability, and a 
small HOMO-LUMO energy gap. The porphyrins can conduct electrons through their  
π-system which is the basis of many wires. 
A non natural molecular design of directly meso-meso-linked porphyrins arrays,[14] as 
a model of light-harvesting antenna as well as a molecular photonic wire is shown in  
figure 13. The preparation of meso-meso directly linked zinc(II) porphyrins arrays up to  
128-mer (Z128) is achieved by repetitive Ag(I)-salt-promoted dimerisation reaction.  
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Figure 13: 8-mer of meso-meso directly linked zinc(II) porphyrins arrays. 
 
Here, the porphyrin units are close enough to each other to allow for a rapid energy 
transfer. The properties of these giant arrays are favourable for the use as photonic molecular 
wires, and the linear shape allows a prediction of the entire molecular length by the number of 
porphyrins (8.35 Å per one porphyrin unit). The large electronic interactions between the 
neighbouring porphyrins are favourable for rapid excitation-energy hopping, and each 
porphyrin unit retains its invidual character due to the orthogonal geometry, thus minimizing 
the formation of any energy sink, which will disrupt the energy flow along the arrays.  
 
In another example,[15] linear porphyrin arrays are self-assembled by hydrogen 
bonding or metal ion coordination, and self-organize in lipid bilayer membranes. This 
illustrates the use of porphyrins as photo-switch conductors (figure 14). The incorporation of 
porphyrins into lipid bilayer membranes to study electron transfer reactions to quinines led to 
the formation of a molecular electronic device that functioned as a photogated transistor.  
An aqueous electron acceptor is placed on one side of the membrane and an electron donor is 
placed on the opposite side. When illuminated with white light, substantial photocurrents are 
observed. Only the assembled structures give rise to the photocurrent, as no current is 
observed from any of the component molecules alone.  
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Figure 14: Schematic of one of four self-assembling porphyrin systems self-organized into 
bilayers to form a functional device. 
 
The orientation of the porphyrins tape (top and bottom arrays) can be in any direction 
such that the porphyrin planes are perpendicular to the bilayer-water interface. It is difficult to 
quantify the yield of membrane-spanning porphyrin arrays, so it is reasonable to expect some 
monomers-to-trimers to be present in the system. The electron donor, D, is K4Fe(CN)6 and the 
acceptor, A, is anthraquinonesulfate (AQS). 
 
 
1.1.6 Antenna complex of the natural photosynthetic system 
 
Multiporphyrins are not only used to study electron transfer from the photoexcitated 
state, but they are also suitable for mimicking the antenna effect of the natural photosynthetic 
system. In the natural photosynthetic systems, light energy absorbed by one of the 
chromophores in the antenna complexes is transferred through intra- and interantenna 
complexes until it attained the reaction center. Porphyrin arrays, in which fast photoinduced 
energy transfer occurs, are useful models to mimic natural photosynthesis. Various designs of 
porphyrins-based artificial antennae,[16] such as stars,[17] windmill,[18] macroring,[19-21] 
dendrimer,[22-24] and linear arrays,[25, 26] have been studied. A linear antenna with terminal 
acceptors as an exemple is shown in figure 15, where the formation of the light-harvesting 
antenna-acceptor composite is achieved by heterocomplementary coordination.[6] 
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Figure 15: light-harvesting antenna-acceptor composite. 
 
The linear antenna which has two free zinc imidazolyl porphyrin terminals is mixed 
with manganese porphyrins, an acceptor porphyrin, to obtain the large antenna acceptor 
composite. 
In another design, complexes of porphyrins with fullerenes to form light-harvesting 
antenna ensembles have been studied. Photoinduced electron transfer occurs in a molecular 
dyad consisting of a fullerene covalently linked to synthetic porphyrin,[27] as shown in figure 
16. Fullerenes, which are available since 1990, have been found to be an excellent electron 
acceptor moieties for incorporation into multicomponent ‘‘supermolecules’’ which act as 
artificial reaction center.  
 
 
Figure 16: Sequence of electron-transfer reaction in photoexcited Fc–ZnP–H2P–C60. 
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A fullerene moiety is linked to an array of two porphyrins (i.e., ZnP and H2P ). In 
ZnP–H2P-C60, the ZnP moiety acts as an antenna molecule, transferring its singlet excited-
state energy to the lower-lying H2P. In polar benzonitrile, this energy transfer is followed by a 
sequential electron transfer yielding Fc–ZnP–H2P•+–C60 •–, then Fc–ZnP•+–H2P–C60 •–and 
Fc•+–ZnP–H2P–C60•–. Considering the overall efficiency of 40 % for (i) funneling light from 
the antenna chromophore (i.e., ZnP) to the H2P chromophore, (ii) charge-injection into the 
fullerene core and (iii) charge-shift, this artificial reaction center reproduces the natural 
system very well. 
Recent advances in understanding the photosynthetic antenna system and 
improvements in synthetic and spectroscopic methods allowed the development of artificial 
light-harvesting antennae which absorb light and then transfer this excitation energy among 
various chromophores.  
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1.1.7 Optoelectronic devices 
 
The development of new photoactive molecular devices could lead to significant 
improvement in energy conversion and transport. The combination of both chromophores 
(porphyrins and fullerenes) seems ideal for fulfilling an enhanced light-harvesting efficiency 
of chromophores throughout the solar spectrum and a highly efficient conversion of the 
harvested light into the high energy state of the charge separation by photoinduced electron 
transfer. Self-assembled monolayers (SAMs) of fullerenes and porphyrins have been used as 
artificial photosynthetic materials and photonic molecular devices. In particular, the 
construction of photoactive ITO electrodes based on a layer-by-layer approach[28-30] such as 
the example shown in figure 17, is a promising approach. Porphyrin-linked fullerenes bearing 
positively charged functionalities are synthesised, which allow the control of the thickness 
and the control of the assembled films. The specific alignment and the orientation of the 
system are guaranteed by the free-base tetraphenylporphyrin-fullerene donor–acceptor 
ensemble which facilitate the electron transfer among adjacent layers and the repulsion of 
equally charged substrates restricts each assembly restructuring to single-layers. 
 
 
 
Figure 17: Schemetic illustration of photocurrent generation in ITO electrodes covered with a 
single-layer film of H2P–C60. 
 
Electrostatic and van der Vaals interactions have been used for the step-by-step 
deposition of layers containing the fullerene-porphyrin dyad as the active layer. This 
photoactive ITO/H2P–C60 electrode gives rise to largely improved light harvesting features in 
the visible light. In response to visible light irradiation, injection of electrons into the ITO 
conduction band occurs directly from the photochemically generated H2P•+–C60 •– radical pair 
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and indirectly via electron transport mediated through suitable electron carriers. Considering 
the simplicity of this approach, combined with the useful efficiency found for monolayer 
coverage, porphyrins could be a potent alternative in fabrication of photoactive molecular 
devices. 
 
 
 
 
 
Figure 18: TiO2 nanoparticles modified with dyes with some reference compounds employed 
and supramolecular assemblies of fullerene, porphyrin and fluorescein dye derivatives on 
TiO2 nanoparticles. 
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Another example of organization of supramolecular assemblies of fullerene, porphyrin 
and fluorescein on TiO2 nanoparticles developed by Fukuzumi et al.[31] is shown in figure 18. 
TiO2 nanoparticles were modified with a porphyrin derivative and fluorescein derivatives. 
The dye-modified TiO2 nanoparticles were deposited on nanostructured OTE/SnO2 (OTE: 
optically transparent electrodes) together with nanoclusters of fullerene (C60) from 
acetonitrile/toluene (3:1, v/v) using an electrophoretic deposition technique. The dye-
modified TiO2 composite electrodes [OTE/SnO2/(dye + C60)n] have broad as well as high 
absorbance properties in the visible region, exhibiting the photo response under visible light 
excitation using an I-3 /I- redox couple. The incident photon to photocurrent efficiency (IPCE) 
for these electrodes increases in order: OTE/SnO2/ (H2P)n < OTE/SnO2/(H2P-COO–TiO2)n < 
OTE/SnO2/(H2P-COO–TiO2 + C60). The IPCE value can be further improved by replacing 
H2P-COOH with a fluorescein derivative containing an electron donor moiety. 
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1.2 DNA 
1.2.1 The molecular structure of DNA 
 
Carrying the hereditary information in all living cell, DNA came into the researcher’s 
focus in the early 1950s, when its molecular structure was elucidated. In 1953, Watson and 
Crick proposed its structure to be a double-stranded helix.[32] DNA is built from monomeric 
units called nucleotides which are composed of three fragments: a sugar, a heterocycle and 
phosphate. The sugar deoxyribose is in the furanoside form, which is connected by a  
β-glycosyl linkage with one of the four heterocyclic bases to produce the different 
nucleosides: adenosine, cytidine, guanosine and thymidine. In DNA, the nucleosides are 
linked by 3’,5’-phosphodiester bonds to form a linear polymer. In the DNA duplex, hydrogen-
bonded base-pairs of adenine with thymine (A-T) and guanine with cytosine (G-C) (figure 19) 
are stacked at 3.4 Å distance by van der Waals contact. 
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Figure 19: Hydrogen-bonded base-pairs. 
 
A right-handed rotation of 36° between adjacent base-pairs produces a double helix of 
two antiparallel strands with 10.5 base-pairs per turn and 20 Å diameter. The arrangement of 
two strands generates two grooves with similar depth but different width along the double 
helix which are the major and the minor grooves (figure 20). 
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Figure 20: Three-dimensional structure of B-DNA. 
 
Three DNA conformations are believed to be found in nature, A-DNA, B-DNA and  
Z-DNA (figure 21). The B-type described by Watson and Crick is the most commonly found 
in living cells. All conformations differ by their density, diameter and helical structure. An  
A-type helix is usually formed in RNA-RNA duplexes and RNA-DNA duplexes, whereas 
DNA-DNA duplexes adopt the B-type form. Depending on the sequence of the DNA and on 
the environmental conditions, a left-handed Z-type is formed, e.g. in GC-rich sequences under 
high salt concentration conditions. 
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Figure 21: Space filling structures of A-, B-, and Z-DNA. 
 
There are different and independent effects which may stabilize the DNA strand, 
depending on the environment and the sequences. The stability of the DNA double helix is 
due to: 
 
? the hydrogen bonds which contribute 15-25 kJ mol -1 and 25-40 kJ mol -1 per base pair 
for A-T and G-C, respectively.  
 
? the stacking of the aromatic by the partial overlap of the π–systems of the two 
neighbouring bases.  
 
? permanent electrostatic effects, induced dipole attractions and solvophobic effects. 
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1.2.2 DNA in nanotechnology and supramolecular chemistry 
 
DNA has recently become one of the most attractive supramolecular scaffolds to 
produce nanoscaled entities and shows increasing importance in nanobiotechnology,[33, 34]  
e.g. to specifically connect nanoparticles, to create nanomechanical devices, and to construct 
protein arrays and nanowires.[32, 35-37] The specific bonding of DNA base pairs can be used to 
direct the assembly of structured materials which leads to a new field of DNA exploitation in 
nanotechnology. “The nucleic-acid ‘system’ that operates in terrestrial life is optimized 
(through evolution) chemistry incarnate. Why not use it to allow human being to sculpt 
something new, perhaps beautiful, perhaps useful, certainly unnatural,” Roald Hoffmann, in 
American Scientist, 1994. Two different types of nanotechnological constructions can be 
used: the ‘top-down’ system, where devices are made smaller (e.g. by using lithography), and 
the ‘bottom-up’ construction, where atoms or molecules are used to create the desired devices 
(e.g. by self-assembly). Single-stranded overhangs (termed “sticky ends”) can be used to 
direct the intermolecular associations of different DNA molecules. Figure 22 illustrates two 
double-helical strands with complementary overhangs which under appropriate conditions 
could cohere in a sequence–specific fashion and can be ligated.  
 
 
 
Figure 22: Sticky-ended cohesion.[38] 
 
The double helix is just a line, but a ‘line’ may be curved. In biological systems, DNA 
branched at the level of secondary structure is found. It displays symmetry that allows its 
branch point to migrate. That represents a simple way to design and to assemble synthetic 
DNA sequences that are stable as they lack the above mentioned symmetry. The structural 
DNA nanotechnology combines the two concepts of stable branched DNA molecules with 
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sticky-ended cohesion. An example of branched sticky-ended junction assembled as a group 
of four units to produce a quadrilateral is shown in figure 23. The sticky ends on the outside 
can be extended to form a lattice in two or tree dimensions by addition of further components. 
 
 
 
 
Figure 23: (a) Sticky-ended assembly of branched molecule, (b) A stick cube.[39] 
 
Synthetic branched DNA molecules with programmed sticky ends self assemble into 
desired structures. The construction of the first artificial DNA structure was a stick-cube 
(Figure 23) whose edges contained two turns of the DNA double helices. The structure 
consists of six cyclic interlocked single strands, each linked twice to its four neighbours. 
Since this famous example of Seeman, more complex polyhedra and constructions have been 
done like Knots and Borromean rings constructed with three intricately interlinked rings. 
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Structurally controlled crossover DNA motifs, called “DNA tiles” have been used as 
building blocks for the creation of one- and multi-dimensional nanostructures. For exemple, a 
DNA nanostructure[32] self-assembles into two distinct lattice forms: nanoribbons or two-
dimensional nanogrids. The 4 x 4 tile (figure24) contains four four-arm junctions oriented 
with a square cavity and pointing in four directions (N, S, E, W). It is composed of nine 
strands where one of them is participated in all four junctions.  
 
 
Figure 24: The 4 x 4 tile strand structure. 
 
Based on this structure, other versions of the 4 x 4 tile are prepared[33], assembled and 
visualised with AFM; e. g. a self-assembly of nanoribbons (figure 25). The 4 x 4 nanoribbons 
act, after metallization, as a scaffold for the production of highly conductive silver nanowires. 
 
 
 
Figure 25: Self-assembly of nanoribbons. 
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Figure 26: Oligonucleotides and 13-nm Au particles: DNA-induced assembly.  
 
Recently, by utilising these crossover DNA molecules, extended structures such as 
DNA-nanoparticles conjugates have been created to build a variety of two and three-
dimensional materials. DNA is used as a synthetically programmable assembler for nanoscale 
inorganic building blocks into functional materials. Both Au nanoparticles and DNA strands 
are mixed together, [33] and then using the molecular recognition properties associated with 
DNA to guide the assembly of those particles into extended structures (figure 26). 
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1.2.3 Porphyrins-DNA interactions 
1.2.3.1 Non-covalent interaction 
 
The DNA-binding interactions of 5,10,15,20-tetra(N-methylpyridinium-4-yl) 
porphyrin, denoted H2T4, and related cationic porphyrins with DNA have long been of 
interest due to the potential for therapeutic applications and the novel binding interactions. 
The exploration of porphyrins in intracellular media is in photodynamic therapy, for targeting 
diseased cells or viruses. Porphyrins act as a sensitizers, they absorb into the red end of the 
visible spectrum, at wavelengths that penetrate tissue efficiently. Cationic porphyrins, an 
amphiphilic molecule with good water soluble system, have a natural affinity for DNA. Fiel et 
al. initiated the studies and showed that cationic porphyrins like H2T4 can bind to DNA 
(figure 27). In vivo, cationic porphyrins enter cells via pinocytosis and accumulate in 
mitochondria. Because these same cations bind to telomeric DNA, they also act as inhibitors 
of telomerase, an enzyme which have an important influence on tumor longevity. 
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Figure 27: H2T4.[40, 41] 
 
Depending on the nature of the DNA and the porphyrin substrate, monomeric 
porphyrins can bind to DNA in multiple ways. Three major binding modes have been 
proposed for cationic porphyrin binding to DNA: intercalation and two types of outside 
binding. The first type is the outside binding involving both placement of porphyrin in the 
minor or major groove and electronic interaction with the phosphate backbone, and the 
second type is the stacking of the porphyrin along the DNA helix. The binding of porphyrins 
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to DNA is presumably stabilized by electronic interactions between the positively charged 
substituents on the porphyrin periphery and the negatively charged phosphate oxygen atom of 
the DNA backbone. In the case of intercalation, favorable aromatic –  stacking interactions 
between the porphyrin macrocycle and nucleic acid bases are also involved. Coulombic 
interactions, van der Waals’ forces, and hydrophobic effects provide for stability of the 
assemblies, while the pyridiniumyl substituents and axial ligands on metalated forms pose 
important steric constraints. Competitive binding studies involving DNA hairpin substrates 
reveal that the base composition, not the sequence, dictates the mode of binding. DNA 
sequences which are rich in guanine-cytosine (G≡C) base pairs support intercalative binding. 
Spectroscopic consequences in the Soret region include a strong bathochromic shift (Δλ ≥ 15 
nm), marked hypochromism (H ≥ 35%), and an induced circular dichroic (CD) signal with a 
negative amplitude due to the transferred chirality of the DNA onto the porphyrin. In contrast, 
DNA sequences that are rich in adenine-thymine (A=T) base pairs support external binding, 
in which case the Soret band undergoes a smaller bathochromic shift (Δλ ≤ 8 nm), shows 
weaker hypochromism (H ≤ 10%), and gives an induced CD signal with the opposite sign.  
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1.2.3.2 Covalent DNA-porphyrin conjugates 
 
To study the structure and the dynamics of nucleic acids, the use of molecular probes has 
attracted widespread attention. There are four known ways in which small molecules can bind 
DNA: intercalation, groove binding, electrostatic binding and capping. Unlike the first three 
non-covalent binding modes, the latter mode not only specifies the binding mode and the 
position of the molecule, but can stabilize the oligonucleotide through the π-π stacking 
interactions of the adjacent terminal base pairs. Capping is carried out by covalently linking a 
small molecule to the end of the DNA strand and is base pair specific. Berova et al.[42-45] 
worked on porphyrin-based molecular caps and explored the effect of capping on DNA 
structures. 
 
 
 
Figure 28: Tetraarylporphyrin attached to the cytosine via phosphate linker.[45] 
 
A non-charged hydrophilic tetraarylporphyrin is attached to the 5’ end of the self 
complementary oligonucleotide (ODN) where the porphyrin is coupled to the cytosine via 
phosphate linker (figure 28). By using CG sequences which are known to form stable Z-form 
structure at high salt concentration, they explored the possibility of following the B- to  
Z-DNA transition and to study the effect of a bulky porphyrin on the salt-induced B- to  
Z-DNA transition. The porphyrin chromophore allows the simultaneous detection of the B- to 
Z-DNA transition via the porphyrin Soret band circular dichroism exciton couplet signal 
around 420 nm and the oligonucleotide CD region below 300 nm (figure 29), at micromolar 
concentrations. 
a b 
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Figure 29: CD spectra of ~ 10 µM porphyrin–ODN a in 50 mM potassium phosphate buffer, 
(pH = 7.0 at different NaCl concentrations).On the left, the arrows show increasing amount of 
sodium chloride. On the right black line, with 0.0 M NaCl; grey line, with saturated NaCl; 
black dash-dotted line, with saturated NaCl and 3 mM nickel(II) chloride . 
 
 
Below 300 nm increasing amounts of salt induced a dramatic change in the CD 
spectrum which is a consequence of the conformational change from right-handed B-DNA to 
left-handed Z-DNA. Without NaCl, the duplex a exists in the B-DNA conformation, while in 
saturated NaCl solution it exists predominantly, but not completely, in the Z-DNA form. In 
addition, an exciton coupled CD can be observed in the porphyrin Soret band absorption 
region (around 420 nm) in a. Figure 30 shows how the Soret region of the CD spectrum of  
8-mer a sensitively reflects the change from B-DNA to Z-DNA.  
 
 
 
 
 
 
 
 
 
Introduction  53 
 
 
 
 
Figure 30: a) Schematic representation of the antiparallel duplex 1P with porphyrins serving 
as molecular caps. b) Diagram demonstrating the overlap of the porphyrin with a guanine–
adenine base pair.[42] 
 
 
Another example of an oligonucleotide duplex with noncanonical Watson-Crick 
guanine-adenine (G-A) base pairs by covalent linked terminal porphyrins, is shown in figure 
30. Berova and coworkers attached the same neutral hydrophilic tetraarylporphyrin to the  
5’ position of the 5’- GAGAGAGA - 3’ strand through a short and flexible phosphate linker. 
The CD of the porphyrin–d(GA)4 a shows a spectrum which is characteristic of a highly 
ordered structure with A-like features. Such characteristic CD spectrum is directly associated 
with an organized secondary structure in which the bases are close enough to interact with 
each other. Spectroscopie studies show the porphyrin-induced stabilization of the non-self-
complementary DNA sequence. Depending on environmental factors, Guanine–adenine 
repeat strands (d(GA)n) self-associate into parallel- and antiparallel stranded homoduplexes, 
but the porphyrin end-capping induce a highly ordered antiparallel duplex structure which is 
in contrast with the uncapping ODN. 
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DNA provides an ideal supramolecular scaffold for assembling porphyrins in defined 
structures[46, 47] which are capable of self-assembly given an appropriate connectivity to a 
specific nucleobase. Thus Endo and Majima have synthesized a tetraphenylporphyrin-based 
DNA-porphyrin conjugate with linkages between each meso-phenyl porphyrin group and the 
central phosphorus atom of a 10-mer strand of DNA. The spacing of the 10 bases in a 10-mer 
corresponds to one helical turn. They used a thiolate tether through a phosphoramidite linkage 
which reacted with a maleimide-substituted porphyrin to give two synthetic oligonucleotides: 
CGGCTpACTCC and GTGCTpAGCGG, where p denotes the position of the 
tetraphenylporphyrin linked to the phosphoramidite. Those DNA-porphyrin strands were then 
mixed with four equivalents of complementary 20-mer non-porphyrinic strands. They 
obtained a double-helical complex with two DNA-porphyrin strands linked to four 
complementary strands (figure 31).  
 
 
 
Figure 31: Four-DNA double-helix assembled structure containing two porphyrin derivatives. 
 
Two different porphyrins such as a free base (H2-Porph) and a Zn-porphyrin  
(Zn-Porph) that show different photochemical properties were incorporated into the DNA 
structure. The four double-helix assembled DNA structures containing the heterogeneous 
porphyrin dimer were constructed, and the arrangements of these porphyrins were 
programmed by the sequence of the complementary strand. Fluorescent lifetimes of the 
systems indicated a singlet transfer between the freebase and the zinc porphyrins within the 
one complex, which proves the possible incorporation of multiple and different porphyrin 
chromophores into DNA structures by using the appropriate sequence programming of the 
DNA strands. 
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1.3 Project 
1.3.1 Research  
 
The aims of this project is to explore the use of DNA as a supramolecular template to 
connect specific electrochemically and photophysically active molecules, namely porphyrins, 
and place the units in a predetermined orientation via formation of the double stranded helix 
of DNA. This new arrangement, which can be termed DNA Architectonics, is designed to 
function as a scaffold to create a multifunctional molecule on the nanometre scale. 
Nucleotides will be substituted with different porphyrins, which are promising candidates for 
a variety of different applications due to their central metal binding site, their relative ease of 
functionalisation, and their physicochemical properties. The porphyrin units will be connected 
through the backbone of the DNA (Scheme 3), which is independent of the porphyrin 
structure. The changes in the porphyrin structure should not alter the base pairing abilities of 
the DNA and the capacity to form helical superstructures to provide the spatial arrangement. 
The reason is that the modification at the 5-position of thymine will point outwards of the 
DNA, and the porphyrin will be located in the major groove.  
 
 
Figure 32: Schematic representation of the DNA-as-scaffold concept. 
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The order of the individual units is programmable via the DNA sequence; changing 
the sequence allows shuffling of the units without the need to redesign the building blocks. 
There seems to be virtually no limitation in the diversity of incorporated porphyrins, because 
one specific nucleobase can be substituted with variable porphyrins. The relative distance of 
the porphyrins can be varied easily by introducing natural nucleotides without porphyrin 
substituents between the modified nucleobases which is a good compromise to prevent 
porphyrins stacking, and allows alteration of the electronic interactions between the 
porphyrins. The tertiary structure of dsDNA (e.g. A, B, Z helix, see chapter 1) is highly 
dependent on the experimental conditions (pH, ionic strength, solvent, base sequence) 
allowing changes in the spatial arrangement to be made while maintaining the porphyrin 
structure and sequence. 
 
 
 
Figure 33: Schematic representation of the modified duplexes and superposition of the 
calculated structures of DNA and porphyrin-DNA. 
 
To date, procedures where porphyrins have been coupled to the nucleobase and 
successfully been incorporated into DNA according to our proposed route, have not been 
reported; meaning that this project is unique in its design. 
Pyrimidine-5-substituents and 7-deazapurine-7-substituents are known to be located in 
the major groove of dsDNA and do not destabilise the double helical structure. Chromophores 
for FRET analysis,[48, 49] functional groups derived from amino acid sidechains[50-53] and  
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4d-transition metal complexes[54-56] were successfully incorporated into DNA, using solid 
phase synthesis or enzymatic synthesis (PCR).[57, 58] These studies indicate that the proposed 
project is feasible, provided that the following requirements, which are crucial for success, are 
fulfilled.[54] Several aspects of the obtained porphyrinyl-DNA will be studied: electrochemical 
and photophysical properties, energy and/or electron transfer within the individual porphyrin 
units, mass spectrometry, solubility and structure of the porphyrinyl-DNA in organic solvents, 
and possibly other DNA-ligand interactions in the presence of the porphyrins. 
 
 
1.3.2 Plan of the synthetic route 
 
In order to demonstrate the concepts feasibility, several steps (Scheme 3) of the project 
have to be established: (i) the synthesis of the porphyrin with the appropriate substituents,  
(ii) protection the nucleoside, which is here the 5-iodouracile, with the right protecting group, 
(iii) synthesis of the porphyrin substituted nucleotides via Sonogashira coupling, and 
convertion to the phosphoramidite building blocks, (iv) and finally incorporation of the 
building blocks into DNA starting from small oligomers to longer oligomers with different 
structures and number of porphyrins.  
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Scheme 3: Synthesis of the building blocks. 
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2 Syntheses 
2.1 Porphyrin synthesis 
2.1.1 Methodology 
 
The method used in this work allows the synthesis of porphyrins bearing different 
meso substituents. The dipyrromethane provides the starting point for each porphyrin. The 
desired porphyrin has been prepared by statistical reaction of a dipyrromethane and two 
different aldehydes. In each case, the resulting three porphyrins are then separated 
chromatographically. The synthesis starts with the deprotection of the carboxylic acid by 
hydrogenolysis followed by decarboxylation in acidic condition (scheme 4). The individual 
steps i and ii were not concerted. The dipyrromethane was first condensed with two different 
aldehydes to give the dicarbinol which condensed with a second dipyrromethane to give the 
porphyrinogen. Finally, a quinone (DDQ) is added to oxidize the porphyrinogen to the 
porphyrin in yield of ~10%. The low yield can be explained by the polymerisation of the 
tetrapyrrole intermediate formed during the reaction, which results in black polymeric side 
products. 
 
 
 
R' =R'' = OH R1 = C2H4CO2CH3,
C6H13
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Scheme 4: Mechanism of the porphyrin synthesis. 
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2.1.2 Synthetic route 
 
Four structurally different diphenyl porphyrins as target compounds were chosen, 
which have one alkynyl phenyl substituent for the attachment to the uracil base.[59, 60]  
One porphyrin, the diphenyl porphyrin 22, is bearing ester side chains, which can be 
hydrolysed to render the porphyrins soluble in water. The two other porphyrins 24 and 25 
have alkyl chains, thus ensuring good solubility in organic solvents. The porphyrin 23 has a 
phosphonate group on the phenyl substituent. The phosphonic acid, obtained after 
deprotection, could be attached to oxide surfaces such as TiO2.[61] 
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Figure 34: The four structurally different diphenyl porphyrins 22-25. 
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2.1.2.1 Porphyrin components 
 
For the different porphyrins syntheses, several compounds as starting material were 
required. To introduce an alkynyl phenyl substituent on the porphyrin, we synthesised the  
4-(3-hydroxy-3-methylbut-1-ynyl)benzaldehyde 3.[62] The ethynyl moiety is protected with 
propan-2-ol for the porphyrin synthesis; this protecting group introduces a polarity in the 
porphyrin structure which leads to a better purification. Then, it will be removed after the 
porphyrin synthesis under basic conditions. Normally the most common protecting group, 
used for the porphyrin synthesis, is the TMS group. But in our case, the TMS group will have 
the same rf-value on the TLC plate as the tert-butyl group, and the unsymmetrical porphyrin 
won’t be isolated from the two other symmetric ones. 
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(a) K2CO3, CuI, PPh3, Pd/C 10%, DME/H2O, 87%. 
 
Scheme 5: The synthesis of 4-(3-hydroxy-3-methylbut-1-ynyl)benzaldehyde 3. 
 
The cross-coupling of p-bromobenzaldehyde to 2-methyl-3-butyn-2-ol was achieved 
in the presence of a catalytic amount of palladium on activated charcoal, copper(I) iodide, 
triphenylphosphine and potassium carbonate. The reaction mixture was refluxed at 80°C for 
16h and the coupled product was obtained as yellow oil with good yield 87% after column 
chromatography. 
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(a) ClC(CH3)3, AlCl3, toluene; (b) NBS, (PhCO)2O2, CCl4; (c) (CH2)6N4, c.HCl 37%, MeOH/H2O. 
 
Scheme 6: Synthesis of 3’,5’-di-tert.butylbenzaldehyde 7. 
 
The 3,5-di-tert-butyltoluene was prepared by Friedel–Crafts tert-butylation reaction of 
toluene using tert-butyl chloride in the presence of aluminium chloride as catalyst.[63-65] 
Aluminium trichloride (4%) was added in portions over a period of 8h, to a rapidly stirred 
solution of toluene and 3’,5’-di-tert-butyl chloride. This is an interesting reaction since the 
methyl group activates the ortho and para sites of toluene. The isolation of the meta 
functionalised product indicates the reversibility of the reaction and that the di-tert-butylation 
of the meta isomer is presumably slower than that of the first formed ortho or para isomers. 
After distillation, the obtained 3,5-di-tert-butyltoluene was brominated using  
N-bromosuccinimide and AIBN ,to afford the bromomethyl derivate.3,5-Di-tert-butyl-
benzaldehyde was prepared from 3,5-di-tert-butyl(bromomethyl)benzene by oxidation with 
hexamethylenetetramine.  
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The synthesis of the phosphonate derivate 10 is shown in scheme 7.[66] 
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(a) (EtO)2PHO, Net3, Pd(PPh3)4, 95°C, 36h, 10%; (b) 15% H2SO4 on silica, 24h, RT., 54%. 
 
Scheme 7: diethyl (3-carbonylphenyl)phosphonate synthesis 10. 
 
The commercially available 2-(3-bromophenyl)-1,3-dioxolane, which provided an 
ideal starting material, was reacted with diethylphosphonate using palladium as catalyst in a 
standard Arbusov reaction. Then the aldehyde was unmasked under acidic conditions to give 
the phosphonate derivate 10. 
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Two different dipyrromethane were synthesised[64, 67, 68] as it is shown in scheme 8. 
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Scheme 8: The synthesis of two different Dipyrromethane 20 and 21. 
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1-iodohexane and 2, 4-pentadione were treated with potassium carbonate in acetone, 
to give the 3-hexyl-2,4-diketone 15 which could be isolated by distillation. This 3-hexyl- 
2,4-diketone 15 was then reacted with the oxime 17 and Zinc in acetic acid to give the hexyl 
substituted pyrrol 19. The oxime 17 was readily synthesised from benzoyl acetoacetate by 
treatment with sodium nitrite in water. α-Acetylation of the hexyl-derived pyrrole was 
achieved by treatment with Lead acetate in acetic acid. Dimerisation of this acetylated pyrrole 
was done by refluxing the compound in hydrochloric acid and methanol to obtain 
dipyrromethane 21. According to the same procedure, we obtained the dipyrromethane  
20 [69, 70] by using the acryl acid ester 12 instead of 1-iodohexane 13. 
 
 
2.1.2.2 Porphyrin synthesis 
 
The Zinc metallated porphyrins ZnDPP (22-25) [67, 71] were obtained from the two 
different dipyrromethane (20, 21), the benzaldehyde derivate (26, 7, 10) and the alkynyl 
benzaldehyde 3. Generally, 2 equivalents of the appropriate dipyrromethane (20 or 21),  
1 equivalent of alkynyl benzaldehyde 3, and 1 equivalent of the appropriate benzaldehyde 
derivate (26 or 7 or 10) were used. But the use of 1.5 equivalents of the protected alkynyl 
benzaldehyde[62] 3 increased the yield of the desired porphyrin. The yield of the porphyrin 
synthesis is increased by using a 3’,5’-di-tert-butyl-phenyl side group instead of the 
benzaldehyde. 
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Scheme 9: Synthesis of the different diphenyl porphyrins 22-25. 
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The ZnDPP 22 was synthesised from the corresponding hexyl-derivatised substituted 
pyrrole 20, the synthesis is shown in Scheme 9. Removal of the benzoyl protecting group 
from dipyrromethane 20 by hydrogenolysis gave the bis α-acid. The decarboxylation of the 
dipyrromethane was carried out by treatment with concentrated TFA, giving the α-deprotected 
but unstable dipyrromethane, which was used immediately without further purification.  
The unsymmetrical porphyrin 22 was one of three possible products and was synthesised via a 
statistical procedure (the other two products being the symmetrical di-phenyl and the 
symmetrical di- protected ethynyl porphyrins). The reaction sequence began with an acid 
catalysed condensation of two equivalents of the α-free dipyrromethane 20, with one 
equivalent of the benzaldehyde 26, and 1.5 equivalent of protected alkynyl benzaldehyde 3. 
Subsequent DDQ oxidation of the ensuing porphyrinogen gave a statistical mixture of 
symmetrical and unsymmetrical porphyrins. In each case, the unsymmetrical porphyrin was 
one of the three possible products. The desired porphyrin 22 could then be isolated, after 
several column chromatographies on silica gel. The deprotection of the acetylene group with 
sodium methoxide, and the final metalation with zinc acetate gave the acetylene Zinc 
porphyrin complex ZnDPP(AcO)2. The DDP 22 was obtained in 4% yield when the ester 
chain was not hydrolysed by the sodium methoxyde.  
According to the same procedure, the DDP 24 was synthesised from 2 equivalents of 
dipyrromethane 21, one equivalent of the benzaldehyde 26, and 1.5 equivalent of protected 
alkynyl benzaldehyde 3. We obtained the DDP 24 in low yield 5%, but when we used the 
tert-butylbenzaldehyde 7 instead of the benzaldehyde 26, we increased the yield of the DDP 
25 to 8%.  
The DPP 23 was obtained using the same procedure from 2 equivalents of dipyrromethane 21, 
one equivalent of the phosphonate benzaldehyde 10, and 1.5 equivalent of protected alkynyl 
benzaldehyde 3 in good yield (9%). 
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2.2 Nucleotide Synthesis 
 
Thymidine and its demethylated derivative 2’-deoxy-uracile represent the ideal 
nucleobase for this study. In contrast to the other bases, it does not require the use of 
protecting groups. The 5’-Iodo-uracil is commercially available. Selective TBDMS and DMT 
protections of the deoxyribose for the 5’- or 3’- positions were used for the ribose as shown in 
scheme 10.[72-74] First; we chose the TBDMS protecting group to protect the 5’ or 3’ position 
for possible further dimerisation of the porphyrin-nucleoside in solution. The synthesis of 5’-
TBDMS-dU 27 was carried out by selective protection of the 5’ position. The protection was 
achieved with 1.5 equivalent of TBDMS-OTf and Imidazole in DMF for 1 hour at 0°C 
followed by an additional hour at ambient temperature. To obtain the 3’-TBDMS-dU 29, we 
protected the 5’- and the 3’- position of the 5-Iodo-Uracil with 2 equivalents of TBDMS-OTf 
in presence of two equivalents of Imidazole in dry DMF, and doubled reaction time to four 
hours. In both reactions, the products were obtained in high yields after usual workup and 
recrystallisation in CHCl3-Hexane. The doubly protected 3’,5’-di-TBDMS-dU 28 can be 
deprotected selectively at the 5’- position with acetic acid in H2O/THF mixture at 40°C for 
three days.  
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Scheme 10: Selective protection of 5-Iodo-Uracil. 
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Then, we chose the DMT-protection to be compatible with DNA synthesis. This 
protecting group react selectively with the 5’-OH and is easily removed by acidic treatment. 
The nucleoside was stirred with 1.3 equivalent of dimethoxytrityl chloride in dry pyridine 
overnight, followed by a hydrogenocarbonate treatment to avoid a significant amount of 
detritylation. We obtained the 5’-O-protected Iodo-uracil 30 in good yield. 
The same strategy for the protection deprotection can also be applied to the porphyrin-
nucleoside but we obtained lower yield. The protection of the nucleobase before the coupling 
reaction gave higher yields compared to the protection of the porphyrin-nucleoside. 
We found that TBDMS or DMT-protection of the hydroxyl groups on the sugar moiety did 
not affect the efficiency of the coupling, thus we used pre-protected 5-I-dU for the coupling 
with the alkynyl porphyrin. 
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2.3 Synthesis of the Porphyrin Building Blocks 
2.3.1 Methodology 
 
Using a Sonogashira coupling[51, 55] with acetylene porphyrins (22-25) and 2’-
deoxyuridine (27, 29, 30) lead to the desired building blocks. To demonstrate the possible 
diversity, several different structural porphyrins (chapter 2.1.5) can be incorporated into DNA 
in solution or using solid support by phosphoramidite chemistry.  
 
2.3.2 Results 
 
The coupling of the porphyrin to the nucleobase to obtain the building blocks 31 to 38 
was performed using Sonogashira coupling by adapting a published procedure. 
R'' R''
R'' R''
Zn
R'''
R'''
R' = DMT, TBDMS
R'' = C2H4CO2CH3, C6H13
R''' = H, C(CH3)3, P(O)(OC2H5)2
O
OH
NR'O
HN
O
O
IR1 - I =
R2 =
L = P
PdL4
2 L
Pd I
L
R1
L
Pd L
R1
L
R'
Pd L
R1
L
R2
R2 R1
Cu R2
CuI
Et3NH+ I-
Et3NH+ I- R2
H R2Et3N
R1 - I
Ox. RedRed. Elim.
Trans-
metallationtrans/cis
Isomerisation
 
Scheme 11: Sonogashira coupling mechanism.  
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The coupling, between the 5-Iodo-uracile and the porphyrin acetylene groups was 
achieved using tetrakis(triphenylphosphine)palladium (0) as catalyst and iodide copper (I) as 
co-catalyst. Triethylamine was used as a base to deprotonate the acetylene group. 
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Scheme 12: Synthesis of the diphenyl porphyrin substituted TBDMS nucleosides. 
 
Using 3 equivalents of the nucleoside, and increasing the quantity of palladium 
catalyst to 40% with respect to the nucleoside, increased the yield substantially. The coupling 
reaction was monitored by TLC, and products were identified by MALDI-TOF MS analysis 
and NMR spectroscopy. The reaction time varied from two to four days, and we obtained the 
porphyrin-nucleoside (31-38) with 30%-98% yield. 
With TBDMS protection, the impurities from the residual catalyst were not always removed 
by purification on silica gel and recrystallisation. For the products 33 and 34, we needed a 
final purification on Lipophilic Sephadex LH20 using CH2Cl2/MeOH 1:1 as eluent to give 
pure material, which can be proved by 1H NMR spectroscopy. The impurities, detected by a 
multiplet at 7 ppm, disappeared. Then, we could use these building blocks 33 and 34 to 
synthesise the dimer in solution via phosphoramidite chemistry, as it is shown in scheme 15. 
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(a) Pd(PPh3)4,CuI, NEt3, DMF, rt , 24h, 43-98%. 
 
Scheme 13: Synthesis of the diphenyl porphyrin substituted DMT nucleosides. 
 
With the DMT-protection, purification on silica gel and recrystallisation gave the pure 
product 35-38, which will further be used to synthesis modified DNA on solid support 
(chapter 4). We obtained the building block with alkyl chain 35 and 37 in good yield  
(97-98%) compared to the one  with ester chain 36, where the coupling yield achieved was 
only 43%. 
 
2.4 Synthesis of the Phosphoramidite Building Blocks 
2.4.1 Methodology 
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Scheme 14: Mechanism of the phosphoramidite synthesis. 
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The alcohol group is activated by the DIEA base; the thus obtained nucleophile attacks 
the CEP-Cl phosphate followed by chloride elimination and ammonium chloride formation. 
The phosphoramidite obtained is very sensitive to oxygen; and readily forms the inactive 
phosphine oxide. 
 
2.4.2 Results 
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40 R = C2H4CO2Me, R' = H, R" = DMT
41 R = C6H13, R' = H, R" = DMT
42 R = C6H13, R' = ter t.butyl, R" = DMT
33 R = C2H4CO2Me, R' = H, R" = TBDMS
19 R = C2H4CO2Me, R' = H, R" = DMT
35 R = C6H13, R' = H, R" = DMT
37 R = C6H13, R' = ter t .butyl, R" = DMT
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(a) N(C3H6)3, CEP-Cl, CH2Cl2, 2h30, 70-98%. 
 
Scheme 15: Phosphoramidite synthesis. 
 
Due to the phosphine sensitivity, inert atmosphere techniques were applied during all the 
phosphoramidite manipulation; i.e. synthesis, purification and utilisation.  
The porphyrin-substituted nucleotides (19, 33, 35, and 37) were converted to the 
phosphoramidite (39-42) by treatment with CEP-Chloride and DIEA. The conversion into the 
phosphoramidite could be achieved up to 98% yield. The phosphoramidite was characterized 
by NMR (31P) which shows a peak at 145.5 ppm. 
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3 Porphyrin-Substituted Dinucleotides 
The next step of the project was the dinucleotide synthesis with two porphyrin building 
blocks. The building blocks were dimerised to the corresponding homo- and hetero-porphyrin 
dinucleotides. The synthesis was performed in solution and/or on solid phase in order to 
compare the reactivity of the phosphoramidite building blocks under both conditions. We then 
studied the formation of duplexes with the complementary diadenosine using spectroscopy 
methods. 
 
3.1 Modified Dinucleotides Synthesis 
3.1.1 Dimerisation in solution 
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(a) 1H-tetrazole, DCM, 2h. 
 
Scheme 16: Synthesis of the dimer 44 in solution. 
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 The 5’-TBDMS protected phosphoramidite building block was obtained using the 
standard phosphorylation procedure described in chapter 2.4. We found that our 
phosphoramidite building block is more sensitive to oxidation, compared to a sole 
phosphoramidite nucleobase, due to the presence of the porphyrin as a photosensitiser.[75]  
In the presence of both light and oxygen, the phosphoramidite is rapidly converted to the 
inactive phosphate. We therefore investigated the use of borane as protecting group. After the 
formation of the phosphoramidite 39, 3.5 equivalents of borane were added for in-situ 
protection. The reaction mixture was stirred overnight under inert atmosphere and in the dark. 
A chromatography column under argon with ethyl acetate gave the desired product 43 in good 
yield (63%) and was characterised by NMR spectroscopy and Maldi-TOF spectrometry.  
The borane, acting as a Lewis acid, formed a dative bond with phosphorus to prevent the 
phosphine oxidation. The building block 43 was dissolved in CH2Cl2 and transferred via 
Teflon canula into a CH2Cl2 solution of the corresponding ZnDPP substituted porphyrinyl 
deoxyuridine 34. This solution contained 5 equivalents of 1H-Tetrazole as activating agent 
for the coupling reaction. The desired dimer 44 was not formed, and we suppose that in this 
case the dative bond was to strong and was not cleaved during the process, thus preventing 
activation and coupling to occur. Then, the dimer synthesis was performed using a different 
activating agent and two different building blocks. 
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(a) N-(phenyl)imidazolium triflate, DCM, 2h; (b) tBuOOH, 15 min. 
 
Scheme 17: Synthesis of the dimer 46 in solution. 
 
The 5’-TBDMS protected phosphoramidite building block 45 was obtained using the 
same standard phosphorylation procedure. For the solution-phase synthesis of the hetero-
porphyrin dimers, the phosphoramidite 45 was used without any further purification, and 
transferred via Teflon canula into a CH2Cl2 solution of the ZnDPP substituted 3’-TBDMS 
porphyrinyl deoxyuridines. The solution, containing 1.5 equivalents of N-(phenyl)- 
imidazolium triflate as activating agent[76] for the coupling reaction, was stirred for two hours. 
Then, the phosphonate was oxidised by addition of tBuOOH and stirring the reaction mixture 
continued for 15 min. After work up with NaHCO3/Na2S2O3 (1:1, v/v), the product was 
isolated by successive chromatography using preparative TLC (CH2Cl2/MeOH, 10:1) and 
then by sephadex column LH20 (CH2Cl2/MeOH, 5:1) to remove side products. The purified 
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dinucleotide was finally dissolved with ammonium hydroxide (25%) in methanol (1:3, v/v) 
and stirred overnight to remove the β-cyanoethoxy group. The desired hetero-porphyrin 
dinucleotide 46 was obtained in 5% yield. 
 
 
3.1.2 Dimerisation on solid phase 
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Scheme 18: Synthesis of the dimer 47 on solid support. 
 
In order to compare the phosphoramidite reactivity, we dimerised the 5’-DMT 
protected nucleotide 40 under solid phase conditions. The dimer synthesis was achieved on a 
universal solid support II (15 µmol) and was performed following a modified standard 
procedure for deprotection, oxidation, and capping in an automated DNA synthesizer. This 
procedure is described in chapter 4. The coupling of the building block to the solid support 
and the formation of the internucleosidic linkage were done manually outside the synthesizer. 
First, the solid support was washed with the activator solution (1H-Tetrazole in acetonitrile), 
and then the first building block (15 mM in CH2Cl2) was passed through the column with 1ml 
activator for 20 min until the synthesis was completed.  
The DMT-protecting group was left on the 5’-position of the second building block for 
solubility reasons. The dinucleotide was cleaved from the solid support and the phosphate 
group was deprotected with ammonium hydroxide (25%) in methanol (1:3, v/v) overnight at 
room temperature.  
The homo-porphyrin dinucleotide was purified by LH20 sephadex column 
(CH2Cl2/MeOH, 1:1) and obtained as a mixed free base and metallated dimer  
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5’-DMTdUZnDPPdUDPP, because the first Zn metallated porphyrin was demetallated during the 
DMT deprotection under acid condition (3% trichloroacetic acid in CH2Cl2). The dimer 47 
was re-metallated with zinc acetate in CHCl3/MeOH (1:3, v/v), followed by a final Sephadex 
column to obtain the pure d(UZnDPP)2 in less than 1 mg. The low yield cannot be rationalised 
because the trityl monitoring showed a coupling efficiency of ~90%.  
 
 
3.2 Syntheses of the Adenosine dimer 
 
In this project, it is important for the modified oligonucleosides to retain the ability to 
form duplexes with the complementary natural nucleic acid. To study the interaction between 
the porphyrin-modified dimer with the complementary base, we synthesised the adenosine 
dimer. The adenosine dimer was prepared using a standard procedure. The phosphotriester 
synthesis is shown in the scheme 19.  
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(a) Dioxane, pyridine, 1h, rt. 
 
Scheme 19: Synthesis of the phosphotriester 48.  
 
A solution of 2-Chlorophenyldichloridate in dioxane was added dropwise to a solution 
containing 1-hydroxy-6-methyl-benzotriazotes and pyridine in dioxane. The reaction mixture 
was stirred for 1h and the pyridinium chloride formed was filtered off under argon. A 0.2 M 
stock solution of phosphorylating agent 48 was obtained by this procedure. The chemical 
synthesis of nucleosides via the phosphotriester 48 implies the preparation of appropriately 
protected building blocks.  
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(a) Benzoylchloride, (CH3)3SiCl, pyridine, 44 %; (b) DMTrCl, TEA, rt, 24 h, 78 %, (c) 
Phosphorylating agent, pyridine, 15 min, rt; (d) compound 22, pyridine, 1h, rt, 87 %; (e) 1 
CCl2C(O)2H in DCM, 10 min, 57 %; (f) Syn-2-pyridine-2-calboxaldoxime, Tetramethylguanidine, 
pyridine, 20h at 25°C; (g) NH3 32 %, 2h at 50°C. 
 
Scheme 20: Synthesis of the adenosine dimer 53. 
 
The benzoylation of the amine position of the adenosine with benzoylchloride and 
trimethylchlorosilane in pyridine gave the 6N-benzoyl adenosine 50. The 5’-OH- position was 
protected with dimethoxytrityl chloride in pyridine and gave the 5’-DMT-6N-benzoyl 
adenosine 51. The coupling reaction in dioxane between the protected adenosine 51 and the 
partly protected nucleoside component 50 was performed using the phosphorylating agent 48, 
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which gave the protected dimer 52 in 87% yield. The DMT was cleaved with dichloroacetic 
acid in DCM, the chlorophenyl group could be cleaved in presence of syn-2-pyridine-2-
calboxaldoxime and tetramethylguanidine. The adenosine dimer 53 was obtained in 80% 
yield after a final deprotection of the benzoyl group in presence of ammonia and purification 
by RP-HPLC. 
 
 
3.3 Duplex Formation (or spectroscopy analysis) 
 
The Uv-vis absorption spectra of the dinucleotides are shown in figure 35 (straight 
lines), together with the calculated spectra obtained from a superposition of the individual 
building blocks (dotted lines). The data are compiled in table 1. It should be noted that an 
accurate measurement of the extinction coefficients of 47 was not possible due to the low 
amount of material obtained; however, from the absorbance we estimate the solution to be 
around 10-6 M in 47. A comparison of the calculated and measured spectra reveals that the 
absorption maxima of the dinucleotides do not exactly match with the calculated spectra, thus 
electronic interactions between the chromophores occur. The strength of the interaction is 
highly dependent on the structure of the porphyrins in the dimers. The homo-porphyrin 
dinucleotide 46a,[77] synthesised in solution, was added to this study. The dimer is substituted 
by a tetraphenylporphyrin (TPP). Slight blue shifts are observed in the case of 46a (Δλ ~1 to  
2 nm). The steric hindrance due to the meso-phenyl groups obviously does not allow the 
porphyrin cores to approach close enough to induce strong electronic coupling. The mixed 
dimer 46b shows a spectrum which differs greatly from the calculated spectrum of 
dUZnTPPdUZnDPP: the absorbance seems to be dominated by the electronic properties of the 
TPP part, and small red shifts for the B-band and Q-band absorptions are observed. In the 
DPP homodinucleotide 47, the B-band absorption at 419 nm is marginally shifted by about 3 
nm to lower energy, but in the Q-band region an additional peak at 629 nm is observed. This 
additional absorption maximum is not due to incomplete metallation, because in the mixed 
free base–zinc dinucleotide originally isolated three additional weak maxima at 648, 711 and 
740 nm are visible (data not shown), which are absent in 47. Also, the free base DPP does not 
exhibit any absorbance in this region.[78] 
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Figure 35: Uv-Vis absorption spectra of the dinucleotides 46 and 47 (solid lines), the 
duplexes with the complementary d(A)2 (dashed lines), and of the calculated spectra of the 
dimers (dotted lines). The measurements were performed in CHCl3 solutions (10-6 M). 
 
 
In order to check the interaction with the complementary strand, a saturated 
methanolic solution of the complementary diadenosine 53 was added to the porphyrin dimer 
solution (1.5 ml). A titration from 10 µl to 100 µl by ten fractions was done. The absorption 
changed gradually until 60 µl were added, then the maxima intensity decreased due to the 
dilution. The spectra of the mixture after addition of 60 µl are represented in figure 35 
(dashed line). 
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In the case of 46a, the extinction coefficients slightly increased, but again the shifts of 
the absorption maxima hardly changed. The dA2-dUZnTPPdUZnDPP duplex show a large shift in 
the B-band and the Q-band regions and the values for λmax are in-between those of 46b and 
47. The titration experiment with 47 resulted in no change of the spectrum. Since 47 was not 
soluble in pure CHCl3 unlike 46a and 46b, a minimum of 10% of methanol was necessary to 
solubilise 47. Thus, the duplex formation with d(A)2 was suppressed due to the high content 
of the protic solvent which normally destabilises hydrogen bonded systems.  
In the dinucleotides, the two chromophores may approach sufficiently close to show 
electronic interactions, which are stronger in the case of the sterically less hindered DPP 
derivatives 46b and 47. Upon formation of the helical duplex d(A)2-46b, the porphyrins might 
be rotated away from each other, and the weaker electronic coupling results in an overall blue 
shift of the absorbance of the dimer. However, to determine the exact nature of the 
interactions more spectroscopic investigations will be necessary. In the case of d(A)2-46a, no 
significant changes are observed. 
 
 
 B-band Q-bands 
46a 427 (5.96) 556 (4.65) 598 (4.24) 
 
d(A)2-46a 428 (6.01) 558 (4.81) 598 (4.40) 
 
d(UZnTPP)2 calcd. 428 (5.93) 559 (4.67) 598 (4.18) 
 
46b 427 (5.96) 555 (4.65) 598 (4.24)  
d(A)2-46b 418 (6.01) 546 (4.81) 578 (4.40)  
dUZnTPPdUZnDPP calcd. 426 (5.93) 551 (4.67) 597 (4.18)  
47 419 546 577 (sh) 629 
d(UZnDPP)2 calcd. 416 543 577  
 
Table 1: Absorption maxima λmax (log ε) of the dinucleotides, the duplexes with d(A)2, and of 
the calculated spectra obtained by addition of the building blocks. Measurements were 
performed in CHCl3 (10-6 M, 25°C). 
 
In the MALDI-TOF mass spectrometer, irradiation with the laser induced photolytic 
fragmentation of the dinucleotides, probably due to radicals generated from the photoexcited 
state of the porphyrins. We had previously observed cleavage of functional groups and atom 
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transfer in MALDI-TOF MS.[79] Suppression of this fragmentation could be achieved to some 
extent by varying the matrix use,[80] and most useful proved to be a combination of dihydroxy 
acetophenone together with p-nitro aniline. When the dinucleotides are mixed with an excess 
(50 equivalents) of the complementary d(A)2, formation of the duplex is also observed. For 
47, the complexation was much less obvious, and d(A)2-53 displayed m/z peaks 
corresponding to multiple salt adducts.  
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4 Tri- and tetranucleotide porphyrin arrays 
 
The next step was the incorporation of porphyrin substituted nucleotides into 
tetranucleotides using phosphoramidite chemistry on solid support in a DNA synthesiser. 
Both diphenyl and tetraphenyl porphyrin nucleosides were used as building blocks to 
introduce chirality into the porphyrinic arrays. We synthesised a trinucleotide in order to 
compare the reactivity of the diporphyrin arrays with the individual porphyrins. Using 
spectroscopic methods, we studied the duplex formation with the complementary tetra-
adenosine. Because no interaction between the porphyrin arrays and the complementary 
strands were evident, we used the PNA as neutral complementary strand to obtain more 
information on possible duplex formation. 
 
4.1 Methodology 
 
The predominant method for oligonucleotide synthesis nowadays is the 
phosphoramidite approach introduced by Beaucage and Caruthers.[81] The synthesis is 
performed on a solid phase like glass with controlled pore width (CPG) and starts with the  
5´-end deprotection of the CPG-bound nucleoside (scheme 21). The 5’-O-positions of the 
phosphoramidite building blocks are usually protected by the acid-labile 4,4’-dimethoxytrityl 
group, which was introduced in 1962 by Khorama and co-workers, and which allows a 
convenient optical in-line monitoring of the coupling efficiencies. The generated free 
hydroxyl group reacts with the 3´-phosphoramidite of the following nucleoside which has to 
be activated with 1H-tetrazole for a smooth and fast reaction. Remaining hydroxyl groups are 
capped to prevent elongation of failure strands. The resulting dinucleoside phosphite is 
oxidized to the corresponding phosphate with a mixture of iodine in water, and the cycle starts 
again. During the synthesis, the porphyrin building block is introduced instead of one of the 
unmodified base with increasing the coupling time to 10 min. At the end of the synthesis, 
ammonia is used to release the product from the solid support and to deprotect the exocyclic 
amino groups of the nucleobases. Generally, the nucleophilic NH2 groups of the adenine, 
guanine and cytosine nucleosides are masked by acylation. Up to date, optimization of the 
phosphoramidite approach led to the synthesis of oligonucleotides with coupling times lower 
than one minute and coupling efficiencies higher than 99% per base for DNA. Regarding the 
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modular system of this synthetic procedure, the covalent introduction of fluorescent groups at 
specific positions of any DNA sequence is easily performed. 
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Scheme 21: Solid support modified DNA synthesis.[82] 
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4.2 Synthesis of the tri- and tetranucleotide 
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Scheme 22: Solid phase synthesis of tri- and tetranucleotide porphyrin arrays with M = H, Zn. 
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Scheme 23: Reference porphyrins with M = H, Zn. 
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The two phosphoramidite building blocks 42 and 45, obtained from the DMT-
protected porphyrin nucleotides,[77, 78] were used for both the tri- and tetranucleotide 
synthesis. DCM solutions (20 mM) of the building blocks were prepared and used for the 
synthesis of the porphyrin-oligonucleotides 54 to 58 in an automated DNA synthesiser in 
standard mode (trityl on) on a 15 μmol scale; the coupling time for the modified building 
blocks was increased to 15 minutes. This method allowed the synthesis of chiral homo- and 
heteroporphyrin tetramers. The incorporation of the two successive porphyrins introduced 
chirality into the arrays through the DNA’s ribose moiety without the need of enantioselective 
synthesis. Cleavage from the solid support was achieved with a mixture of 25% ammonium 
hydroxide and methanol at 40°C over night. Due to the low solubility of 54, 55 and 57 in this 
solvent mixture, a second treatment of the solid support was necessary using 25% ammonium 
hydroxide and dioxane 1:1 at 40°C over night. The crude products were purified on lipophilic 
sephadex (LH 20, DCM-MeOH 1:1). The yields of the final products as free-base porphyrins 
H2-54 to H2-58 were in the range of 30 to 45%. The products were characterised by MALDI-
ToF mass spectrometry (figure 36) which showed the expected m/z peaks for porphyrin arrays 
for the diporphyrins H2-54 to H2-56. The porphyrin arrays are initially isolated in the free 
base form. Remetallation of the porphyrin arrays to give the zinc derivatives Zn-54 to Zn-58 
was performed using the standard methods for porphyrin metallation with zinc acetate in 
DCM-methanol.[78] Excess zinc salts were removed on a second lipophilic sephadex column.  
 
 
 
 
Figure 36: Maldi-Tof mass spectra of the free-base tetranucleotides 54-56. 
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To gain insight into the influence of the porphyrin substitution on the structure and the 
stability of the modified DNA, we have performed absorption, emission, and CD 
spectroscopy. These techniques were also used to determine the duplex formation. The 
absorbance and emission spectra were determined using chloroform solutions of 2.5×10-6 M 
and 2.3×10-8 M concentration, respectively. The concentrations used for the circular 
dichroism spectroscopy were variable and are indicated in figure 40. The 1H NMR spectra 
were recorded either in CDCl3 (0 or 10 mM TBA-PF6) or CD3CN using a 600 MHz Bruker 
NMR spectrometer as 8.4×10-4 M solutions. All solvents were degassed and filtered through 
basic alumina prior to preparing the samples. All oligonucleotides were soluble under the 
conditions indicated, and no aggregation was observed in any experiment 
 
 
4.3 Complementary DNA strand synthesis 
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Figure 37: Tetra-adenosine 61 and tetra-thymidine 62 synthesis on solid support. 
 
Using the same method as before, the complementary tetra-adenosine 61 and the 
unmodified tetra-thymidine 62 were synthesised in the DNA synthesiser using the standard 
mode (trityl on) on a 15 μmol scale (figure 37). For solubility reasons, the DMT group was 
kept on the non-modified DNA strands. Cleavage from the solid support was achieved with a 
mixture of 25% ammonium hydroxide and methanol at 40°C over night. A first purification 
step on liphophilic sephadex gave no pure material. Then, the crude products were purified by 
HPLC and were characterised by MALDI-ToF mass spectrometry which showed the expected 
m/z peaks for the dA4 and dT4. The relative amount were determined by UV-visible 
spectroscopy using the calculate extinction coefficient (ε = 55 400 for dA4 and ε = 33 000  
for dT4). The 1H NMR spectra were recorded in CD3CN using a 600 MHz Bruker NMR 
spectrometer. 
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4.4 UV-Visible Spectroscopy 
 
The spectra of the free base trinucleotides 57 and 58 containing one of the porphyrins 
are identical to the spectra of either diphenyl porphyrin (H2DPP H2-59) or tetraphenyl 
porphyrin (H2TPP H2-60). The presence of the DNA backbone therefore does not influence 
the absorbance of the porphyrins, and no electronic interactions between the chromophores 
and the nucleobases occur, as was already observed in the porphyrin nucleotide building 
blocks (chapter 2). 
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Figure 38: Uv-vis spectra of the diporphyrin arrays. The insets show the expanded Q-band 
region of the porphyrins. 
 
 
In contrast to the dinucleotide-diporphyrin arrays described in chapter 2, the spectra 
obtained from the tetranucleotides can be reproduced by a superposition of the spectra of 
either the individual building blocks or the trinucleotide arrays. The UV-vis absorbance 
spectra of the diporphyrin arrays H2-54, H2-55 and H2-56 are shown in figure 38. The 
absorbance maxima λmax (logε) of the porphyrinic absorptions in the arrays are compiled in 
Table 2. The B-band absorbances are 411 nm (5.62) for H2-54, 418 nm (5.40) for H2-55, and 
419 nm (5.72) for H2-56, which are expected values for porphyrins. The four Q-band 
absorbances can be found in the 450 nm to 700 nm region which is typical for free base 
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porphyrins. Upon addition of the complementary tetra-adenosine dA4 the absorbances remain 
largely unchanged apart from a small hypochromism in the array H2-55 (figure 38). 
Apparently, no change in the electronic environment is induced by addition of the tetra-
adenosine. 
The corresponding zinc derivatives Zn-54, Zn-55 and Zn-56 (table 2) show maxima 
for the B-band absorbances which are red-shifted only marginally in 3, and by about 6 nm in 
55 and 56 compared to the free base porphyrins (the spectra are displayed in Figure 38 
bottom). This shift difference is a common value for zinc metallated porphyrins; the values 
found are 413 nm (lgε = 5.32) for Zn-54, 424 nm (4.76) for Zn-55, and 425 nm (5.48) for  
Zn-56. Again, upon addition of the complementary tetra-adenosine no significant change in 
the electronic spectra could be observed. The electronic ground state of the porphyrins 
therefore is not altered when incorporated into the oligonucleotide, nor is it influenced by the 
absence or presence of the complementary strand. Excitonic coupling does not occur because 
unhindered rotation around the internucleosidic linkage seems to prevent a close contact. 
 
 
 B-band absorption Q-band absorptions 
H2-54 412 (5.30) 510 (4.21) 541 (3.81) 576 (3.88) 652 (3.53) 
Zn-54 413 (5.32)  540 (4.10) 574 (3.78)  
H2-55 418 (4.75) 513 (3.63) 544 (3.49) 575 (3.37) 648 (3.20) 
Zn-55 424 (4.76)  545 (3.13) 598 (3.68)  
H2-56 419 (5.38) 516 (4.15) 553 (3.96) 592 (3.75) 646 (3.63) 
Zn-56 425 (5.48)  555 (4.08) 596 (3.51)  
H2-57 417 (4.79) 509 (3.30) 544 (3.43) 575 (3.08)  
H2-58 418 (4.86) 515 (3.76) 552 (3.57) 591 (3.39) 645 (3.28) 
 
 
Table 2: Uv-vis absorbance data for the diporphyrin arrays 54 to 58. Data are recorded in 
CHCl3, c = 2.5×10-6 M, T = 25°C. 
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4.5 Steady state emission spectroscopy 
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Figure 39: Normalised steady state emission spectra of the free-base (top) and zinc 
metallated (bottom) porphyrin arrays. 
 
 
The steady state emission spectra of the diporphyrin systems when irradiated at  
420 nm show emission maxima between 600 and 750 nm which are characteristic for the 
fluorescence from the first singlet excited state S1 of porphyrins. In figure 39, the normalised 
spectra are shown for the diporphyrin arrays as well as for the individual porphyrins. There 
are no differences in the shape of the spectra of all the homo-porphyrin oligonucleotides when 
compared to the fluorescence of the model free-base porphyrins diphenyl porphyrin 59 and 
tetraphenyl porphyrin 60 alone or the combination of 59 and 60. Comparison with the mono-
porphyrin trinucleotide shows that the presence of the DNA backbone also has no influence 
on the excited state behaviour of the porphyrins (data not shown). Some differences in the 
relative intensities of the emission bands are detectable in the zinc metallated arrays.  
The mixed porphyrin arrays H2-55 and Zn-55, on the other hand, behave very 
differently compared to a mixture of the building blocks. Both the shape and the relative 
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intensities of the normalised spectra do not correspond to a simple superposition of either the 
porphyrin building blocks or the trinucleotide porphyrin systems.  
In an equimolar mixture of the free base porphyrins H2-59 and H2-60, the spectrum 
corresponds well to a superposition of the emission spectra of the individual porphyrins (blue 
lines in Figure 39), whereas in the case of the zinc metallated porphyrins Zn-59 and Zn-60, 
the spectrum is dominated by the emission of the diphenyl porphyrin Zn-59. It should be 
noted that the relative intensity of the emission of the two porphyrins is almost equal in the 
free base form, but in the zinc metallated form the tetraphenyl porphyrin has an emission 
intensity which is about 25 % that of the diphenyl porphyrin.  
In H2-55 and Zn-55, the contribution of the tetraphenyl porphyrin seems much more 
enhanced. In H2-55, the spectrum is very close in shape to the spectrum of H2TPP, which 
indicates that the emission of the DPP part is greatly diminished. Here, also the calculated 
spectrum which is obtained from the normalized spectra of H2-59 and H2-60 represents the 
spectrum of the equimolar porphyrin mixture rather than of the diporphyrin array H2-55. 
Similarly, for Zn-55 the emission spectrum is very different from the spectrum of an 
equimolar mixture of the porphyrins. The emission of the DPP porphyrin does not seem to be 
completely quenched, but the contribution of the TPP part is significantly enhanced. The 
spectrum actually is very close to the calculated spectrum obtained from the normalized 
emission spectra of Zn-59 and Zn-60. It can therefore be assumed that in the arrays an energy 
transfer from the DPP to the TPP part occurs, which increases the emission of the tetraphenyl 
porphyrin and quenches the emission of the diphenyl porphyrin. Since this effect is not 
detected in a mixture of the porphyrins at this low concentration, the enforced close proximity 
of the two chromophores through the oligonucleotide backbone leads to an intramolecular 
electronic communication between the porphyrins. 
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Table 3: Steady state emission data for the diporphyrin arrays 54 to 58. Data are recorded 
in CHCl3, c = 2.3×10-8 M, T = 25°C. 
 
 
4.6 Circular dichroism spectroscopy 
 
The arrays were analysed by circular dichroism (CD) spectroscopy in order to 
determine whether structural changes upon dimerisation with the complementary tetra-
adenosine occur. Induced circular dichroism has become a valuable tool to determine changes 
in the helicity of oligonucleotides, and the porphyrins provide a chromophore allowing to 
detect subtle changes in the supramolecular chirality.[11, 83-88] The CD spectra of the arrays  
H2-54 to H2-56 are shown in Figure 4. The UV-regions of the CD spectra do not show clear 
features, thus the spectra do not indicate highly ordered structures with respect to the 
oligonucleotide backbone. 
Regarding the B-band region of the porphyrins, all three complexes show a similar 
signature in their spectra. The single strand arrays show an induced negative cotton effect at 
416, 424 and 420 nm for H2-54, H2-55 and H2-56, respectively. The values for λmax are  
red-shifted by one to six nm compared to the B-band absorbance of the arrays. A negative 
cotton effect in DNA-porphyrin complexes is normally observed upon intercalation of 
cationic porphyrins into G-C rich sequences.[87, 88]. In the absorbance spectra, neither 
hypochromism nor a bathochromic shift is observed for any of the arrays as compared to the 
building blocks, which would be expected if strong π-interactions with the nucleobases upon 
 λmax (rel. Intensity) 
H2-54 630 (0.92) 695 (1)  
Zn-54 582 (1) 636 (0.75)  
H2-55 655 (1) 704 (sh)  
Zn-55 583 (0.78) 605 (0.84) 646 (1) 
H2-56 653 (1) 716 (0.24)  
Zn-56 606 (0.99) 650 (1)  
H2-57 631 (1) 691 (0.75)  
Zn-57 582 (0.58) 656 (1)  
H2-58 651 (1) 715 (0.22)  
Zn-58 602 (1) 648 (0.98)  
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intercalation would occur. The negative cotton effect can thus be explained by an induced 
chirality from the oligonucleotide backbone of the diporphyrin array. Noteworthy, the CD 
signal is strongest for the array 56, where a sharp signal was also observed. The signal of 54 is 
slightly broadened with a decreased intensity compared to 56. The broadest and also weakest 
induced signal is observed in the array 55. Upon addition of the complementary tetra-
adenosine, the spectra did not change.  
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Figure 40: CD spectra of the free-base porphyrin arrays. Spectra are recorded in CHCl3  
(T = 25°C) at c = 5×10-6 M (H2-54), 13.4×10-6 M (H2-55) and 3.75×10-6 M (H2-56). 
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4.7 1H NMR Spectroscopy 
 
 
 
Figure 41: Region of the 1H NMR spectra of the tetra-nucleotides: a) H2-54 + dA4 61, 
b) dT4 62, c) dA4 61, d) dT4 62 + dA4 61. The spectra shown are recorded in CDCl3  
(10 mM TBA-PF6) for a) and in CD3CN for b)-d). c = 8.4 10-4 M, T = 22°C. 
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It is expected that in aqueous solution, where the calculated melting point of a 
tetramer would be below 10 °C, no duplex formation with the complementary strand takes 
place. This, however, does not necessarily extend to organic solutions. In chloroform, a much 
stronger interaction between an A-T base pair was reported, and the association constant was 
determined to be about 102 M-1 [89] which could lead to an association constant of up to  
108 M-1 in a tetranucleotide. 
In order to verify the presence or absence of any interactions between the arrays and 
the complementary strand, we studied the tetra-nucleotides by 1H NMR spectroscopy.  
The arrays were dissolved, and the complementary strand was added until equimolar amounts 
were present. Either neat CDCl3 solutions or 10 mM TBA-PF6 solutions in CDCl3 were used. 
However, no changes in the 1H NMR spectra were observed upon addition of the 
complementary strand, which is shown in figure 41a with the array H2-54 as representative 
example. Further experiments were performed using both the unmodified tetra-thymidine and 
tetra-adenosine (figure 41 b-d). The spectrum of the equimolar mixture of dT4 and dA4 is a 
superposition of the individual 1H NMR spectra. No changes in the resonances assigned to the 
sugar-phosphate backbone or in the nucleobase region were seen. Also, no low field 
resonances were detected at ~10-15 ppm which would be expected for the nucleobase protons 
when they are integrated into an A-T hydrogen bonding system.[90] The spectra of the natural 
oligo-nucleotides were also measured under different conditions, e.g. in both CDCl3 and 
CD3CN solutions, and in the presence and absence of the non-coordinating buffer TBA-PF6, 
leading to the same results. Also heating to 80 °C for two hours and slow cooling to room 
temperature to simulate the annealing of natural DNA did not have any influence on the 
outcome of the spectra. The same applies for recording the spectra at 5 °C. We therefore 
conclude that the interactions between the two complementary tetra-nucleotides in organic 
solvents are very weak even in unmodified oligonucleotides where the steric repulsion from 
the bulky porphyrins is not present. 
 
We decided then to probe the use of PNA as neutral complementary strand to obtain 
more information on possible duplex formation and to understand the nature of the electronic 
interactions between the chromophores. 
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4.8 Peptide Nucleic Acid 
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Figure 42: PNA, DNA and Protein structures. 
 
Peptide nucleic acids (PNAs) are one of the most interesting of DNA mimics and were 
first reported in 1991 by Nielsen. Since this time, a vast number of studies have been reported 
covering their synthesis, properties and applications. In PNAs, the phosphoribose backbone of 
natural oligonucleotide is made from repeating N-(2-aminoethyl)-glycine units linked by 
peptide bonds. The different bases (purines and pyrimidines) are linked to the backbone by 
methylene carbonyl linkages. Their oligomerization is thus carried out using standard peptide 
chemistry such as Fmoc or Boc chemistry with suitable protecting groups for the purine or 
pyrimidine heterocycles. One protecting groups for the N terminus and one other for the 
nucleobase are required. Unlike DNA or other DNA analogs, PNAs do not contain any 
pentose sugar moieties or phosphate groups. PNAs are depicted like peptides with the  
N-terminus at the first (left) position and the C-terminus at the right. The PNA backbone is 
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not charged, this confers to this polymers a much stronger binding to DNA strands as shown 
in figure 42 This is due to the lack of charge repulsion between PNA and DNA strand. 
Moreover, PNA is resistant to biological degradation by nucleases or proteases, properties 
which make PNA an ideal tool in a number of different areas of research such as gene therapy 
or mRNA profiling. 
 
PNA-PNA  >  PNA-RNA  >  PNA-DNA > DNA-DNA 
 
Figure 42: Relative thermal stability of the hybrid duplexes and natural DNA. 
 
4.8.1 Solid-Phase PNA Synthesis 
 
 
MBHA Resin
DEBLOCK
(20% piperidine in DMF)
Fmoc
H2C
CO2 +
NH2
HN
Swelling f or 1.5h in DMF  
 
Scheme 24: Preparation of the resin. 
 
Manual peptide synthesis[91] was accomplished in a fritted-filter reaction vessel 
(Merrifield vessel) with a two-way valve fitted onto a 25 ml side arm vacuum flask by way of 
a 1-hole stopper. One valve was used to bubble nitrogen through the reaction mixture and the 
other valve was used to evacuate excess reaction solutions and wash solvent using a vacuum 
flask. PNAs are synthesised in a similar way common peptide synthesis is performed, 
whereas the growing chain is elongated by a monomer protected with an N-terminal Fmoc 
and an additional side-chain protection group. After coupling is completed, the terminal 
Fmoc-protection group is removed and subsequent cycles are performed until the desired 
molecule is assembled.  
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Scheme 25: Manual synthesis of the PNA. 
 
The PNA molecules were synthesised on Fmoc-protected Rink resin, the Rink Amide 
MBHA resin with a substitution of about 0.4-0.8 mmol/g. After swelling the resin for 1 h in 
N,N'-dimethylformamide (DMF), 50 mg were distributed to each Merrifield vessel. The 
coupling cycle was started with the cleavage of the Fmoc protection groups. This was done by 
two successive incubations (1 and 5 min) with 4 ml 20% piperidine in DMF. The Fmoc 
groups and piperidine were removed and the resin was washed away five times with 6 ml 
DMF followed by a double coupling (2 x 45 min) of the first monomer (base C). Each of the 
two coupling solutions consisted of 185 µl Fmoc-PNA-monomer (0.3 M in 1-methyl-2-
pyrrolidone (NMP), 185 μl O-(7-azabenzotriazol-1-yl)-N,N,N'N'-tetramethyluronium 
hexafluorophosphate (HATU) (0.6 M in DMF) and 185 μl base mix (0.6 M 
diisopropylethylamine (DIPEA) and 0.9 M 2,6-lutidine in DMF). After coupling, the resin 
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was washed three times with 6 ml DMF. Not elongated sequences were acetylated by 
incubation in 1.5 ml capping mix (5% acetic anhydride and 6% 2,6-lutidine in DMF) for 
5 min. Finally the resin was washed another five times with 6 ml DMF. The cycle was 
repeated until the synthesis of the desired PNA sequence was completed. The progress of 
amino acid couplings can be followed using ninhydrin. The ninhydrin solution turned dark 
blue (positive result) in the presence of a free primary amine but was otherwise colourless 
(negative result). Finally the terminal Fmoc group was removed and the final free amine was 
acetylated as described above. The resin was washed another five times with 6 ml DMF and 
three times with 6 ml 1,2-dichloroethane. After synthesis, the final PNA molecules were 
cleaved from the dried resin and the Bhoc protecting groups were removed by incubation in 6 
ml of 95% trifluoroacetic acid (TFA) and 5% triisopropylsilane (TIS) mixture for 2 h. After 
elution of the molecules with another 6 ml cleavage mix, precipitation of PNAs was done by 
adding 30 ml of ice-cold ether. PNAs were washed another four times with ether, and dried. 
The PNA was first precipitated in acetonitrile and then purified by RP-HPLC. The desired 
PNA strand CAAAAC 63 was obtained in 37% yield. Quality control of the synthesised 
PNAs was done by MALDI-TOF mass spectrometry. The absorption spectra measured in 
water; shows a peak a 259 nm. The PNA extinction coefficient (ε=63 344), which was 
calculated using the UV-visible spectroscopy, was determinated close to the calculate value of 
ε=66 920 using literature data for the PNA-base (A=13.7, C=6.06, G=11.7, T=8.6,  
ml/µmol-cm). However, to determinate the PNA concentration in solution the measured value 
for ε was used. 
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4.8.2 Spectroscopy studies with tetra-nucleotides 
4.8.2.1 UV-Visible Spectroscopy 
 
 
  
 
Figure 43: Uv-vis spectra of the diporphyrin arrays 54 to 56 with the complementary  
PNA 63. Data are recorded in dichloroethane at 20°C and 80°C. 
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In an equimolar mixture of the diporphyrin arrays with the PNA, the relative 
intensities for the B-band absorbance changed compared to the single tetramers. The 
absorbance maximum decreases about 50% for Zn-54., and increases about 25% for Zn-56. 
In the case of the mixed tetramer, the duplex formation leads to a red-shifted by about 22 nm 
and the spectrum shows a second B-band absorbance at 426 nm. The data of the porphyrinic 
absorptions in the arrays are compiled in table 3. In order to study the temperature influence 
on the possible duplex formation, the solutions were slowly heated up to 80°C and cooled 
down to 20°C. The relative absorption is quite the same for Zn-55 and Zn-56 with a 
hypochromicity of 5%. In the case of Zn-54, the spectrum shows a maximum which is 
red-shifted by about 26 nm. The value found is 436 nm. Upon addition of the complementary 
PNA 63, significant changes in the electronic spectra could be observed in all cases.  
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Figure 44: UV-vis spectra of the diporphyrin arrays 54-56 at 20°C and 80°C. 
Data are recorded in dichloroethane. 
 
 
The UV-vis absorbance spectra of the single strand zinc diporphyrin arrays after 
heating are shown in figure 44. In order to compare the spectra, the tetramers solutions were 
heated and cooled down in the same condition as the equimolar mixture with the PNA. The 
absorbance maxima for Zn-56 decrease about 25%, in contrast to Zn-54 where no more 
absorbance is observed. We supposed that the compound Zn-54 was decomposed during the 
heating. This experiment was performed several times with fresh solutions, by changing the 
concentration and the UV cell length, but the results were the same. The absorbance 
300 400 500 600
0,0
0,4
0,8
1,2
λ
ab
so
rb
an
ce
 Zn- 56, 20°C
 Zn- 56, 80°C
300 400 500 600
0,0
0,3
0,6
ab
so
rb
an
ce
λ
 Zn- 55, 20°C
 Zn- 55, 80°C
300 400 500 600
0,0
0,4
0,8
ab
so
rb
an
ce
λ
 Zn- 54, 20°C
 Zn- 54, 80°C
104  Tri- and Tetranucleotide Porphyrin Arrays 
maximum for Zn-55 decreases about 50% and is red-shifted about 28 nm. The value found is 
447 nm. The same experiments have been done with the CD spectroscopy as shown in the 
following section. 
The electronic ground state of the porphyrins change in the presence of the 
complementary PNA, especially for the Zn-54. The single strand tetramer 54 which 
decomposed upon heating, in the presence of the PNA, leads to a spectrum were λmax is  
red-shifted. We assumed that the duplex formed a more stable compound when it is heated 
up. Similarly, for Zn-56 the duplex formed is more stable than the single strand tetramer with 
respect to the decomposition. 
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Figure 45: UV-vis spectra of the diporphyrin array 55 at 20°C and 80°C for c=3.10-6 M and 
c=2.10-5 M. Data are recorded in dichloroethane. 
 
 
The UV-vis absorbance spectrum of the single strand Zn-55 shows one maxima at 419 
nm for a high concentration (c=2.10-5 M) which splits into two peaks at 423 and 445 nm for a 
lower concentration (c=3.10-6 M). This complex shows a different spectrum when the 
measurement is performed at higher temperature. For the higher concentration, a 
hypochromicity of 35% is observed at 80°C and a second smaller peak at 445 nm appears. 
At this point, there is no clear explanation for this observation. 
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 Temp. B-band absorption  Q-band absorptions 
Zn-54 20°C 412 (5.34)  539 (4.24) 573 (4.04) 
Zn-54+PNA 20°C 411 (5.04)  536 (4.05) 571 (3.88) 
Zn-54+PNA 80°C 438 (4.83) 410(sh) 539 (3.92) 571 (3.83) 
Zn-55 20°C 419 (4.70)  514 (3.51) 550 (3.40) 
Zn-55+PNA 20°C 442 (4.65) 428(sh) - - 
Zn-55+PNA 80°C 442 (4.59)  - - 
Zn-56 20°C 422 (5.52)  553 (4.74) 595 (4.57) 
Zn-56+PNA 20°C 422 (5.48)  555 (4.65) 597 (4.45) 
Zn-56+PNA 80°C 424 (5.39)  555 (4.34) 597 (4.09) 
 
Table 3: UV-Vis absorbance data for the diporphyrin arrays 54 to 56. Data are recorded in 
dichloroethane, c=1.6 10-5 M for Zn-55, c=5 10-6 M for Zn-54 and Zn-56, T = 20°C. 
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4.8.2.2 Circular Dichroism Spectroscopy 
 
 
 
 
Figure 46: CD spectra of modified tetranucleotides 54-56. Single stands (left) and  
double strands (right) from 20°C to 80°C. 
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The arrays were then analysed by CD spectroscopy in order to determine the structural 
changes upon dimerisation with the complementary PNA. The CD spectra of the arrays Zn-54 
to Zn-56 are shown in figure 46. For the duplexes, the UV-regions of the CD spectra show the 
expected signal, the intensity double with the PNA addition. The spectra indicate ordered 
structures with respect to the oligonucleotide backbone. 
Regarding the B-band region of the porphyrins, all three complexes show different 
spectra when the measurements were performed at higher temperature as shown in figure 46. 
The induced CD signal for the porphyrin in the B-band regions shows a weak negative peak at 
424 nm for Zn-56, and at 412 nm for Zn-54. In Zn-55 case, the spectrum indicates a bisignate 
CD signal with a negative peak at 412 nm and a positive peak at 433 nm. When the 
measurements were performed at higher temperature, this signal increased for Zn-55 and 
decreased for Zn-56 with a bathochromic shift of 6 nm. The most interesting effect is noticed 
for Zn-54, the negative peak becomes positive.  
Upon addition of PNA, the spectra show a hypochromicity of 50% for Zn-56 and a 
bathochromic shift of 31 nm for Zn-55 on going form from the single strand to the double 
strand at 20°C. At higher temperature, this signal increases for Zn-56, whereas it decreases for 
Zn-55 and the broad negative peak at 443 nm split into two negative peaks at 421 and 439 
nm. In Zn-55 case, an additional bathochromic shift (Δλ=17 nm) is measured. A 
hypochromicity (65 %) for Zn-54 is observed, and the same effect as in the double strand at 
higher temperature is observed, the negative peak becomes positive.  
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Figure 47: CD spectra of modified tetranucleotides 54-56. Single stands at 20°C, heated at 
80°C and cooled down at 20°C. 
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We are currently performing a detailed study of a diphenyl-tetraphenyl porphyrin 
hybrid system based on a tetranucleotide scaffold (54 to 56) using time- and energy-resolved 
laser spectroscopy. The tetranucleotide scaffold is used to make diporphyrin arrays of either 
homo porphyrinic or heteroporphyrinic composition. Preliminary results from laser photolysis 
show that energy transfer occurs from the diphenyl porphyrin, which acts as a donor, to the 
tetraphenyl porphyrin, which is the acceptor. No energy transfer is observed simply by mixing 
the individual porphyrins in solution, thus the DNA scaffold provides the close spatial 
arrangement necessary to induce the energy transfer. Though the electronic features of the 
donor and acceptor porphyrin do not differ greatly, the energy transfer is sufficient to proof 
the concept (manuscript in preparation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48: Force-field (AMBER*, MacroModel) minimised structures of the tetramers with 
the PNA. (The cytosine bases are missing.) 
 
The structure calculations of the modified tetramers 54-56 with PNA and the non-modified 
tetramers 63-64 were done by Dr Eugen Stulz (figure 48). 
54 
55
62 + 63 
56
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5 21-mer Oligonucleotides 
 
We have shown in the previous chapter that the phosphodiester linkage of nucleotides 
is suitable to connect two different porphyrins which leads to an enhanced electronic 
interaction between the chromophores.[77, 92] The next step of this work is to further explore 
the use of longer oligonucleotides (ODN's) to create multiporphyrin arrays. We have 
performed more spectroscopic studies (absorption, emission and CD spectroscopy) to 
determine the influence of the porphyrin substitution on structure, the thermodynamic 
stability of the modified DNA, and to see whether the electronic properties of the porphyrins 
are altered upon placement in the major-groove of the double stranded DNA (dsDNA). 
 
 
5.1 Synthesis 
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Scheme 26: Structure of the phosphoramidite building block and sequences of the DNA 
strands. 
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The diphenylporphyrin (DPP) derivatised phosphoramidite building blocks 41, and 
42[92] were incorporated site specifically into longer oligo-deoxynucleotides (ODN's) 64-67 
(scheme 26) using the standard solid phase automated DNA synthesis described in previous 
chapters. The nucleotides were synthesised on a 1.0 µmol scale. The building blocks were 
incorporated site specifically into a 21-mer. It should be pointed out that either 41 or 42 was 
used; no mixed porphyrin strands were made. We incorporated first one central porphyrin, 
then two porphyrins separated by one thymidine, finally three, and five consecutive 
porphyrins. In a parallel project, using the tetraphenylporphyrin (TPP) derivatised 
phosphoramidite building block 45, the same modified DNA strands were synthesised and up 
to eleven consecutive porphyrins were incorporated. The successful incorporation of different 
amounts of porphyrins in a row into the sequence shows that there seems to be no synthetic 
limitation in the amount of modifications per DNA strand. The synthesis was carried out in 
both trityl-OFF mode and trityl-ON mode. The solid phases were dried under argon and 
incubated overnight with 1 ml concentrated ammonium hydroxide at 45°C. The porphyrins 
are obtained in the free-base form and can be re-metallated by standard metallation procedure 
using Zn(OAc)2 in H2O. 
 
 
3' ATG CTA AGC TPT GAT CGA TGC C
3' ATG CTA AGC PTP GAT CGA TGC C
3' ATG CTA AGC PPP GAT CGA TGC C
5'
5'
5'
68
69
70  
 
Scheme 27: DNA strands sequences with the fluorous tag. 
 
 
For oligonucleotides 69-70, we introduced an additional oligonucleotide bearing a 
fluorous dimethoxytrityl (FDMT) group at the 5'-position ("FDMT-on synthesis") for the last 
coupling step with increasing the coupling time to 3 min. The 5'-O-FDMT-dC-
phosphoramidite (scheme 27) was used as 0.1 M solution in acetonitrile for the installation of 
a single FDMT-on nucleotide (figure 49) at the 5' terminus, which was used for fluorous 
affinity chromatography purification. 
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Figure 49: 5'-O-FDMT-dC-phosphoramidite. 
 
 
5.2 DNA Strands Purifications 
 
 Different approaches were made to find the appropriate method for a successful 
purification. Using standard methods like HPLC, column chromatography (silica or sephadex) 
or gel electrophoresis gave no pure material. Finally, all the strands were purified by 
recognition of the complementary strand on solid support or by Prof. Bannwarth’s method of 
fluorous affinity chromatography which lead to a satisfying purification. 
 
5.2.1 Purification via Solid Support 
 
 
3' - ATG - CTA - AGC - PTP - GAT - CGA - TGC - 5'
5' - TAC - GAT - TCG - AAA - CTA - GCT - ACG - TTT - TA
OAS
65
71
Spaceur
 
 
Figure 50: Sequence of DNA strand on OAS for DNA purification. 
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 The complementary strand 71 was synthesized on oligo affinity support (OAS) which 
uses a polystyrene bead. In contrast to CPG (controlled pore glass), the base deprotection was 
achieved using ammonium hydroxide without cleaving the strand from the resin. The 
attachment to the support is through the N6-position of Adenosine and the oligonucleotide can 
only be cleaved specifically from the support by periodate oxidation followed by  
ß-elimination to yield the 3'-phosphate. Then, the purification of the modified DNA strand 
was done by hybridizing with the complementary stand in PTT buffer at 80°C for 10 min, and 
then slowly cooled down to 4°C. After washing the OAS with water, the desired pure strand 
was cleaved with methanol.  
 
5.2.2 Purification via Fluorous Purification System 
 
 
 
Using Prof. Bannwarth’s method for oligonucleotide purification, the introduced 
fluorous tag allows the tagged oligonucleotide to be selectively retained on the Fluoro-Pak™ 
column. The affinity of the fluorous tag on the oligonucleotide for the Fluoro-Pak™ 
adsorbent is high, much higher than the affinity of a DMT group for an RP adsorbent. The 
non-fluorous components of the mixture are less well retained than they would be with 
normal RP adsorbents. Without removing the ammonia used in the deblocking step, the crude 
deprotected FDMT-on oligonucleotide was passed through the column. The fluorous 
purification system, in a solid-phase extraction (SPE) mode, promotes complete adsorption of 
the fluorous-tagged oligonucleotide onto the column, which allows non-fluorous impurities to 
be washed away. Removal of the fluorous tag with diluted TFA, affords the desired 
oligonucleotide. To quantify the final oligonucleotide, we determined the optical density at 
260 nm. 
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5.3 UV-Visible Spectroscopy 
 
 
 
Figure 51: UV-vis spectra of X in the dsDNA-form (black) and ssDNA (red); dsDNA at 
15°C, ssDNA at 80°C.  
 
 
 The electronic absorption spectra show that the total porphyrin absorbance decreases 
with increasing the amount of porphyrin modification per DNA strand. The spectra do not 
change immediately after mixing of the porphyrin-DNA with the complemntary strand at 
ambient temperature, but when the system is heated up to 80°C, and cooled down to 15°C, 
a substantial increase in absorbance occurs. 
 In the multi-porphyrin modified strands, a substantial broadening of the porphyrin 
B-band absorption at ~410 nm indicates electronic interactions between the chromophores. 
The interactions are present even if the porphyrins are separated by a non-modified 
nucleotide. The figure 51 shows the single stand ss-1P, ss-2P and ss-3P at 80°C when the 
bases become unstacked, the wavelength of maxima absorbance does not change but a 
hyperchromicity of 10% is observed compared to the single strands at 15°C. An additional 
small bathochromic shift (Δλ = 3 nm) is measured in ss-3P case.  
 When the UV-vis spectra of the single strand are recorded at 80°C, the spectrum of 3P 
shows the same absorption coefficient with a red-shift of 10 nm compared to ds-3P. The 
porphyrin B-band absorption shows a hyperchromicity of 12% and 40% for 2P and 1P, 
respectively. But the largest change occurring in ds-2P at 15°C, the absorbance maximum at 
414 nm becomes two maxima at 414 and 371 nm. The interactions between the two 
porphyrins seem to be stronger in the double strand. In the dsDNA at 15°C and in the ssDNA 
at 80°C, the porphyrin extinction coefficient decreases linearly from 1P to 3P. 
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The structure calculations of the 21-mer oligonucleotides substituted by one, two and three 
porphyrins (figure 52) were done by Dr Eugen Stulz. 
 
ODN-Strand Temp.  absorption maxima [nm (lgε)] 
ss-1P 80°C 411 (5.21) 
ds-1P 20°C 411 (5.41) 
ss-2P 80°C 370 (sh), 414 (5.11) 
ds-2P 20°C 413 (5.16) 
ss-3P 80°C 428 (4.90) 
ds-3P 20°C 428 (4.92) 
 
Table 4: UV-Vis absorbance data for the modified single strand and double strands. 
Data are recorded in PTT buffer. For 1P, c= 2.8 10-6 M, for 2P, c= 2.2 10-6 M  
and for 3P, c= 3.3 10-6 M. 
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5.4 Circular Dichroism Spectroscopy 
 
 
 
Figure 53: CD spectra of modified porphyrin-DNA arrays 1P-3P. Single strands on the left 
and double strands on the right. 
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Figure 54: CD spectra of unmodified 21-mer. 
 
 
 The CD spectra of strands 1P-3P shows features of B-type DNA for all strands with a 
bisignate CD profile (figure 53). Also for the single stranded forms, the base stacking 
increases substantially compared to the natural DNA (figure 54), even when measured at 
higher temperatures. The spectra of single strands show an increase in the 250 nm signal with 
increasing the amount of porphyrin modifications. The induced CD signal for the porphyrin in 
the B-band region shows a relatively broad signal for 2P and a negative peak at 416 nm for 
1P. In the case of 3P, the spectrum indicated a bisignate CD profile which could be 
interpreted by a major groove stacking of the porphyrins in the ouble strand.[93] This is in 
contrast to the spectra of 1P and 2P. The previously analysed building block 37 gave an 
induced negative signal as well.  
Normally, a negative induced signal indicates intercalation of the porphyrin within the 
base-stacking of the DNA.  This, however, is not a feasible alternative structure. Firstly, the 
porphyrins are covalently attached to the nucleobase, and intercalation would have to be 
accompanied by base flipping of the uridine. The porphyrin then cannot be accommodated in 
the DNA unless the adjacent base is also flipped out. Secondly, the linker would dictate the 
porphyrin into a position where severe steric clashes with the complementary strand would 
occur. Thus, a much larger destabilisation of the dsDNA would be expected as is measured. 
Steric effects also play a crucial role in tetra-aryl porphyrin intercalation and do not favour 
this structure. In addition, the melting experiments with the mismatched complementary 
strand support hydrogen bonding in the system. Thus, the negative induced signal can only be 
explained by the intrinsic properties of the array. It seems that the acetylene linker[94] inhibits 
the chiral perturbation which the DNA should transfer onto the porphyrin B-band. Even 
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though the porphyrins interact which each other electronically (see below), their electronic  
environment is only locally perturbed by the chiral deoxyribose, leading to a negative Cotton 
effect within the B-band region, as seen in the CD spectra. The building blocks themselves 
give rise to a strong negative induced CD signal, and also tetranucleotides with two tetra 
phenyl porphyrins show the same spectral characteristics. It seems that in our case induced 
CD spectroscopy is not applicable for structure determination as compared to non-covalent 
DNA-porphyrin and DNA-drug interactions, or where the chromophore is attached to the 
DNA via sp3-carbon containing linke. 
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5.5 Melting temperature 
 
 Thermal denaturing experiments of the porphyrin-DNA duplexes were measured 
using CD spectroscopy. The porphyrins incorporated into the DNA strand destabilized the 
duplex. The ODN with one central porphyrin shows a melting temperature of 42.4 °C 
compared to the unmodified DNA strand with a higher one (63.5 °C). The ODN, which 
contains two porphyrins, shows a lower melting temperature of 37.1 °C; here, the 
destabilisation effect of the duplex increases. But the incorporation of the three consecutive 
porphyrins increases the melting temperature to 41.6 °C; this system seems to stabilise the 
porphyrin-DNA duplexes, due to the hydrophobic interactions between the porphyrins. 
For ODN 3P, the melting temperature, obtained with CD spectroscopy (41.6 °C) is 
approximately the same as obtained with the UV-vis peltier machine (42.2 °C). The CD 
measurements therefore give an accurate Tm value. 
 
 
ODN-
strand 
Conc. 
(mol/l) 
ε (calc.) Tm [°C]  
by CD 
Tm [°C]  
by UV 
21-mer 5 10-6 M 207 000 65 63.5 
1P 2.8 10-6 M 198 904 42.4 - 
2P 2.2 10-6 M 195 708 37.1 - 
3P 3.3 10-6 M 193 112 41.6 42.2 
 
Table 5: Melting temperatures of ODN’s in PTT buffer (500 mM NaCl, 50 mM KH2PO4, 
pH 7.0). Tm: melting temperature of the duplex with the complementary strand. 
 
 
 
 
 
 
 
 
 
 
21-mer Oligonucleotides  119 
5.6 On-bead hybridisation 
 
 
   
  1P    2P    3P 
 
 
      5P 
 
Figure 55: Hybridization of OAS with the modified DNA-strand using the BV filter. 
 
 
After hybridizing with the complementary stand in PTT buffer (chapter 5.2.1), the 
DNA strands were kept on the oligo affinity support (OAS). The beads were washed with 
water and suspended in TEAA buffer to be observed under the microscope using the BV filter 
(excitation at 400-440 nm, emission at 475 nm). In the case of the 1P, 2P, 3P, and 5P, the 
beads were found to be fluorescent. These measurements were done a second time in water 
and gave the same results. This study shows the possibility to attach the porphyrins to beads 
via a non-covalent binding mode. 
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6 Summary and outlook 
6.1 Summary 
 
In conclusion, we have shown a general route to porphyrin modified uridine and 
deoxyuridine, where the substitution pattern and the metallation state of the porphyrin are 
variable without affecting the synthetic route and the solubility can be tuned by varying the 
substituents on the porphyrins. 
Then, we have presented the synthesis of porphyrin dimers based on dinucleotide 
formation, where the building blocks are connected through a phosphate diester backbone in 
analogy to the natural DNA structure. The general route to substituted nucleosides via 
Sonogashira coupling allows introduction of a much larger diversity of structurally different 
porphyrins, and the mode of connection is independent of the substitution pattern of the 
porphyrin. Both solution and solid phase synthesis can be applied, and by varying the building 
blocks the composition of the dimer can be chosen. In this case, the solid support synthesis is 
advantageous due to the much easier purification of the product, even if the yield was low. 
Both Uv-vis spectroscopy and mass spectrometry reveal that the presence of two consecutive 
porphyrins does not hinder the specific recognition of the complementary nucleobase. 
The oligonucleotide backbone was shown to be a suitable template for the synthesis of 
both homo- and heteroporphyrinic diporphyrin arrays. We have shown that the electronic 
ground state properties of the porphyrins are largely unaffected upon incorporation into the 
oligonucleotide when measured in organic solvents. But the excited state is strongly 
influenced by the presence or absence of a neighbouring porphyrin, and electronic interactions 
occur depending on the structure of the adjacent porphyrin. The photophysical properties of 
the diporphyrin array can therefore be tuned simply by reprogramming the sequence of the 
incorporated building blocks. There was no spectroscopic evidence for the formation of any 
duplex with the complementary tetra-adenosine; this is also supported by the fact that the  
1H NMR spectra of the mixtures are represented by a superposition of the individual 1H NMR 
spectra under different conditions. But the use of PNA, as neutral complementary strand, 
leads to a duplex formation. Both CD and UV-vis spectroscopy indicate an interaction 
between the two strands which is different with the three tetramers. Especially with the 
tetramer 54, no decomposition was observed in presence of PNA when the temperature was 
increased.  
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Finally, we have incorporated different amount of porphyrin in a 21-mer DNA strand, 
which indicate that the backbone of natural DNA can be used to sequence specifically 
assemble porphyrin, leading to new stacked arrays on the nanometre scale. The synthesis of 
new strands in combination with other porphyrins and more detailed spectroscopic 
evaluations are currently under way, i.e. evaluation of energy or electron transport for which 
this system is a promising candidate. DNA will certainly lead to new functional molecules on 
the nanometre scale when substituted with a diversity of electronically active molecules such 
as porphyrins, transition metal complexes or amino acid side-chain derived groups which we 
anticipate in future. 
 
 
6.2 Outlook 
 
The next steps of this project is divideded into four stages: i) synthesis of specific 
DNA porphyrin sequences for structure and physical analysis; ii) evaluation of the constructs 
for structure and energy and/or electron transfer; iii) study of the arrays towards their ability 
to function as electronic wires in artificial membranes and between nano-gaps (part iv). The 
results of the two first parts will be used to design the exact composition of the final 
porphyrin arrays for the desired purpose. To achieve the goals, the following strategic tasks 
are planned. 
 
6.2.1 Synthesis of DNA porphyrin arrays for structural studies 
 
To obtain a better understanding of the structural aspects of the modified DNA and 
physical properties of the porphyrin arrays, a set of ODN's (1’ to 5’) with various amounts of 
porphyrins will be synthesised, which is different from our first DNA strands (Scheme 2). 
This will allow a more precise analysis of the impact of the porphyrin substituents on the 
stability and structure of the dsDNA. The introduction of mismatches in the complementary 
strand is necessary to proof the base-pairing ability of the modified nucleotide. In this part, 
other modifications of the DNA to obtain more stable duplexes will be introduced (ODN's 6’, 
8’ to 9’). These include the use of LNA-nucleotides (12’)[95-97] and capping nucleotides such 
as stilbenes (25).[98, 99] The use of peptide nucleic acids (PNA) as complementary strand was 
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shown to greatly stabilise the duplex in DNA-PNA hybrids.[100, 101] This will also be applied 
to our system, and two different approaches are anticipated. A complementary strand 
comprising of only PNA units will show whether the porphyrin-DNA part can form DNA 
(porphyrin)-PNA hetero-duplexes of similar thermodynamic stability as natural DNA-PNA 
hetero-duplexes. The use of a PNA-DNA(porphyrin)-PNA hybrid system will be used to 
determine whether the stability of the flanking sequences of the porphyrin array alters the 
overall physical properties of the chromophore system. All the porphyrin arrays described 
will be thoroughly studied using absorption and emission spectroscopy (steady state and time 
resolved, in collaboration with Dr Pavlos Lagoudakis, Southampton), and CD spectroscopy. 
If applicable, the use of NMR spectroscopy and X-ray crystallography is anticipated to 
determine the structure of the arrays. The arrays will also be adsorbed on surfaces and 
analysed using AFM and STM techniques (in collaboration with Dr Iris Nandhakumar, 
School of Chemistry, Southampton). Cyclic voltammetry studies and EHMO calculations can 
be performed at Southampton and in the laboratories of Dr Fabrizia de Biani (Siena, Italy). A 
further strategically important system to be studied in this part is a self-complementary strand. 
Here, in the duplex the alternating porphyrin units will be on adjacent strands (ODN's 10’ and 
11’) so that the same porphyrin array is obtained as with the DNA-DNA(porphyrin) system. 
This study is necessary to determine whether the substituents can be attached to 
complementary strands and the functional molecule is obtained by hybridisation (see also part 
below). 
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6.2.2 Synthesis of Donor-Acceptor systems  
 
Time resolved fluorescence spectroscopy will be performed to study the energy 
transfer mechanisms and efficiencies between the porphyrin units. The photophysical analysis 
will be done by Dr Pavlos Lagoudakis who has the required instrumentation to undertake 
these studies. For this purpose, either Ni(II) or Au(II) porphyrins as central unit will be 
incorporated into the arrays (Scheme 28). With these systems, either quenching of the 
fluorescence (nickel) or enhancement of the fluorescence (gold) is expected giving better 
access to the rates and quantum yields of the energy transfer. Whether or not LNA 
nucleotides, capping reagents or different counter strands will be used is depending on the 
outcome of part a). In addition to changing the central metal of the porphyrin, we will also use 
different porphyrin structures (DPP or TPP) to study the electronic interactions in the arrays. 
As we have observed with the mixed porphyrin arrays , energy transfer from one porphyrin to 
another is possible. Since the efficiency of energy transfer between porphyrins of the same 
metallation state is not very efficient, the combination of porphyrins containing different 
central metals will be much more informative due to the enhanced quantum yield of the 
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energy transfer. With the results obtained in this part of the project we will be able to design 
the best system for the applications in energy and electron transfer (see below). 
 
6.2.3 Synthesis of electronic wires for charge separation through artificial membranes 
 
The incorporation of up to eleven porphyrins into the DNA strand has already been 
achieved. Assuming a dsDNA structure which is not too far away from the natural DNA this 
means that we have a porphyrin array of ~4 nm at hand. This length is sufficient to span a 
lipid bilayer similar in size to a cellular membrane. Aim of this part of the project is to 
incorporate the conjugates within the membrane of either phospholipid vesicles or within a 
membrane which separates two compartments in order to obtain functionalized polymolecular 
assemblies that will allow the transport of electron across the bilayers.[15, 102, 103]  
The conjugates will have at one end an electron acceptor and on the other end an electron 
donor, as schematically shown in Figure 2. Attachment of alkyl chains to the meso-phenyl 
group of the porphyrin may be necessary to direct the porphyrins into the lipid bilayer and for 
orienting the units appropriately. The functional membranes, for example based on  
1-palmitoyl-2-oleoly-sn-glycero-3-phosphocholine (POP),[104] will be prepared and 
characterized by dynamic light scattering, electron microscopy, absorption and emission 
spectroscopy and possibly NMR spectroscopy, in collaboration with Prof. Peter Walde 
(ETHZ, Switzerland). 
The specific composition of the porphyrin array for the cross-membrane electronic molecular 
wire will strongly depend on the outcome of the studies of parts a) and b). So far, the 
following design is anticipated: two DNA strands of the sequence (dX)15(dUPorphdA)6 (14 and 
15’) will be synthesised, where the dX-sequence is non-identical in the two strands. The 
alternating sequences (dUPorphdA)6 of the two strands will then be hybridised within the lipid 
bilayer. If the self-complementarity in the sequences proves problematic, the formation of 
homo-duplexes may be prevented by extending the dUPorphdA-sequence by a few nucleotides 
with a different sequence in 14’ and 15’. This approach has advantages over the synthesis of a 
DNA strand having the full length of the porphyrin array: i) the shorter overall length of the 
DNA and the smaller amount of porphyrins which are separated by an unmodified nucleotide 
predicts an increase in the yield of the DNA synthesis and should facilitate the purification of 
the porphyrin-DNA; ii) the hydrophobic porphyrin modification should be a driving force to 
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direct this part of the DNA into the lipid bilayer, thus the two strands 14’ and 15’ can be 
added from the opposite side and hybridise within the bilayer; iii) the remaining unmodified 
sequences of the DNA will be directed into the aqueous environment and can be used to 
attach complementary strands which are modified with either electron donor (e.g. boron-
dipyrrin, ferrocene; strand 16’) or acceptor (e.g. anthraquinone, pyrromellitimide; strand 17’) 
moieties.[105-107] The donor and acceptor units can be placed at various distances to the 
electronic wire. To additionally improve the photoinduced electron transfer, the donor site can 
contain viologens and the acceptor site NADH or analogues thereof. The project will focus on 
the use of DPP and TPP, either in the free base or metallated form, to create the wire (the  
two-strand approach would also allow to have an alternating free base-metallo porphyrin 
array). The diphenyl porphyrin is expected to have π-π-overlap of about 5-10 % between the 
individual building blocks in the double helix, thus behaving as an extended π-conjugated 
system along the periphery of the DNA. The tetraphenyl porphyrin, on the other hand, will 
not do so, which could have a profound impact on the electron transfer capability of the wire. 
The conjugates will serve as a system to study the electron transfer in multiporphyrin systems 
in a hydrophobic environment that will help to stabilise the photophysically active units in 
analogy to the natural antenna complex of the photosynthetic system, and create a system 
capable of charge separation upon photo-irradiation. 
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6.2.4 Synthesis of electronic wires for electron transport in break junctions or nano-
gaps 
 
Immobilisation of the constructs on surfaces will be a major point of interest. The 
electronic communication between the porphyrins allows creating electronic wires as outlined 
above. Electrons can be transported from a donor to an acceptor site, where the porphyrins act 
as a wire, especially if they are in their photoexcited state. If the aromatic cores are in direct 
contact, either through covalent connection or through π-π interactions, the electronic 
communication is enhanced. Here, an overlap of the π-system may be directed through the 
use of the diphenyl-substituted porphyrins in the dsDNA. An overlap area of about 5-10% of 
the porphyrin cores in adjacent modified nucleotides is expected according to basic structure 
calculations. To date, only a limited range of homoporphyrinic systems for long-range 
electron transfer have been studied.[1, 14, 15] Data are only scarce, and none of these conjugates 
have been explored on surfaces. Direct electron transfer between metal electrodes and using 
porphyrins has so far not been investigated. By introducing a thiol, phosphonate or isocyanate 
modified porphyrins at both the 3'- and the 5'-end of the oligonucleotide, the modified dsDNA 
will adsorb on gold, platinum, palladium or titanium dioxide surfaces and thus opens the 
possibility to be studied via AFM and STM. The modifications can easily be introduced at the 
phenyl substituents of the porphyrins, and we have already synthesised a corresponding 
phosphonate porphyrin (preliminary results). The ability of dsDNA to remain intact when 
adsorbed onto surfaces is well known.[108] Of special interest will be the investigation of the 
porphyrinyl-DNA to act as an electronic wire sandwiched between electrodes, either in a 
break junction or in nanogaps, perhaps even on the single molecule level. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
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7 General experimental conditions 
7.1 Reaction instruments and physical data 
 
Nucleic acid synthesizer 
 
Device: PerSeptive Biosystems Expedite 8909 nucleic acid synthesis system. The DNA 
synthesis related chemicals were supplied by Glen Research. For this work, only 500 Å pore 
CPG columns were used. 
 
 
1H NMR spectroscopy 
 
Devices: Varian Gemini VXR400 (400 MHz), Bruker dpx500 (500 MHz). Chemical shifts (δ) 
are indicated in ppm, relative to SiMe4 (δ = 0.00) or based on the solvent signals of the 
partially deuterated nuclei of chloroform-d1 (δ = 7.26 ppm), dimethylsulfoxid-d6 (δ = 2.50 
ppm) or methanol-d4 (δ = 3.31 ppm). All spectra are interpreted by first order Fourier 
transformation and the coupling constants (J) were given in Hertz (Hz).The signals were 
abbreviated as followed: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet.  
All solvents were provided by Cambridge Isotope Laboratories, Inc.. 
 
 
13C NMR spectroscopy 
 
Devices: : Varian Gemini VXR400 (101 MHz), Bruker dpx500 (125 MHz). Chemical shifts 
(δ) are indicated in ppm and are relative to the following solvent signals: chloroform-d1  
(δ = 77.0). The spectra were broad-band proton decoupled; the classification of the signals 
was achieved by APT or DEPT. 
 
 
 
 
 
 
132  General Experimental Conditions 
31P NMR spectroscopy 
 
Devices: Bruker dpx400 (162.0 MHz). Chemical shifts (δ) are indicated in ppm and are 
relative to the spectra reference of an external standard of triphenylphosphate in chloroform  
(δ = -18). The spectra were broad-band proton decoupled. 
 
 
UV-Vis and fluorescence spectroscopy 
 
Devices: Perkin-Elmer Bio-Lambda II spectrometer, featuring a PTP-6 Peltier unit and 
FluoroMax-2. Molar extinction coefficients (εM) are referred to a cell path of 1 cm at 260 nm 
for oligonucleotides and at 420 nm for porphyrins. The background was done with 
appropriate solvent before measurement. 
 
 
Melting points 
 
Devices: Büchi 530 and Hund Wetzlar V200. The melting points are given in degrees 
centigrades [°C] and are uncorrected. 
 
 
Circular dichroism spectroscopy 
 
Device: Chirascan Circular Dichroism Spectrometer, 150 W Xe arc, air cooled. The elipticity 
is referred to a cell path of 1 cm and the data were collected from 650 nm to 200 nm (1s/nm). 
The data was given in mdeg and corrected to delta epsilon using the formula: 
 
Δε= θ / (10 x conc x pathlength x 3298) 
 
Molar elipticity (θ) = 3298 Δε 
Δε = θ / (10 x conc x pathlength x 3298) 
elipticity (θ)  is as measured by the instrument in mdeg  
conc is in mol/litre  
pathlength is in centimetres.  
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Fluorescen microscopy 
 
Devices: Olympus Microscope SZX12, and Olympus Camera Camedia C-3000 Zoom. The 
Microscope was used with three different filters: 
 
Filter Excitation  Emission 
BU 330-385 420 
U 400-440 475 
GFPA 460-490 510-550 
 
 
MALDI-TOF mass mpectroscopy (Matrix-assisted Laser Desorption Ionization Time-
of-Flight) 
 
Device: Perseptive Biosystems Voyager-DE PRO. The spectrometer was run in linear mode 
at 25 KV acceleration voltages for both positive and negative ions. Probes desorption and 
ionisation was induced by a N2-LASER (337 nm, 3 ns pulses, 0.2 mJ per pulse, and 
acquisition of 10 to 100 pulses). The signals are referred to the unfragmented, single charged 
molecule ions [M-H]- and [M+H]+. The data are given in mass units per charge (m/z). 
 
Matrix preparation for Maldi-Tof 
 
• Matrix A: 2-4 mg p-nitroaniline was dissolved in 0.2 ml DCM. 
 
• Matrix B: 0.6 ml of solution 1 was mixed with 0.3 ml of solution 2: 
 
? Solution 1: 2-4 mg 2 6-dihydroxyacetophenone was dissolved in 1 ml 
MeCN/H2O. 
? Solution 2: a 0.5 M solution of ammoniumtartrate (92 mg in 1 ml H2O) was 
prepared. 
 
• Matrix C: 2-4 mg sinapinic acid was dissolved in 0.2 ml acetonitrile/water or 
acetonitrile/0.1% TFA. 
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• Matrix D: a saturated solution of 3-hydroxypicolinic acid (139.1 g/mol) in 
acetonitrile/water was prepared. 
 
7.2 Assignment of protons in the 1H NMR spectra 
 
Porphyrin nomenclature 
 
N HN
NH N
3 4
5
6
7
8
1
2
Porphyrin
Nomenclature
Porphyrin
Representation in this Work
=
9
10
15
20
 
 
Scheme 29: Nomenclature of the porphyrin. 
 
The nomenclature as shown above is normally used in the literature. The positions 5, 10, 15 
and 20 are referred as meso-position. In this work, we represented the porphyrin as described 
in scheme 29. The protons in the 1H NMR spectra were numbered in the same way as the 
related carbon atoms.  
 
 
Numbering of the nuclei 
 
The protons in the 1H NMR spectra are numbered the same as the related carbon atoms. 
Atoms within the sugar backbone of the nucleotides are marked by an additional prime. 
If geminal hydrogen atoms show distinguished signals, the high-field and the low-field shifted 
nuclei are set apart by an additional “a” or “b”, respectively. Scheme 30 demonstrates the 
numbering of the atoms in 2’-deoxyadenosine and 5-Iodouracil.  
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Scheme 30: Nomenclature of the 2’-deoxyadenosine and 5-Iodouracil. 
 
7.3 Separation and purification methods 
 
Thin layer chromatography (TLC) 
 
The reactions were monitored by TLC using Merck silica gel 60 F254 aluminium sheets 
(0.2 mm layer). The compounds were detected by two subsequent procedures: 
 
1. fluorescence quenching detection at 254 nm, 
2. dipping into a solution consisting of: 
a) Cerium sulphate, or 
c) 15% H2SO4 in methanol, or 
d) Potassium permanganate, 
 
followed by heating. 
 
The compounds containing porphyrins were detected by fluorescence quenching detection at 
366 nm. 
TLC retention factors (Rf) were indicated together with the appropriate solvent mixture. 
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Flash column chromatography (FC) 
 
Flash column chromatography was performed on silica gel Fluka 60 (40–63 µm). The 
solvents used were of technical grade and were re-distilled prior to use. The mixture ratios of 
solvents were referred to the parts of the volume. 
 
 
High performance liquid chromatography (HPLC) 
 
Devices: Hewlett-Packard 1050 chromatograph, Kontron Instruments, and Thermo Finnigan 
Spectra System with UV detection at 260 nm. Columns for reversed-phase HPLC: Merck 
(VWR) LiChroSpher 100 (RP-18e, 5 um, 250 x 4 mm, Flow: 1.0 ml min-1) and Merck (VWR) 
LiChroSpher 100 (RP-18e, 10 um, 250 x 10 mm, Flow: 7.5 ml min-1). Solvents used were 
acetonitrile HPLC grade (Fisher scientific), Methanol HPLC analysed (J.T.Baker), 0.1 M 
aqueous TEAA (solution purchased as 1.0 M stock solution from Fluka and diluted by 9 parts 
of nanopure water prior to use), 0.1 M aqueous TEAA with 1% acetonitrile, and 1 mM 
aqueous TFA (J.T.Baker). 
 
 
Size exclusion chromatography (Gel Permeation) of oligonucleotides and building blocks 
 
The compounds were purified using the appropriate column’s size and sephadex: 
 
? Sephadex (Sigma-Aldrich, dry bead diameter: 40-120 µm) G10 (Mw > 700), G15 
(Mw > 1500), and G25 (1K< Mw > 5K) were used with H2O/MeOH (1:1) as eluent.  
 
? Lipophilic Sephadex (Sigma-Aldrich) LH 20 (dry bead diameter: 25-100 µm) was 
used with DCM/MeOH (1:1) as eluent.  
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7.4 Further Instruments 
 
Centrifuge, thermomixer and vortexer 
 
Devices: Picofuge and Eppendorf 5415 C centrifuges. Eppendorf 5436 thermomixer. Bender 
& Hobein AG Vortex Genie 2. 
 
 
Drying of DNA containing probes 
 
Devices: Eppendorf Concentrator 5301. 
 
 
Syringes and micropipette 
 
Syringes 5 µl, 10 µl, 25 µl, 50 µl, 100 µl, 250 µl, 500 µl (Hamilton) and syringe 2.5 ml 
(Schmidlin) were used for samples preparations. 
 
Micropipette 1-5 µl, 10 µl, 100 µl (SOCOREX) and 200 µl, 1000 µl (Gilson Pipetman). 
 
 
Precision cells 
 
The UV-Vis cells (110 Quartz SUPRASIL, 10 mm) and the Fluo cells (119 Quartz 
SUPRASIL, 10 mm) were provided from Hellma. 
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7.5 Solvents and chemicals 
 
Solvents 
 
Technical grade solvents for extraction and flash column chromatography were distilled prior 
to use. HPLC grade solvents, provided by Fluka, J.T.Baker and Fisher were used for 
Sephadex column Chromatography. For all other reaction in water-free environment, or for 
analytic purposes, absolute solvents from Fluka were used without further purification. The 
THF, DCM and MeOH used for reactions still contained their chemical stabilizers. Nanopure 
Water for buffer preparation was provided by Barnstead ultrapure water system. Acetone 
freshly distilled over CaSO4 semihydrat was used for synthesis (34g of CaSO4 for 300 ml 
acetone). 
 
Chemicals 
 
5-Iodo-2’-deoxyuridine was purchased from BERRY & Associates. Chemicals for DNA 
synthesis were provided by Glen Research and TEAA (1M) stock solutions were obtained 
from Fluka. All other chemicals were provided by Fluka, Aldrich, Acros, Merck, Scharlau 
and Fisher, and were highest grade available. 
 
 
7.6 Buffer and solution  
 
Preparation of PTT (phosphate buffer saline) 50 mM buffer, pH=7: 
 
0.05 M KH2PO4 (0.68 g, 5 mmol) and 0.5 M NaCl (2.92 g, 50 mmol) were mixed together in 
100 ml nanopure water. The pH of the solution was adjusted to 7.0 with 10 N aq. NaOH 
solution. 
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Preparation of 0.1 M TEAA buffer (± 1% acetonitrile): 
 
TEAA (1M, 100 ml) (Fluka) was diluted in 900 ml nanopure water and 10 ml acetonitrile was 
added if necessary.  
 
 
Preparation of 10 mM TRIS buffer, pH=7: 
 
Tris(hydroxymethyl)aminomethane (0.30 g) and Boric acid (2 g) were mixed together in 250 
ml nanopure water. The pH of the solution was adjusted to 7.0 with 10 N aq. NaOH solution. 
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8 General Synthetic Procedure 
8.1 Syntheses 
 
All reactions were carried out in standard laboratory glassware of appropriate dimensions. 
Most of the reactions at ambient pressure were performed under argon atmosphere.  
 
 
8.2 Reversed-Phase HPLC 
 
Generally, reversed-phase columns provided by Merk (LiChroSpher 100-5, RP-18e,  
250 x 4 mm, Flow: 1.0 ml min-1 and LiChroSpher 100-10, RP-18e, 250 x 10 mm, Flow: 
7.5 ml min-1) were used. For separation of oligonucleotides an acetonitrile gradient was 
applied, whereas detection was achieved by UV absorption at 260 nm. Most of the tritylated 
oligonucleotides eluted at an acetonitrile fraction range between 25%-30%. For PNA 
purification, an acidic buffer was used. In order to avoid aggregation effects, the column 
temperature was always set to 55°C.  
 
 Solvent A Solvent B 
Program 1 0.1 M TEAA 
 
Acetonitrile 
Program 2 0.1 M TEAA + 1% 
acetonitrile 
Acetonitrile 
Programme 3 
 
0.1 M TEAA 0.1 % TFA 
 
 
8.3 Formation of the double-stranded DNA 
 
Equal amounts of the complementary single strands were dissolved in 1.0 ml of buffer 
solution (pH = 7.0 with NaOH, 50 mM KHPO4, 500 mM NaCl), heated to 75°C for 5 min, 
and then cooled to RT over 2h to provide a clean annealing. 
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8.4 Quantification of oligonucleotides via UV absorption 
 
Firstly, the micromolar extinction coefficients at 260 nm (εµm, 260) of the oligonucleotides 
were calculated according to a standard incremental method, which applies the following 
empirical equation. (Eq. 1)[109, 110]: 
 
 εµm, 260 = [ (8.8 x nT) + (7.3 x nC) + (11.7 x nG) + (15.4 x nA) ] x 0.9 (1) 
 
Secondly, the absorption at 260 nm of the corresponding aqueous oligonucleotides solutions 
was determinated using a Quartz UV-transparent cell (d = 10 mm), and the amount calculated 
applying the Beer-Lambert Law (Eq. 2): 
 
    AU = ε . c . d   (2) 
 
 
8.5 Mass determination 
 
Probes which contained salts were de-salted by Reversed-Phase ZipTip (MILLIPORE) prior 
to mass determination. A solution of the analyte (1 µl) was mixed on the sample plate 
together with the appropriate matrix solution and crystallized on air. Tetraphenylporphyrin 
(Mw = 614.2) and tetraestertryphenylporphyrin (Mw = 846.27) were used for the calibration of 
the spectrometer device. 
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9 Preparation of components for the porphyrin synthesis  
9.1 Synthesis of the dipyrromethane with ester chain 
 
3-ester-2, 4-diketone 14: 
 
 
O O
CO2Et
CO2Et
O OO O
CO2Et
+ +
11 12 14 72
EtOH
Na
 
 
Sodium (0.44 g, 0.02 mol) was dissolved in ethanol (300 ml), then 2,4-pentadione 11 (103 ml, 
1 mol, 1 eq) was added after the sodium was dissolved, followed by ethyl acrylate 12 (109 ml, 
1 mol, 1.0 eq). The reaction mixture was heated under reflux for 2h, and then kept at RT 
overnight. Acetic acid (0.66 g, 0.01 mol) was added and the solution stirred for an additional 
30 min. After removal of all volatiles under reduced pressure, ethyl 4-acetyl-5-oxohexanoate 
14 (110 g, 0.55 mol, 55 %) could be isolated as a yellowish oil after distillation under 
vacuum. 
 
C10H16O4: 200.10 g/mol 
 
bp: 110°C at 0.13 mbar 
 
TLC: Rf = 0.32; EA:Hex (1:3) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.14 (2H, m, -OCH2CH3); 3.75 (1H, t, 3JHH = 7.0 Hz, 
-CHCOCH3); 2.3 (2H, m, -CH2-CO2Et); 2.21 (6H, s, -COCH3); 2.16 (2H, dt, 3JHH = 7.2 Hz, 
4JHH = 2 Hz, -CH2-CH2CO2Et), 1.26 (3H, t, 3JHH = 7.2 Hz, -CO2CH2CH3). 
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Ester derivated pyrrol 18: 
 
O
O O
N
HO
+
O O
CO2Et
O
O O
H
NBnO2C
16
17 14
18
NaNO2/H2O
AcOH
Zn
AcOH
CO2Et
 
 
A solution of sodium nitrite (47.7 g, 0.68 mol, 3 eq) in water (100 ml) was added to a well 
stirred solution of benzoyl acetoacetate 16 (100.3 g, 0.52 mol, 1 eq) in acetic acid (165 ml, 
2.6 mol, 5 eq) over an hour at 10°C. After stirring the cooled solution for 4 further h, it was 
kept at RT overnight to yield oxime 17. 
The previous reaction mixture was added to a suspension of 3-hexyl-2,4-diketone 14 (110 g, 
0.55 mol, 1 eq) and Zinc dust (68.9 g, 1.04 mol, 2 eq.) in acetic acid (165 ml, 2.7 mol, 5.2 eq) 
over 1h at 60°C. The solution was stirred at 100°C for 45 min then 1h at RT. The reaction 
mixture was poured into an ice-water bath. The ester was separated by filtration, washed with 
water, dissolved in DCM and evaporated. Recrystallisation in ethanol at -18°C gave the ester 
derivated pyrrol 18 (142,5 g, 0.43 mol, 83 %). 
 
C19H23NO4: 329.16 g/mol 
 
TLC: Rf = 0.28, EA:Hex (1:3), turns orange with phosphomolybdic acid solution. 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.89 (1H, s, -NH); 7.36 (5H, m, -C6H5); 5.27 (2H, s, 
-OCH2-C6H5); 4.11 (2H, m, -CO2CH2CH3); 2.68 (2H, t, 3JHH = 8 Hz, -CH2CO2Et); 2.40 (2H, 
m, -CH2CH2CO2Et); 2.28 (3H, s, -CH3 (α)); 2.19 (3H, s, -CH3 (β)); 1.22 (3H, t,-CO2CH2CH3). 
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α-Acetyl ester derived pyrrole 73: 
 
H
NBnO2C
H
NBnO2C
O
O
18 73
Pb(OAc)4
Acetic acid
CO2Et CO2Et
 
 
 
The α-acetylation of the ester-derived pyrrole 18 (142.5 g, 0.43 mol, 1 eq) was achieved by 
treatment with lead acetate (230 g, 0.52 mol, 1.2 eq) in acetic acid (220 ml, 3.5 mol, 8 eq). 
The reaction mixture was stirred for 3h at RT, then 100ml methanol was added and the 
mixture was kept in the fridge (-18°C) to obtain a white precipitate  73 (116 g, 0.31 mol,  
73 %) which was filtered and kept under inert atmosphere (else it turns pink). 
 
C21H25NO6: 387.17 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.38 (1H, s, -NH); 7.40 (5H, m, -C6H5); 5.27 (2H, s, 
-OCH2-C6H5); 5.02 (2H, s, -CH2CO2CH3); 4.09 (2H, m, -CO2CH2CH3); 2.73 (4H, m,  
-C2H4CO2Et); 2.26 (3H, s, -CO2CH3); 2.02 (3H, s, -CH3 (β)); 1.21 (3H, t, -CO2CH2CH3). 
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Dipyrromethane with ester chain 20 
 
 
H
NBnO2C
O
O
H
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R
H
N CO2Bn
R
R =
C2H4CO2Me
73 20
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MeOH
CO2Et
 
 
Dimerisation of acetylated pyrrole 73 (116 g, 0.31 mol) was obtained by refluxing compound 
73 in hydrochloric acid 37% (155 ml) and methanol (400 ml) for 3h, then the solvent was 
evaporated. The crude product was dissolved in DCM, washed with a sat. aqueous NaHCO3 
solution and water. Recrystallisation in MeOH at -18°C gave the dipyrromethane 20 (22.9 g, 
37 mmol, 12%) as a yellowish powder. 
 
C35H38N2O8: 614.26 g/mol 
 
MALDI-TOF: m/z: 614.02 [M·]+ 
 
TLC: Rf = 0.1; Hex/EA, (5:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.08 (2H, s, -NH); 7.36-7.39 (10H, m, -C6H5); 5.24 
(4H, s, -OCH2-C6H5); 3.96 (2H, s, -CH2- meso); 3.56 (6H, s, -CH3 (β)); 2.75 (4H, t,  
3JHH = 7.0 Hz, -CH2CH2CO2Et); 2.51 (4H, t, 3JHH = 7.0 Hz, -CH2CH2CO2Et); 2.28 (6H, s,  
-CO2CH3). 
 
 
 
 
Preparation of Components for the Porphyrin Synthesis  147 
9.2 Synthesis of the dipyrromethane with hexyl chain 
 
3-hexyl-2,4-diketone 15: 
 
 
O O
I
O O O O
+ +
11 13 15 74
K2CO3
Acetone
 
 
 
1-Iodohexane 13 (100 ml, 0.68 mol, 1.07 eq) and 2, 4-pentadione 11 (65.3 ml, 0.64 mol,  
1 eq) were treated with potassium carbonate (93.7 g, 0.68 mol, 1.07 eq) in 250 ml acetone for 
24 h at 60°C, to give 3-hexyl-2,4-diketone 15 and undecane-2,4-dione 74. The reaction 
mixture was filtred and washed with acetone. After removal of all volatiles under reduced 
pressure, 3-hexyl-2, 4-diketone 15 (73 g, 0.39 mol, 58%) could be isolated as a yellow oil 
after distillation under vacuum. 
 
C11H20O2: 184.15 g/mol 
 
bp: 68°C with 0.06 mbar (Lit.:[111] 123-124°C with 21.3 mbar). 
 
TLC: Rf = 0.56, PE:EA (1:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 3.62 (1H, t, 3JHH = 7.0 Hz, -CH-meso); 2.18 (6H, s, 
 -CH3); 1.84 (2H, dt, 3JHH = 7.3 Hz,  3JHH = 7.0 Hz, -CH2-C5H11); 1.31 (8H, m, -CH2-C4H8-
CH3); 0.88 (3H, t, 3JHH = 6.7 Hz, -C5H10-CH3). 
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hexyl derivated pyrrol 19: 
 
 
O O
15
+
O
O O
O
O O
N
HO
NaNO2
H2O/AcOH
Zn
AcOH
H
N
C6H13
R
R = CO2Bn
16
17
19
 
 
 
Sodium nitrite (12.0 g, 0.17 mol, 1.0 eq) in water (27 ml) was added to benzoyl acetoacetate 
16 (30 ml, 0.17 mol, 1.0 eq) in acetic acid (33.8 ml, 0.59 mol, 3.4 eq) over one hour at 10°C. 
Then, the mixture was stirred at 10°C for 4h, and at RT overnight, to yield oxime 17. 
 
The previous reaction mixture was added to a suspension of 3-hexyl-2,4-diketone 15 (32 g, 
0.17mol) and Zinc dust (33.7 g, 0.52 mol, 3.0 eq.) in acetic acid (46 ml) over 1h at 60°C. The 
solution was stirred at 100°C for 45 min and 1h at RT. The reaction mixture was poured into 
an ice-water bath. The ester was separated by filtration, washed with water, dissolved in DCM 
and evaporated. Recrystallisation in ethanol at -18°C gave the hexyl derivated pyrrol 19 (9 g, 
28 mmol, 17%). 
 
C20H27NO2: 313.20 g/mol 
 
TLC: Rf = 0.69; PE:EA (2:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.73 (1H, t, s, -NH); 7.36-7.33 (5H, m, -C6H5); 5.29 
(2H, s, -OCH2-C6H5); 2.33 (2H, t,  3JHH = 7.6 Hz, -CH2-C5H11); 2.28 (3H, s, -CH3), 2.17 (3H, 
s, -CH3); 1.40 (2H, m, -CH2-CH2-C4H9); 1.28 (6H, m, -C2H4-C3H6-CH3); 0.88 (3H, t,  
3JHH = 7.0 Hz, -C5H10-CH3). 
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α-Acetyl hexyl derived pyrrole 75: 
 
 
H
N
C6H13
19
H
N
C6H13
O
O
75
Pb(OAc)4
HOAcO
O
O
O
 
 
The α-acetylation of hexyl-derived pyrrole 19 (9 g, 28.9 mmol, 1 eq) was achieved by 
treatment with lead acetate (12.3 g, 28.7 mmol, 1 eq) in acetic acid (45 ml). The mixture was 
stirred for 30 min at 120°C and 1h at RT. The reaction mixture was evaporated to a volume of 
20 ml, and 50 ml of methanol were added to crystallise the product. A white precipitate 75 
(2.45 g, 6.6 mmol, 23%) which was filtered and kept under inert atmosphere (else it turns to 
pink). 
 
C22H29NO4: 371.21 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.12 (1H, s, -NH); 7.37-7.34 (5H, m, -C6H5); 5.00 
(2H, s, -CH2-CO2CH3); 2.42 (2H, t,  3JHH = 7.6 Hz, -CH2-C5H11); 2.28 (3H, s, -CH3), 2.06 
(3H, s, -CO2CH3); 1.31-1.29 (8H, m, -CH2-C4H8-CH3); 0.88 (3H, t, 3JHH = 6.7Hz, -C5H10-
CH3). 
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Dipyrromethane with hexyl chain 21: 
 
 
H
N
C6H13
R
H
N
R
H
N
C6H13
R
O
O
75
R = CO2Bn
21
HCl
MeOH
C6H13
 
 
Dimerisation of acetylated pyrrole 75 (2.45 g, 6.85 mmol) was obtained by refluxing in 
hydrochloric acid 37% (1.3 ml) and methanol (40 ml). The mixture was refluxed for 3h, and 
the solvent was evaporated. The crude product was dissolved in DCM, washed with a solution 
of NaHCO3 sat. and water. Recrystallisation in MeOH (-18°C) overnight gave the 
dipyrromethane 21 (1.45 g, 2.38 mmol, 35%) as a brown precipitate. 
 
C39H50N2O4: 610.38 
 
TLC: Rf = 0.1; Hex/EA, (5:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.12 (2H, s, -NH); 7.35-7.32 (10H, m, -C6H5); 5.27 
(4H, s, -CH2-CO2CH3); 3.82 (2H, s, -CH2-meso); 2.34 (4H, t,  3JHH = 7.6 Hz, -CH2-C5H11); 
2.28 (6H, s, -CH3); 1.25-1.22 (8H, m, -CH2-C4H8-CH3); 0.86 (6H, t,  3JHH = 6.8Hz, -C5H10-
CH3). 
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9.3 Synthesis of the derivate benzaldehyde 
 
3, 5-Di-tert-butyltoluene 5: 
 
 
tButBu
AlCl3
ClC(CH3)3
4 5
 
 
 
Aluminium trichloride (3.96 g, 0.03 mol) was added in 8 portions, over 8h, to a rapidly stirred 
solution of 2-chloromethylpropane (166 ml, 1.53 mol, 2 eq) in toluene 4 (81.6 ml, 0.77 mol, 
1 eq) in a 500 ml round bottomed flask fitted with a silicon oil bubbler. After 12h, water was 
added and the product was extracted with Et2O. The solvent was removed under reduced 
pressure and the residue purified by vigreux distillation. The crude crystalline product 5  
(81.1 g, 0.39 mol, 52 %) was used without further purification. 
 
C15H24: 204.35 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.25-7.49 (m, 2H, Haro); 7.05-7.02 (m, 1H, Haro); 
2.36 (s, 3H, -CH3); 1.33 (18H, s, -C(CH3)3). 
 
 
3,5-Di-tert-butyl-bromomethylbenzene 6: 
 
tButBu tButBu
Br
AIBN
N-bromosuccinimide
CCl4
5 6
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A mixture of 3,5-Di-tert-butyltoluene 5 (35.95 g, 0.176 mol), N-Bromosuccinimide (47.3 g, 
0.23 mol, 1.3eq), and AIBN (azo-bis-isobutyronitrile) (157.6 mg, 0.88 mmol) in 
tetrachloromethane (130 ml) was refluxed for 3h. The solution was cooled and the solvent 
was removed by distillation. The residue was dissolved in dichloromethane, the precipitated 
filtered and the product concentrated by distillation. The crude product 6 (22g, 78 mmol, 
44%) was used without further purification in the next step. 
 
C15H23Br: 282.10 g/mol 
 
 
3,5-Di-tert-butylbenzaldehyde 7: 
 
 
tButBu
tButBu
Br O
HMTA
HCl
MeOH/H2O
6 7  
 
 
A mixture of 3,5-Di-tert-butyl-bromomethylbenzene 6 (22g, 78 mmol) and HMTA 
(hexamethylenetetramine) (102.4 g, 0.73 mol) in methanol/water (200 ml, 1:1) was refluxed 
for 4h. Concentrated aqueous HCl (60 ml) was added dropwise and the mixture refluxed for 
0.5h. The solution was cooled and extracted into dichloromethane (3x150 ml), the solvent 
removed under reduced pressure and the residue recrystallised from ethanol/water to give the 
compound 7 (12 g, 55 mmol, 70%) as a white crystalline solid. 
 
C15H22O: 218.17 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.00 (1H, s, CHO); 7.71 (m, 3H, Haro); 1.33 (18H, 
s, -C(CH3)3). 
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4-(3-hydroxy-3-methylbut-1-ynyl)benzaldehyde 3: 
 
 
OH
H
O
OH
H
O
Br H+
K2CO3
CuI
Pd(Ph3)4
Pd/C
1 2 3
 
 
 
A suspension of 4-bromobenzaldehyde 1 (10 g, 50 mmol), K2CO3 (34.3 g, 250 mmol, 5 eq), 
CuI (0.77 g, 4 mmol, 0.08 eq), triphenylphosphine (2.1 g, 8 mmol, 0.16 eq), palladium on 
activated charcoal (2.1 g, 2 mmol, 0.08 eq) in dimethoxyethane/water (60 ml/60ml) was 
degassed with argon and stirred at RT for 30 min. Then, 2-methylbut-3-yn-2ol 2 (24.5 ml,  
250 mmol, 5 eq) was added dropwise via syringe, and the mixture heated at 80°C for 16h. The 
suspension was filtered over celite, extracted with 35 ml acetic acid. The organic phase was 
washed with water (2x20 ml), dried over MgSO4 and evaporated. The residue was purified by 
flash chromatography (ethyl acetate/hexane, gradient from 1:4 to 1:3) to obtain the pure 
product 3 (8.8 g, 47 mmol, 87 %) as yellow oil. 
 
C12H12O2: 188.08 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.93 (1H, s, -CHO), 7.75 (2H, d, J = 8.29, -C6H5), 
7.49 (2H, d, J = 8.29, -C6H5), 1.89 (1H, s, -OH), 1.57 (6H, s, -CH3). 
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Diethyl 3-(dioxolan-2’-yl)phenylphosphonate 9: 
 
 
Br
O
O
P
O
O
O O
O
TEA
Pd/C
P(Ph3)3
Toluene
ClOP(OEt)3
8 9
 
 
 
Diethyl phosphonate (3.3 ml, 21.8 mmol, 1.1 eq) and triethylamine (3.4 ml, 24 mmol, 1.1 eq) 
were added via syringe to 2-(3-bromophenyl)-1,3-dioxolane 8 (3.32 ml, 24 mmol, 1 eq) in 
toluene (5 ml) under argon. Palladium on activated Charcoal (1.6 g, 1.22 mmol, 0.05 eq.) and 
triphenylphosphine (1.6 g, 4.88 mmol, 0.22 eq) were added, and the reaction was heated to 
95°C for 36 h. The crude product was filtered through Celite, washed with ether–hexane 
 (50:50 as eluent) and all volatiles were evaporated to yield the crude product as a deep yellow 
oil, purified by flash column chromatography (EE/Hex, 4:1) to give diethyl-3-(dioxolan-2’-
yl)phenylphosphonate (550 mg, 1.9 mmol, 10 %) as a yellow oil. 
 
C13H19O5P: 286.10 g/mol 
 
TLC: Rf = 0.20, EA, turned yellow with KMNO4 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.40–7.90 (4 H, m, -C6H4); 5.78 (1 H, s, -CH(OR); 
4.10-3.98 (8H, m, –CH2CH3, –OCH2CH2O–); 1.29 (6 H, t, J = 6.2, -CH2CH3). 
 
31P-NMR (167 MHz, CDCl3): δ (ppm) = 13.3 (s) 
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1-diethyl (3-carbonylphenyl)phosphonate 10: 
 
 
P
O
O
O O
O
P
H
O O
O
O
Si
DCM
Sulf uric acid
9 10  
 
 
Aqueous 15% sulfuric acid (0.6 ml) was adsorbed onto silicagel (5 g) suspended in DCM  
(14 ml). Diethyl 3-(dioxolan-2- yl)-phenylphosphonate 9 (0.55 g, 1.9 mmol) was then added 
in DCM (14 ml) and the reaction stirred for 24 h at RT. The mixture was filtered, washed with 
DCM (150 ml), and solvent removed in vacuo. The crude product was purified by flash 
column chromatography to afford diethyl (3-carbonylphenyl)phosphonate 10 (0.25 g, 1 mmol, 
54 %) as a yellow oil. 
 
C11H15O4P: 242.07 g/mol 
 
TLC: Rf = 0.28, EA/PE, (70:30) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.0 (1H, s, -CHO), 8.31 (1H, ddt, 4JHH = 0.6 Hz, 
3JHH = 1.5 Hz, 3JHP = 12.8 Hz, -CH(o)), 8.05-8.09 (2H, m, -CH(o) and -CH(p)), 7.45–7.66 (1H, 
m, -CH(m)), 4.10–4.20 (4H, m,–CH2CH3), 1.36 (6H, t, J = 6.7, –CH2CH3),  
 
 
31P-NMR (167 MHz, CDCl3): δ (ppm) = 13.5 (s) 
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9.4 Synthesis of the protected oligonucleotides 
 
3’,5’-Bis-O-tert.-butyldiphenylsilyl-5’-iodo-uracil 28: 
 
O
OTBDMS
NTBDMSO
HN
O
O
I
O
OH
NHO
HN
O
O
I TBDMS-OTf
Imidazole
2826  
 
1 g (2.82 mmol, 1 eq.) of 5-iododeoxyuridine 26 was dried three times by co-evaporation with 
pyridine (3×2 ml), and suspended in DMF (10 ml). 0.81 g (11.8 mmol, 4.2 eq.) of imidazol 
was added, followed by a slow addition of tert.-butyldimethylsilylchloride (1.3 ml, 5.7 mmol, 
2 eq.) via syringe in a ice bath. The reaction mixture was stirred for 2h at O°C and then 2h at 
RT. The solution was poured into 10 ml of 10 % aqueous tartaric acid, and the mixture was 
extracted 3 times with AcOEt. The organic phase was washed with H2O (25 ml), NaCl sat. 
and dried over Na2SO4. After removal of all the solvent under reduced pressure, the residue 
was kept in the Kugelrohr at 40°C for 3h. A flash chromatography on silica gel 
(CH2Cl2/MeOH 50:1) gave the protected iodouracil 28 (1.46 g, 2.51 mmol, 90 %) as a white 
foam.  
 
C21H39IN2O5Si2: 582.14 g/mol 
 
Maldi-TOF: m/z: 582.73 [M·]+ 
 
TLC: Rf: 0.58, DCM/MeOH (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.16 (s, 1H, -NH), 8.09 (s, 1H, H-(6)), 6.28-6.25  
(m, 1H, H-1’), 4.40-4.38 (m, 1H, H-3’), 3.99-3.98 (m, 1H, H-4’), 3.90-3.86 (m, 1H, H-5’),  
3.77-3.74 (m, 1H, H-5’), 2.28 (m, 1H, H-2’), 2.01-1.98 (m, 1H, H-2’), 0.94 (s, 9H,  
-SiC5’(CH3)3), 0.89 (s, 9H, -SiC3’(CH3)3), 0.14 (d, J = 4.28 Hz, 6H, -Si(CH3)2), 0.07  
(d, J = 3.28 Hz, 6H, -Si(CH3)2). 
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5’-O-tert.-butyldimethylsilyl-5’-iodo-uracil 28: 
 
 
O
OH
NTBDMSO
HN
O
O
I
O
OH
NHO
HN
O
O
I TBDMS-OTf
Imidazole
DMF
26 27  
 
 
The 5’-O-tert.-butyldiphenylsilyl-5’-iodo-uracil 27 was prepared according to the general 
procedure described for derivative 28. The reaction time was reduced to the half. The residue 
was diluted in warm CH2Cl2 (4 ml) and precipitated with hexane (15 ml). The precipitate was 
filtrated and washed with hexane. The compound 27 was obtained as white foam (362 mg, 
0.62 mmol, 22 %). 
 
C15H25IN2O5Si: 468.06 g/mol 
 
TLC: Rf: 0.72, CH2Cl2/MeOH (3:2) 
 
Maldi-TOF: m/z: 468.37 [M·]+ 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.52 (s, 1H, -NH), 8.10 (s, 1H, H-(6)), 6.31-6.28 
 (m, 1H, H-1’), 4.48-4.47 (m, 1H, H-3’), 4.09-4.08 (m, 1H, H-4’), 3.90-3.89 (dd, 1H, H-5’), 
3.85-3.84 (dd, 1H, H-5’), 2.44-2.39 (m, 2H, H-2’), 2.08 (m, 1H, 3’-OH), 0.93 (s, 9H,  
-SiC5’(CH3)3, 0.14 (s, 6H, -Si(CH3)2). 
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3’-O-tert-butyldimethylsilyl-5-iodo-uracil 29: 
 
 
O
OTBDMS
NTBDMSO
HN
O
O
I
O
OTBDMS
NHO
HN
O
O
IAcOH
H2O-THF 1:1
O
OTBDMS
NDMTO
HN
O
O
I
Route 1
Route 2Cl2CHCO2H
DCM
28 29
76  
 
 
Synthetic route 1: 
 
 
400 mg (0.69 mmol, 1eq) of 3’,5’-bis(tert-butyldimethylsilyl)5-5’-iodo-uracil 28 were 
dissolved in THF (4 ml) followed by addition of a mixture of acetic acid (3.3 ml) and H2O  
(1 ml). The reaction mixture was stirred at 35°C for 4 days under argon, and diluted with 
CH2Cl2 (7 ml). The organic layer was washed with NaHCO3 (3 × 12 ml), H2O (2 × 8 ml), 
NaCl (1 × 12 ml), and dried over Na2SO4. Filtration and evaporation of the solvent under 
reduced pressure yielded the crude product which was purified by a flash chromatography on 
silica gel (CH2Cl2/MeOH 100:0.5) to yield 117 mg (0.25 mmol, 36 %) of  
3’-O-tert-butyldimethylsilyl-5’-iodo-uracil 29 as a white foam. 
 
 
 
Preparation of Components for the Porphyrin Synthesis  159 
Synthetic route 2: 
 
 
300 mg (0.369 mmol, 1eq) of 3’-(tert-butyldimethylsilyl)-5’-O-DMT-iodo-uracil 76 were 
dissolved in DCM (10 ml), and 0.3 ml of dichloroacetic acid were added. The reaction 
mixture was stirred at RT for 30 min. The organic layer was washed with NaHCO3 and dried 
over Na2SO4. Filtration and evaporation of the solvent under reduced pressure yielded the 
crude product which was purified by a flash chromatography on silica gel (CH2Cl2/MeOH) 
from 0.5 % to 10 %) to yield 135 mg (0.29 mmol, 75 %) of 3’-O-tert-butyldimethylsilyl-5’-
iodo-uracil 29 as a white foam. 
 
C15H25IN2O5Si: 468.06 g/mol 
 
TLC: Rf: 0.52, CH2Cl2/MeOH (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.22 (s, 1H, -NH), 8.03 (s, 1H, H-(6)), 6.14-6.15 
 (m, 1H, H-1’), 4.49-4.48 (m, 1H, H-3’), 3.98-3.97 (m, 2H, H-5’), 3.81-3.78 (m, 1H, H-4’), 
2.28-2.27 (m, 2H, H-2’), 2.00 (m, 1H, 5’-OH), 0.89 (s, 9H, -SiC3’(CH3)3), 0.08 (s, 6H,  
-Si(CH3)2). 
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5’-O-DMT-iodo-uracile 30: 
 
 
O
OH
NDMTO
HN
O
O
I
O
OH
NHO
HN
O
O
I DMTr-Cl
TEA
26 30
 
 
 
5’-iodo-uracil 26 (2 g, 5.65 mmol, 1 eq) was co-evaporated with 3×2 ml pyridine and 
dissolved in 15 ml of pyridine with molecular sieves (4 Å) under argon. After one and a half 
hours, TEA (1.6 ml, 11.29 mmol, 2 eq) was added followed by the addition of dimethoxytrityl 
chloride (2.49 g, 7.34 mmol, 1.3 eq). The reaction mixture was stirred overnight at RT, and 
diluted with AcOEt (100 ml). The solution was washed with NaHCO3 (2 × 100 ml) and H2O 
(75 ml). The aqueous layer was extracted again with AcOEt and the combined organic layers 
were dried over NaSO4. After removal of all volatiles under reduced pressure, flash 
chromatography (CH2Cl2/MeOH 20:1 + 1 % TEA) afforded 2.32 g (3.54 mmol, 63 %) of  
5’-O- DMT -5’-iodo-uracile 30 as white foam. 
 
C30H29IN2O7: 656.10 g/mol 
 
Maldi-TOF: m/z: 656.47 [M·]+ 
 
TLC: Rf: 0.7, CH2Cl2/MeOH (20:1) +1% TEA 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.13 (s, 1H, -NH), 7.41 (d, J = 7.2 Hz, 2H, Haro), 
7.33-7.24 (m, 6H, Haro), 7.22 (s, 1H, H-(6)), 6.85 (d, J = 9.2 Hz, 4H, Haro), 6.33-6.28 (m, 1H, 
H-1’), 4.55-4.54 (m, 1H, H-3’), 4.09-4.08 (m, 1H, H-4’), 3.80 (s, 6H, -O-CH3) 3.40-3.37 (m, 
2H, H-5’), 2.50-2.45 (m, 2H, H-2’), 2.30 (m, 1H, 3’-OH). 
 
Porphyrin Synthesis  161 
10 Porphyrin Synthesis 
10.1 Zn Diphenylporphyrin with ester chain 
 
Protected acetylene porphyrin 77 
 
N HN
NH N
O OO O
O OOO
OH
H
N
H
N
CHO
HO
CHO
CO2MeMeO2C
CO2BnBnO2C
1. H2, Pd-C
2. TFA
3. DDQ++
20
3
26
77  
 
 
To a solution of dipyromethane 20 (4 g, 6.8 mmol, 2 eq) in THF (50 ml), MeOH (6 ml), TEA 
(2 ml), and finally 320 mg of Pd/C (10%) were added. The reaction mixture was degassed 
with H2 for 30 min, and kept under H2 for 2h at rt. After filtration of the reaction mixture via 
canula under Ar, the residue was washed twice with a 10:1 degassed mixture of THF and 
MeOH. After removal of the solvent under reduced pressure, the oily residue was dried at the 
vacuum line for several hours to give a white foam (rf = 0, Hex/EE, 5:1). The resulting 
deprotected dipyrromethane was dissolved in degassed TFA (35 ml) at O°C under Ar. The 
reaction mixture was stirred in the dark at O°C for 10 min, and then at RT for 1.5 h until 
everything was dissolved. 0.34 ml (3.4 mmol, 1 eq.) of benzaldehyde and 0.96 g (10.2 mmol, 
1.5 eq.) of the alkynyl-benzaldehyde were dissolved in 70 ml of MeOH, the solution was 
degassed with Ar, and added to the reaction mixture over a period of 30 min at -10°C via 
canula. The mixture was allowed to stir at RT for 2h, and DDQ (2.32 g, 10.2 mmol) was 
added. The dark green solution was stirred for 1.5 h (in the light), diluted with CH2Cl2 (50 ml) 
and neutralised with TEA (36 ml) in an ice bath. The organic layer was washed 3 times with 
water and NaCl sat., dried over Na2SO4, and filtered. After removal of all volatiles under 
reduced pressure, flash chromatography (CH2Cl2/AcOEt 10:1) followed by a crystallisation 
(CHCl3/MeOH) afforded 552 mg (574 µmol, 8.5%) of the protected diphenylporphyrin as a 
purple solid. 
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C57H60N4O9: 944.4 g/mol 
 
Maldi-TOF: m/z: 946.11 [M·]+ 
 
TLC: Rf = 0.33, CH2Cl2/AcOEt (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.26 (s, 2H, H-meso), 8.04-8.01 (m, 4H, H-aro), 
7.99-7.74 (m, 5H, H-aro), 4.35 (m, 8H, -CH2-CH2-CO2Me), 3.66 (s, 12H, -OCH3), 3.15  
(m, 8H, -CH2-CH2-CO2Me), 2.50 (d, J = 12.4 Hz, 12H, -CH3), 1.79 (s, 6H, -C(CH3)2OH), 
2.43  (s, 2H, -NH). 
 
 
Zinc protected acetylene diphenylporphyrin 78:  
 
 
N HN
NH N
O OO O
O OOO
OH
N N
N N
O OO O
O OOO
OHZn
Zn(OAc)2.2H2O
CHCl3/MeOH
77 78  
 
 
To a solution of protected diphenylporphyrin 77 (150 mg, 156 µmol, 1eq) in a 1:5 mixture of 
MeOH and CHCl3 (6ml), 1.71 g (7.8 mol, 50 eq.) of zinc acetate were added. The mixture 
was refluxed for 5 min. After removal of the solvent under reduced pressure, the residue was 
dissolved in CH2Cl2; the white solid was filtered off and washed with CH2Cl2. The solvent 
was removed under reduced pressure, and the zinc protected diphenylporphyrin 78 (160 mg, 
156 µmol, 100%) were isolated as a red solid. 
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C57H58N4O9Zn: 1006.35 g/mol 
 
Maldi-TOF: m/z: 1009.3 [M·]+ 
 
TLC: Rf = 0.35, CH2Cl2/AcOEt (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.20 (s, 2H, H-meso), 8.04-8.01 (m, 4H, H-aro), 
7.99-7.74 (m, 5H, H-aro), 4.34-4.30 (m, 8H, -CH2-CH2-CO2Me), 3.68 (s, 12H, -O-CH3), 3.15 
(m, 8H, -CH2-CH2-CO2Me), 2.46 (d, J = 12.4 Hz, 12H, -CH3), 1.79 (s, 6H, -C(CH3)2OH). 
 
 
Zinc acetylene diphenylporphyrin 22:  
 
 
N N
N N
O OO O
O OOO
Zn
N N
N N
O OO O
O OOO
HZnOH
NaOMe
Toluene
78 22  
 
Zinc protected diphenylporphyrin 78 (160 mg, 159 µmol, 1 eq.) was dissolved in anhydrous 
toluene (25 ml), and sodium methoxide (260 mg, 4.68 mmol, 30 eq.) was added. The reaction 
mixture was refluxed under Ar for 4h. The solution was diluted with toluene (20 ml), and the 
organic layer was washed with 2M HCl (2 × 10 ml), brine (2×10 ml), and dried over NaSO4. 
After removal of all volatiles at reduced pressure, recrystallisation from CHCl3/MeOH gave 
the diphenylporphyrin 22 (110 mg, 114 µmol, 73%) as a red solid. 
 
C54H52N4O8Zn: 948.31 g/mol 
 
Maldi-TOF: m/z: 949.6 [M·]+ 
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TLC: Rf = 0.85, CH2Cl2/AcOEt (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.21 (s, 2H, H-meso), 8.05-8.03 (m, 4H, H-aro), 
7.90-7.70 (m, 5H, H-aro), 4.32-4.30 (m, 8H, -CH2-CH2-CO2Me), 3.66 (s, 12H, -OCH3), 3.34 
(s, 1H, -CH), 3.14 (m, 8H, -CH2-CH2-C O2Me), 2.50 (d, , 12H, J = 12.4 Hz, -CH3). 
 
 
10.2 Zinc diphenylporphyrin with hexyl chain 
 
Protected acetylene diphenylporphyrin 79:  
 
 
N HN
NH N
OH
H
N
H
N
CHO
HO
CHOCO2BnBnO2C
1. H2, Pd-C
2. TFA
3. DDQ
+ +
21
3
26
79
 
 
To a solution of dipyrromethane 21 (4 g, 6.8 mmol, 2 eq.) 1 in THF (50 ml), MeOH (6 ml) 
and TEA (2 ml), Pd/C (320 mg, 10%) were added. The reaction mixture was degassed by 
bubbling H2 for 30 min, and kept under H2 for 2h at RT. After filtration of the reaction 
mixture via canula under Ar pressure, the residue was washed twice with a 10:1 degassed 
mixture of THF and MeOH. After removal of the solvent under reduced pressure, the oil 
residue was dried at the vacuum line for several hours to give white foam. The resulting 
deprotected dipyrromethane was dissolved in degassed TFA (35 ml) at O°C under Ar. The 
reaction mixture was stirred in dark at O°C for 10 min, and then at RT for 0.5 h until 
everything was dissolved. Benzaldehyde (0.34 ml, 3.4 mmol, 1 eq) and the alkynyl-
benzaldehyde (0.96 g, 10.2 mmol, 1.5 eq) were dissolved in MeOH (65 ml); the solution was 
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degassed with Ar, and added to the reaction mixture over 30 min at -10°C via canula. The 
mixture was allowed to stir at RT for 2h, and DDQ (2.32 g, 10.2 mmol) was added. The dark 
green solution was stirred overnight (in the light), diluted in CH2Cl2 (50 ml) and neutralised 
with TEA (36 ml) in an ice bath. The organic layer was washed 3 times with water and NaCl 
sat., dried over Na2SO4, and filtered. After removal of all volatiles at reduced pressure, flash 
chromatography (CH2Cl2/MeOH, 50:1) afforded (253 mg, 270 µmol, 4.2%) of the protected 
diphenylporphyrin 79 as a purple solid. 
 
C65H84N4O: 936.66 g/mol 
 
Maldi-TOF: m/z: 936.05 [M·]+ 
 
TLC: Rf = 0.45, DCM/EA (95:5) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.17 (s, 2H, H-meso), 8.08-8.05 (m, 4H, H-aro), 
7.89-7.73 (m, 5H, H-aro), 3.95 (m, 8H, -CH2-C5H11), 2.48 (d, J = 10 Hz, 12H, -CH3), 2.16 (m, 
8H, -CH2-CH2-C4H9), 1.83 (s, 6H, -C(CH3)2OH ), 1.71 (m, 8H, -C2H4-CH2-C3H7), 1.50-1.25 
(m, 16H, -C3H6-C2H4-CH3), 0.89-0.91 (m, 12H, -C5H10-CH3), -2.45 (s, 2H, -NH). 
 
 
Zinc acetylene diphenylporphyrin 24:  
 
 
N N
N N
HM
N HN
NH N
OH
1. NaOMe, Toluene
2. Zn(OAc)2.2H2O
79 80 M= 2H
24 M = Zn
 
 
166  Porphyrin Synthesis 
 
Protected diphenylporphyrin 79 (250 mg, 0.27 mmol, 1 eq.) was dissolved in anhydrous 
toluene (50 ml), and  sodium methoxide (406 mg, 7.52 mmol, 30 eq) was added. The reaction 
mixture was stirred at reflux under Ar for 3h. The solution was diluted with toluene (40 ml), 
and the organic layer was washed with 2M HCl (2×20 ml), brine (2×20 ml), and dried over 
NaSO4. Filtration and removal of all volatiles under reduced pressure gave the deprotected 
diphenylporphyrin 80 (150 mg, 150 µmol, 56%) as a purple solid. 
 
The deprotected diphenylporphyrin 80(150 mg, 150 µmol, 1eq) was in a 1:5 mixture of 
MeOH and CHCl3 (6ml), and zinc acetate (1.65 g, 7.5 mmol, 50 eq) was added. The mixture 
was refluxed for 5 min. After removal of the solvent at reduced pressure, the residue was 
dissolved in CH2Cl2 and the white solid was filtered off and then washed with CH2Cl2. The 
solvent was removed at reduced pressure, and flash chromatography (CH2Cl2/AcOEt, 50:1) 
afforded 141 mg (150 µmol, 100%) of the diphenylporphyrin 24 as a red solid. 
 
C62H76N4Zn: 940.66 g/mol 
 
Maldi-TOF: m/z: 940.54 [M·]+ 
 
TLC: Rf = 0.90, DCM/EA (95:5) 
 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.17 (s, 2H, H-meso), 8.08-8.05 (m, 4H, H-aro), 
7.89-7.73 (m, 5H, H-aro), 3.95 (m, 8H, -CH2-C5H11), 3.33 (s, 1H, -CH), 2.48 (d, J = 10 Hz, 
12H, -CH3), 2.16 (m, 8H, -CH2-CH2-C4H9), 1.71 (m, 8H, -C2H4-CH2-C3H7), 1.50-1.25  
(m, 16H, -C3H6-C2H4-CH3), 0.89-0.91 (m, 12H, -C10H5-CH3). 
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10.3 Zinc diphenylporphyrin bearing hexyl chain and di-
tertbutylbenzaldehyde 
 
Protected acetylene diphenylporphyrin 81: 
 
 
H
NBnO2C
H
N CO2Bn
N HN
NH N
OH
OH
OH
+ +
HO
3
7
21
81
1. H2, Pd-C
2. TFA
3. DDQ
 
 
 
To a solution of dipyrromethane 21 (4 g, 6.8 mmol, 2 eq.) 1 in THF (50 ml), MeOH (6 ml), 
TEA (2 ml), and finally Pd/C (320 mg, 10%) was added. The reaction mixture was degassed 
with H2 for 30 min, and kept under H2 for 2h at RT. After filtration of the reaction mixture via 
canula under Ar pressure, the residue was washed twice with a 10:1 degassed mixture of THF 
and MeOH. After removal of the solvent under reduced pressure, the oil residue was dried at 
the vacuum line for several hours to give white foam. The resulting deprotected 
dipyrromethane was dissolved in degassed TFA (35 ml) at O°C under Ar. The reaction 
mixture was stirred in dark at O°C for 10 min, and then at RT for half an hour until everything 
was dissolved. 0.72 g (3.4 mmol, 1 eq) of di-tertbutylbenzaldehyde 7 and 0.96 g (5.25 mmol, 
1.5 eq) of the alkynyl-benzaldehyde 3 were dissolved in MeOH (65 ml); the solution was 
degassed with Ar, and added to the reaction mixture in 30 min at -10°C via canula. The 
mixture was allowed to stir at RT for 2h, and DDQ (2.32 g, 10.2 mmol) was added. The dark 
green solution was stirred overnight (in the light), diluted in CH2Cl2 (50 ml) and neutralised 
with TEA (36 ml) in an ice bath. The organic layer was washed 3 times with water and NaCl 
sat., dried over Na2SO4, filtered and evaporated under reduced pressure. First flash 
chromatography on basic alox (DCM) removed the first porphyrin (symetric  
di-tertbutylporphyrin), a second flash chromatography on silica gel (CH2Cl2/MeOH, 50:1) 
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gave the desired porphyrin. A final recrystallisation (CHCl3/MeOH) afforded 356 mg  
(0.34 mmol, 10%) of the protected diphenylporphyrin 81 as a purple solid. 
 
C73H100N4O: 1048.79 g/mol 
 
Maldi-TOF: m/z: 1048.6 [M·]+ 
 
 
Zinc acetylene diphenylporphyrin 25: 
 
 
N N
N N
N HN
NH N
HO
81
1. NaOMe, Toluen
2. Zn(OAc)2.2H2O
M
82 M = 2H
25 M= Zn
 
 
 
The protected diphenylporphyrin 81 (356 mg, 0.34 mmol, 1 eq) was dissolved in anhydrous 
toluene (60 ml), and 850 mg (0.15 mol, 45 eq) of sodium methoxide was added. The reaction 
mixture was stirred at reflux under Ar for 4h. The solution was diluted with toluene (60 ml), 
and the organic layer was washed with 2M HCl (2×30 ml), brine (2×30 ml), dried over NaSO4 
and evaporated at reduced pressure. We obtained the deprotected diphenylporphyrin (247 mg, 
0.25 mmol, 73%) 82 as a red solid. 
 
To a solution of deprotected diphenylporphyrin 82 (247 mg, 0.25 mmol) in a 1:5 mixture of 
MeOH and CHCl3 (25ml), 2.7 g (12.5 mmol, 50 eq) of zinc acetate was added. The mixture 
was refluxed for 5 min. After removal of the solvent under reduced pressure, the residue was 
dissolved in CH2Cl2 and the white solid was filtered off and then washed with CH2Cl2. The 
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solvent was removed under reduced pressure, and a flash chromatography (CH2Cl2) gave the 
desired diphenylporphyrin 25 (256 mg, 0.25 mmol, 74%) as a red solid. 
 
C70H92N4Zn: 1052.66 g/mol 
 
Maldi-TOF: m/z: 1052.5 [M·]+ 
 
TLC: Rf = 0.95, (CH2Cl2) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.19 (s, 2H, H-meso), 8.06 (m, 2H, H(m)-C6H4), 
7.92 (m, 2H, H(o)-C6H3), 7.87 (m, 2H, H(o)-C6H4), 7.80 (m, 1H, H(p)-C6H3), 3.96 (m, 8H,  
-CH2-C5H11), 3.33 (s, 1H, HC≡C-), 2.45 (d, 12H, J = 10 Hz, 4x -CH3), 2.17 (m, 8H,  
-CH2-CH2-C4H9), 1.73 (m, 8H, -C2H4-CH2-C3H7), 1.53-1.48 (m, 26H, -C3H6-CH2-C2H5 +  
-C(CH3)3), 1.38 (m, 8H, -C4H8-CH2-CH3), 0.90 (m, 12H, -C10H5-CH3). 
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10.4 Zinc diphenylporphyrin bearing hexyl chain and phosphonate group 
 
Synthesis of the acetylene phosphonate diphenylporphyrin 23: 
 
 
H
N
BnO2C
H
N CO2Bn
N N
N N
Zn
OH
OH
OH
P
OEt
O OEt
P
OEt
O OEt
+ +
1. H2, Pd-C
2. TFA
3. DDQ
4. NaOMe, Toluen
5. Zn(OAc)2.2H2O
3
10
21
23
 
To a solution of dipyrromethane 21 (0.82 g, 1.34 mmol, 2 eq.) 1 in THF (12 ml), MeOH  
(1.5 ml) and TEA (0.3 ml), Pd/C (70 mg, 10%) was added. The reaction mixture was 
degassed with H2 for 30 min, and kept under H2 for 2h at RT. After filtration of the reaction 
mixture via canula under Ar, the residue was washed twice with a 10:1 degassed mixture of 
THF and MeOH. After removal of the solvent under reduced pressure, the oil residue was 
dried at the vacuum line for several hours to give white foam. The resulting deprotected 
dipyrromethane was dissolved in degassed TFA (8 ml) at 0°C under Ar. The reaction mixture 
was stirred in dark at 0°C for 10 min, and then at RT for half an hour until everything was 
dissolved. Diethyl 3-formylphenylphosphonate (250 mg, 1 mmol, 0.75 eq) and 0.96 g  
(253 mg, 1.34 mmol, 1 eq) of the alkynyl-benzaldehyde were dissolved in MeOH (13 ml) and 
DCM (2 ml) (diethyl 3-formylphenylphosphonate was not soluble in MeOH). The solution 
was degassed with Ar, and added to the reaction mixture in 30 min at -10°C via canula. The 
mixture was allowed to stir at RT for two and half hours, and DDQ (0.47 g, 2 mmol) was 
added. The dark green solution was stirred overnight (in the light), diluted in CH2Cl2 (15 ml) 
and neutralised with TEA (10 ml) in an ice bath. The organic layer was washed 3 times with 
water and NaCl sat., dried over Na2SO4, and filtered. After removal of all volatiles at reduced 
pressure, a flash chromatography (CH2Cl2/MeOH, 50:1 to 25:1), then a recrystallisation in 
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CHCl3/MeOH gave the protected diphenylporphyrin (94 mg, 87 µmol, 6.5%) as a purple 
solid. 
 
TLC: Rf = 0.48, CH2Cl2/MeOH (25:1) 
 
To a solution of protected diphenylporphyrin (94 mg, 87 µmol) in a 1:5 mixture of MeOH and 
CHCl3 (3ml), 0.94 g (4.4 mmol, 50 eq) of zinc acetate were added. The mixture was refluxed 
for 5 min. After removal of the solvent under reduced pressure, the residue was dissolved in 
CH2Cl2 and the white solid was filtered off and then washed with CH2Cl2. The solvent was 
removed at reduced pressure, and we obtained the protected Zn diphenylporphyrin (100 mg, 
88 µmol, 99 %) as a red solid. 
 
TLC: Rf = 0.24, CH2Cl2/MeOH (50:1) 
 
The protected Zn diphenylporphyrin (100 mg, 88 µmol, 1 eq) was dissolved in anhydrous 
toluene (17 ml), and 250 mg (4.63 mmol, 30 eq) of sodium methoxide were added.  
The reaction mixture was stirred at reflux under Ar for 4h. The solution was diluted with 
toluene (20 ml), and the organic layer was washed with 2M HCl (2×10 ml), brine (2×10 ml), 
and dried over NaSO4. After filtration and removal of all volatiles at reduced pressure, a flash 
chromatography column (CH2Cl2/MeOHt, 50:1) afforded the diphenylporphyrin 23 (60 mg, 
55.6 µmol, 63%) as a red solid. 
 
C66H85N4O3PZn: 1076.57 g/mol 
 
Maldi-TOF: m/z: 1076.08 [M·]+ 
 
TLC: Rf = 0.33, CH2Cl2/MeOH (50:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.19 (s, 2H, H-meso), 8.56 (m, 8H, H(aro)), 4.24  
(m, 4H, -CH2CH3), 3.95 (m, 8H, -CH2-C5H11), 3.33 (s, 1H, HC≡C-), 2.43 (d, 12H, J = 16 Hz,  
-CH3), 2.16 (m, 8H, -CH2-CH2-C4H9), 1.73 (m, 8H, -C2H4-CH2-C3H7), 1.48 (m, 8H, -C3H6-
CH2-C2H5), 1.37 (m, 14H, -C4H8-CH2-CH3 + -CH2CH3), 0.90 (m, 12H, -C5H10-CH3). 
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11 Synthesis of the building blocks 
11.1 5’-O-TBDMS-dUZnDPP 33 
 
O
OH
NTBDMSO
HN
O
O
R R
R R
Zn
R R
R R
Zn
O
OH
NTBDMSO
HN
O
O
R = C2H4CO2Me
Pd(PPh3)4,
CuI, NEt3
22
27
33
 
 
To a solution of 5’-TBDMSO-iodouracile 27 (76 mg, 0.13 mmol, 1.5 eq.) in DMF (2 ml), CuI 
(6.3 mg, 0.033 mmol, 40 %) was added in the dark under Argon. TEA (46 ul, 0.33 mmol,  
4 eq.) was added when all the CuI was dissolved. The porphyrin 22 (80 mg, 83 µmol) was 
dissolved in 2ml of DMF and added to the mixture. Finally, 19 mg (0.017, 20%) of Pd(PPh3)4 
was added, the reaction mixture was stirred under an inert atmosphere for 4 days. The 
solution was diluted with 80 ml of AcOEt, washed with a solution of H2O/NaCl (1:1, 6×25 
ml) and dried over Na2SO4. Evaporation of the solvent at reduced pressure yielded the crude 
product which was purified by column chromatography on silica gel (gradient of 
CH2Cl2/MeOH from 100:0.5 to 50:1). This afforded the 5’-O-TBDMS-dUZnDPP 33  
(124 mg, 0.09 mmol, 95%) as a red solid. 
 
C69H76N6O13SiZn: 1288.45 g/mol 
 
Maldi-TOF: m/z: 1291.6 [M·]+ 
 
TLC: Rf = 0.63, DCM/MeOH (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.09 (2H, s, H-meso), 8.05 (s, 1H, -NH), 8.05-7.98 
(m, 5H, H-aro, ), 7.85-7.77 (m, 6H, H-aro), 6.22-6.20 (m, 1H, H-1’), 5.36-5.35 (m, 1H, H-3’), 
4.22-4.21 (m, 8H, -CH2-CH2-CO2Me), 3.95-3.92 (m, 2H, H-5’), 3.83-3.81 (m, 1H, H-4’), 3.54 
(s, 12H, -O-CH3), 3.12-3.08 (m, 8H, -CH2-CH2-CO2Me), 2.47 (d, J = 10, 12H, -CH3), 2.21-
2.19 (m, 2H, H-2’), 0.99 (s, 9H, -SiC5’(CH3)3, 0.21 (d, J = 6 Hz, 6H, -Si(CH3)2). 
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11.2 3’-O-TBDMS-dUZnDPP 34 
 
O
OTBDMS
NHO
HN
O
O
R R
R R
Zn
R = C2H4CO2Me
Pd(PPh3)4,
CuI, NEt3R R
R R
Zn
O
OTBDMS
NHO
HN
O
O
I
22
29
34
 
 
To a solution of 3’-TBDMSO-iodouracil 29 (76 mg, 0.13 mmol, 1.5 eq.) in DMF (2 ml), CuI 
(6.3 mg, 0.033 mmol, 40 %) was added in dark under Argon. TEA (46 ul, 0.33 mmol, 4 eq.) 
was added when all the CuI was dissolved. The porphyrin 22 (80 mg, 83 µmol) was dissolved 
in DMF (2ml) and added to the mixture. Finally, Pd(PPh3)4 (19 mg, 0.0166, 20%) was added, 
the reaction mixture was stirred under an inert atmosphere for 4 days. The solution was 
diluted with 80 ml of AcOEt, washed with a solution of H2O/NaCl (1:1, 6 × 25 ml) and dried 
over Na2SO4. Evaporation of the solvent at reduced pressure yielded the crude product which 
was purified first by column chromatography on silica gel (gradient of CH2Cl2/MeOH from 
100:0.5 to 100:1.2), then by column chromatography on sephadex G15 (CH2Cl2/MeOH 1:1) 
afforded the 3’-O-TBDMS-dUZnDPP 34 (98 mg, 0.07 mmol, 82%) as a red solid. 
 
C69H76N6O13SiZn: 1288.45 g/mol 
 
Maldi-TOF: m/z: 1291.6 [M·]+ 
 
TLC: Rf = 0.52, DCM/MeOH (20:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.09 (2H, s, H-meso), 8.03 (s, 1H, -NH), 8.05-8.03 
(m, 5H, H-aro, H-(6)), 7.91-7.74 (m, 5H, H-aro), 6.17 (m, 1H, H-1’), 4.99 (m, 1H, H-3’), 
4.32-4.30 (m, 8H, -CH2-CH2-CO2Me), 4.10-4.08 (m, 2H, H-5’), 3.69 (m, 1H, H-4’), 3.68  
(d,  J = 8.08 Hz, 12H, -O-CH3), 3.15-3.13 (m, 8H, -CH2-CH2-CO2Me), 2.31-2.30 (m, 2H,  
H-2’), 2.46 (d, J = 6.32Hz, 12H, -CH3), 0.83 (s, 9H, -SiC5’(CH3)3, 0.05 (d, J = 10.4 Hz, 6H,  
-Si(CH3)2). 
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11.3 3’,5’-Bis-O-TBDMS-dUZnDPP 32 
 
O
OTBDMS
NTBDMSO
HN
O
O
R R
R R
Zn
R = C2H4CO2Me
R R
R R
Zn
O
OTBDMS
NTBDMSO
HN
O
O
I
Pd(PPh3)4,
CuI, NEt322
28
32
 
To a solution of 3’,5’-Bis-O-TBDMS-iodouracil 28 (60.3 mg, 0.10 mmol, 1 eq) in DMF  
(4 ml), CuI (7.9 mg, 41.6 µmol, 40 %) was added in dark under Argon. TEA (31 µl, 416 
µmol, 4 eq.) was added when all the CuI was dissolved. The porphyrin 22 (100 mg, 104 
µmol, 1 eq) was dissolved in DMF (2ml) and added to the mixture. Finally, the Pd(PPh3)4  
(24 mg, 20.8 µmol, 20%) was added, the reaction mixture was stirred under an inert 
atmosphere for 2 days. The solution was diluted with 60 ml of AcOEt, washed with a solution 
of H2O/NaCl (1:1, 6 × 20 ml) and dried over Na2SO4. Evaporation of the solvent at reduced 
pressure yielded the crude product which was purified first by column chromatography on 
silica gel (gradient of CH2Cl2/AcOEt 10:1), then by crystallisation (CHCl3/Hexane). This 
afforded the 3’,5’-Bis-O-TBDMS-dUZnDPP 32 (45 mg, 31 µmol, 30%) as a purple solid.  
 
C75H90N6O13Si2Zn: 1402.54 g/mol 
 
Maldi-TOF: m/z: 1404.78 [M·]+ 
 
TLC: Rf = 0.8, CH2Cl2/EA (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.19 (2H, s, H-meso), 8.16 (s, 1H, -NH), 8.06-7.98 
(m, 5H, H-aro, H-(6)), 7.85-7.74 (m, 5H, H-aro), 6.19 (m, 1H, H-1’), 5.16-5.15 (m, 1H, H-3’), 
4.36-4.32 (m, 8H, -CH2-CH2-CO2Me), 4.03-4.02 (m, 2H, H-5’), 3.30-3.29 (m, 1H, H-4’), 3.70 
(d, J = 3.5 Hz, 12H, -O-CH3), 3.16-3.15 (m, 8H, -CH2-CH2-CO2Me), 1.97-1.95 (m, 2H,  
H-2’), 2.48 (d, J = 15, 12H, -CH3), 0.90 (s, 9H, -SiC5’(CH3)3), 0.88 (s, 9H, -SiC3’(CH3)3), 0.14 
(s, 6H, -Si(CH3)2), 0.07 (s, 6H, -Si(CH3)2).
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dUZnDPP 34 
 
O
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R R
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R R
R R
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TBAF
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To a solution 10 mg (6.96 µmol, 1 eq) of 3’,5’-Bis-O-TBDMS-dUZnDPP 32 in THF (3 ml), 8 ul 
(2.87 µmol, 4 eq) tetrabutylamoniumfluorid (TBAF) was added. The reaction mixture was 
stirred in an ice bath for 24h under argon. An additional quantity of TBAF (4 ul, 1.43 µmol,  
2 eq) was added and the mixture was stirred for an additional 24 h. The solution was diluted 
in CH2Cl2, and a small quantity of CaCl2 was added, and the organic layer was washed with 
H2O (3×5 ml). Drying over Na2SO4 and evaporation of all the solvent at reduced pressure 
gave dUZnDPP 34 (7.5 mg, 6.74 µmol, 97%) as a purple solid. 
 
C63H64N6O13: 1112.45 g/mol 
 
Maldi-TOF: m/z: 1111.03 [M·]+ 
 
TLC: Rf = 0.43, CH2Cl2/MeOH (10:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.09 (2H, s, H-meso), 8.55 (s, 1H, -NH), 8.30  
(s, 1H, H-(6)), 8.04-7.98 (m, 4H, H-aro), 7.89-7.76 (m, 5H, H-aro), 6.20 (m, 1H, H-1’),  
5.27-5.26 (m, 1H, H-3’), 4.23-4.22 (m, 8H, -CH2-CH2-CO2Me), 3.90-3.89 (m, 1H, H-4’), 
3.78-3.63 (m, 2H, H-5’), 3.55 (d, J = 2 Hz, 12H, -O-CH3), 3.11-3.10 (m, 8H, -CH2-CH2-
CO2Me), 2.27-2.20 (m, 2H, H-2’), 2.37 (d, J = 25, 12H, -CH3). 
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11.4 5’-O-DMT-dUZnDPP 36 
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To a solution of 5’-O-DMT-iodouracil 30 (150 mg, 0.23 mmol, 3 eq) in DMF (2 ml), CuI (5.7 
mg, 30.2 µmol, 40 %) was added in dark under Argon. TEA (25 µl, 0.3 mmol, 4 eq.) was 
added when all the CuI was dissolved. The porphyrin 22 (73 mg, 75.6 µmol) was dissolved in 
DMF (2 ml) and added to the mixture. Finally, the Pd(PPh3)4 (17 mg, 15.1 µmol) was added, 
the reaction mixture was stirred under an inert atmosphere for 3days. The solution was diluted 
with 100 ml of AcOEt, washed with a solution of H2O/NaCl (1:1, 6×30 ml) and dried over 
Na2SO4. Evaporation of the solvent at reduced pressure yielded the crude product which was 
purified by column chromatography on silica gel (gradient of CH2Cl2/MeOH from 100:0.5 to 
100:1), afforded the 5’-O-DMT-dUZnDPP 19 (48 mg, 32.5 µmol, 43%) as a purple solid. 
 
C84H80N6O15Zn: 1476.50 g/mol 
 
Maldi-TOF: m/z: 1477.6 [M·]+ 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.18 (s, 2H, H-meso), 7.84 (s, 1H, -NH), 7.34-7.20 
(m, 19H, Haro, H-(6)), 6.83-6.80 (m, 4H, Haro), ), 5.86-5.85 (m, 1H, H-1’), 4.62 (m, 2H, H-3’ + 
H-4’), 4.17 (m, 1H, -OH(3’)), 3.66 (m, 2H, H-5’), 2.58 (m, 2H, H-2’), 4.36-4.35 (m, 8H, -
CH2-CH2-CO2Me), 3.78 (s, 12H, -OCH3), 3.65-3.62 (m, 8H, -CH2-CH2-CO2Me), 3.18-3.11 
(m, 12H, -CH3). 
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11.5 5’-O-DMT-dUZnDPP 35 
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To a solution of 5’-O-DMT-iodouracile 30 (96.3 mg, 146.8 µmol, 3 eq) in DMF (1 ml) with 
moleculars sieves (4 Å), CuI (7.4 mg, 39 µmol, 80 %) was added in dark under Argon. TEA 
(40 µl, 0.48 mmol, 4 eq.) was added when all the CuI was dissolved. The porphyrin 24 
(46 mg, 48.9 µmol, 1eq) was dissolved in 2 ml of DMF and added to the mixture. Finally, the 
Pd(PPh3)4 (22.1 mg, 19 µmol, 40%) was added, the reaction mixture was stirred at inert 
atmosphere for 24 h. The solution was diluted with AcOEt (80 ml), washed with a solution of 
H2O/NaCl (1:1, 6×25 ml) and dried over Na2SO4. Evaporation of the solvent at reduced 
pressure yielded the crude product which was purified by column chromatography on silica 
gel (gradient of CH2Cl2/MeOH from 100:0.5 to 100:1), afforded the 5’-O-DMT-dUZnDPP 35 
(70 mg, 47.7 µmol, 97%) as a purple solid. 
 
C92H104N6O7Zn: 1468.73 g/mol 
 
Maldi-TOF: m/z: 1468.5 [M·]+ 
 
TLC: Rf = 0.37, DCM/EA (1:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.13 (2H, s, H-meso), 8.16 (s, 1H, -NH), 8.05-7.85 
(m, 4H, H-aro), 7.75-7.72 (m, 3H, H-aro), 7.49-7.48 (m, 2H, H-aro), 7.41-7.33 (m, 9H,  
H-aro), 6;88-6.86 (m, 4H, H-aro), 6.44 (m, 1H, H-1’), 4.66 (m, 2H, H-3’ + H-4’), 4.09 (m, 
1H, -OH(3’)), 3.97-3.95 (m, 8H, -CH2-C5H11), 3.65 (m, 2H, H-5’), 2.55 (m, 2H, H-2’), 2.41 
(d, J = 15 Hz, 12H, -CH3), 2.17-2.15 (m, 8H, -CH2-CH2-C4H9), 1.76-1.75 (m, 8H, -C2H4-
CH2-C3H7), 1.51-1.48 (m, 8H, -C3H6-CH-C2H5), 1.40-1.39 (m, 8H, -C4H8-CH2-CH3), 0.89-
0.91 (m, 12H, -C10H5-CH3). 
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11.6 5’-O-DMT-dUZnDPP 37 
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To a solution of 5’-O-DMT-iodouracile (374 mg, 0.57 mmol, 3 eq) in DMF (4 ml) with 
moleculars sieves (4 Å), CuI (29.2 mg, 0.45 mmol, 80 %) was added in the dark under Argon. 
TEA (0.16 ml, 0.76 mmol, 4 eq.) was added when all the CuI was dissolved. The porphyrin 
(200 mg, 0.19 mmol, 1eq) was dissolved in DMF (4 ml) and added to the mixture. Finally, 
88.5 mg (0.23 mmol, 40%) of the Pd(PPh3)4 was added, the reaction mixture was stirred 
under argon for 48 h. The solution was diluted with AcOEt (80 ml), washed with a solution of 
H2O/NaCl (1:1, 6×35 ml) and dried over Na2SO4. Evaporation of the solvent at reduced 
pressure, followed by a chromatography column on silica gel (gradient of CH2Cl2/MeOH 
from 100:0.5 to 100:1) afforded the 5’-O-DMT-dUZnDPP 18 (294 mg, 0.18 mmol, 98%) as a 
purple solid. 
 
C100H120N6O7Zn: 1580.85 g/mol 
 
Maldi-TOF: m/z: 1581.4 [M·]+ 
 
TLC: Rf = 0.44, DCM/MeOH (100:3). 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.11 (s, 2H, H-meso), 8.16 (s, 1H, -NH), 7.94  
(m, 2H, H-aro), 7.85 (m, 3H, H-aro), 7.77 (m, 4H, H-aro), 7.59 (m, 2H, H-aro), 7.49 (m, 4H, 
H-aro), 7;40 (m, 3H, H-aro), 6.92 (m, 4H, m-Bz(m)), 6.39 (m, 1H, H-1’), 4.59 (m, 2H, H-3’ + 
H-4’), 4.15 (m, 1H, -OH(3’)), 3.97 (m, 8H, -CH2-C5H11), 3.62 (m, 2H, H-5’), 2.58 (m, 2H,  
H-2’), 2.45 (d, 12H, J = 8 Hz, -CH3), 2.19 (m, 8H, -CH2-CH2-C4H9), 1.77 (m, 8H, -C2H4-
CH2-C3H7), 1.52 (m, 26H, -C3H6-CH2-C2H5 + –C(CH3)3), 1.40 (m, 8H, -C4H8-CH2-CH3), 
0.92 (m, 12H, -C10H5-CH3). 
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11.7 dUZnDPP 83 
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5’-DMT-dUZnDPP 37 (88 mg, 55.5 µmol, 1eq) was dissolved in dry DCM (5 ml), and 0.25 ml 
of dichloroacetic acid was added. The reaction mixture was stirred at RT for 30 min. The 
organic layer was washed with NaHCO3 and dried over Na2SO4. Filtration and evaporation of 
the solvent at reduced pressure yielded the crude product which was purified by a flash 
chromatography on silica gel (CH2Cl2/MeOH, 20:1) to yield 20 mg (16 µmol, 28%) of 
dUZnDPP 83 as purple solid.  
 
C79H104N6O5: 1216.81 g/mol 
 
Maldi-TOF: m/z: 1217.31 [M·]+ 
 
TLC: Rf = 0.17, CH2Cl2/MeOH (20:1) 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.19 (s, 2H, H-meso), 8.18 (s, 1H, -NH), 8.06  
(m, 2H, H(m)-C6H4), 7.92 (m, 2H, H(o)-C6H3), 7.87 (m, 2H, H(o)-C6H4), 7.80 (m, 1H,  
H(p)-C6H3), 6.39 (m, 1H, H-1’), 4.59 (m, 2H, H-3’ + H-4’), 4.07 (m, 1H, -OH(5’)), 4.15  
(m, 1H, -OH(3’)), 3.96 (m, 8H, -CH2-C5H11), 3.33 (s, 1H, HC≡C-), 3.62 (m, 2H, H-5’), 2.58 
(m, 2H, H-2’), 2.45 (d, 12H, J = 10 Hz, 4x -CH3), 2.17 (m, 8H, -CH2-CH2-C4H9), 1.73  
(m, 8H, -C2H4-CH2-C3H7), 1.53-1.48 (m, 26H, -C3H6-CH2-C2H5 + -C(CH3)3), 1.38 (m, 8H,  
-C4H8-CH2-CH3),0.90(m,12H,-C10H5-CH3).
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5’-O-DMT-dUZnDPP 38 
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To a solution of 5’-O-DMT-iodouracile 30 (109.5 mg, 167 µmol, 3 eq) in DMF (2 ml) with 
moleculars sieves (4 Å), CuI (8.4 mg, 44.4 µmol, 80 %) was added in dark under Argon. TEA 
(50 ul, 222.4 µmol, 4 eq.) was added when all the CuI was dissolved. The porphyrin 23  
(60 mg, 55.6 µmol, 1eq) was dissolved in DMF (2 ml) and added to the mixture. Finally, the 
Pd(PPh3)4 (25.6 mg, 22.2 µmol, 40%) was added, the reaction mixture was stirred under for 
48 h. The solution was diluted with AcOEt (80 ml), washed with a solution of H2O/NaCl  
(1:1, 6×35 ml) and dried over Na2SO4. Evaporation of the solvent under reduced pressure, 
followed by a chromatography column on silica gel (CH2Cl2/MeOH, 50:1) afforded the  
5’-O-DMT-dUZnDPP 38 (53 mg, 33 µmol, 60%)as a purple solid. 
 
C96H113N6O10PZn: 1604.75 g/mol 
 
Maldi-TOF: m/z: 1605.04 [M·]+ 
 
TLC: Rf = 0.48, DCM/MeOH (50:1). 
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12 Synthesis of the phosphoramidite building block 
12.1 5’-O-TBDMS-dUZnDPP phosphoramidite 39 
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The protected 5’-O-TBDMS-dUZnDPP 33 (20 mg, 15.1 µmol) was co-evaporated three times 
with dry pyridine, and dried on the vaccum line over night. The product was disolved in dry 
DCM (2 ml) with molecular sieves (powder) and stirred for an hour. Then, 
diisopropylethylamine (15.4 µl, 90 µmol, 6 eq) and finally the 2-cyanoethyldiisopropylchloro-
phosphoramidite (13.3 µl, 53 µmol, 3.5 eq) was added and the reaction mixture was stirred for 
4h under argon and in dark. The mixture was evaporated and put directly on a 
chromatography column (EA pure) under argon. We obtained the 5’-O-TBDMS-dUZnDPP 
phosphoramidite 39 (14.5 mg, 9.7 mmol, 64%) as a purple solid which was kept under argon 
and in the dark overnight for the next step. (Otherwise, we observed an oxidation of the 
phosphoramidite.) 
 
C78H93N8O14PSiZn: 1488.56 g/mol 
 
Maldi-TOF: m/z: 1488.89 [M·]+ 
 
TLC: Rf = 0.72, EA pure 
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 10.09 (2H, s, H-meso), 8.05 (s, 1H, -NH), 8.05-7.98 
(m, 5H, H-aro, ), 7.85-7.77 (m, 6H, H-aro), 6.22-6.20 (m, 1H, H-1’), 4.22-4.21 (m, 8H, -CH2-
CH2-C O2Me), 3.95-3.92 (m, 2H, H-5’), 3.90-3.93 (2H, m, -CH2CH2CN ); 3.83-3.81 (m, 1H, 
H-4’), 3.54 (s, 12H, -O-CH3), 3.12-3.08 (m, 8H, -CH2-CH2-CO2Me), 2.97-2.92 (2H, m, 
NCH(CH3)2); 2.60-2.63 (2H, m, -CH2CN); 2.47 (d, J = 10, 12H, -CH3), 2.21-2.19 (m, 2H,  
H-2’), 1.07 (12H, s, NCH(CH3)2); 0.99 (s, 9H, -SiC5’(CH3)3, 0.21 (d, J = 6 Hz, 6H,  
-Si(CH3)2). 
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12.2 5’-O-DMT-dUZnDPP phosphoramidite 
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The protected 5’-O-DMT-dUZnDPP 35 (70 mg, 47.7 µmol, 1 eq) was co-evaporated three times 
with dry pyridine, and dried on the vaccum line overnight. The product was dissolved in dry 
DCM (1.5 ml) with molecular sieves (powder) and stirred for an hour. Then, 
diisopropylethylamine (42 µl, 191 µmol, 4 eq) and finally the 2-cyanoethyldiisopropylchloro-
phosphoramidite (35 µl, 143 µmol, 3 eq) was added and the reaction mixture was stirred for 
5h under argon and in the dark. The mixture was evaporated and put directly on a 
chromatography column (DCM/EA, 1:1) under argon. Prior to use triphenylphosphine on the 
column, left for 2h and washed with eluent. We obtained the 5’-O-DMT-dUZnDPP 
phosphoramidite 41 (55.1 mg, 33 µmol, 70%) as a purple solid which was kept under argon 
and in the dark overnight for the next step. (Otherwise, we observed an oxidation of the 
phosphoramidite.) 
 
C101H121N8O2PZn: 1668.83 g/mol 
 
Maldi-TOF: m/z: 1668.18 [M·]+ 
 
TLC: Rf = 0.27, Hex/EA, (5:1) 
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12.3 5’-O-DMT-dUZnDPP phosphoramidite 42 
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The protected 5’-O-DMT-dUZnDPP 37 (146 mg, 92 µmol, 1 eq) was co-evaporated three times 
with dry pyridine, and dried on the vaccum line overnight. The product was dissolved in dry 
DCM (2 ml) with molecular sieves (powder) and stirred for an hour in dark. Then, 
diisopropylethylamine (70 µl, 368 µmol, 4 eq) and finally the 2-cyanoethyldiisopropylchloro-
phosphoramidite (62 µl, 276 µmol, 3 eq) was added and the reaction mixture was stirred for 
two and a half hours under argon and in dark. The mixture was evaporated and put directly on 
a chromatography column (DCM/EA, 1:1) under argon. Prior to use triphenylphosphine on 
the column, left for 2h and washed with eluent. We obtained the 5’-O-DMT-dUZnDPP 
phosphoramidite 42 (131 mg, 73 µmol, 80%) as a purple solid which was kept under argon 
and in the dark overnight for the next step. (Otherwise, we observed an oxidation of the 
phosphoramidite.) 
 
C109H137N8O8PZn: 1780.96 g/mol 
 
Maldi-TOF: m/z: 1781.2 [M·]+ 
 
TLC: Rf = 0.85, DCM/AcOEt (1:1) 
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12.4 Synthesis of the homo- and heterophorphyrinic dimers in solution 
12.4.1 Synthesis of the 1-phenyl-1H-imidazol-3-ium saltz 
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Trifluoromethanesulfonic acid (0.62 ml, 6.95 mmol) was added over 2 min to a solution of  
1-phenylimidazole 84 (1g, 6.95 mmol) in DCM (5 ml), and the reaction mixture was stirred 
for 1h under argon. The reaction mixture was diluted with diethyl ether (5ml). The resultant 
precipitate was collected by filtration, washed with diethyl ether and dried on the vacuum line 
overnight. The 1-phenyl-1H-imidazol-3-ium (NPhlmT) 85 (1.97 g, 6.68 mmol, 96%) was 
obtained as a white powder. 
 
C10H9F3N2O3S: 294.03 g/mol 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.46 (s, 1H, H-aro), 8.07 (s, 1H, H-aro), 7.77-7.64 
(m, 6H, H-aro). 
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12.4.2 Synthesis of the (dUZnDPP)2 dimer 44 
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The DPP building block 33 (20 mg, 15.1 µmol) was dissolved in dry DCM (2 ml). Then, 
CEP-Cl (13.3 µl, 53 µmol, 3.5 eq) and DIEA (14.4 µl, 90 µmol, 6 eq) were added. The 
reaction mixture was stirred in dark under argon. After four hours, borane was added and the 
reaction was stirred overnight. The mixture was evaporated and put directly on a 
chromatography column (EA) under argon. The 5’-O-TBDMS-dUZnDPP phosphoramidite 43 
(14.5 mg, 9.5 µmol, 63 %) was obtained as a purple solid which was dissolved in dry DCM  
(2 ml) with molecular sieves (powder). Then, 1H-tetrazole (5 mg, 71 µmol, 5 eq) and the 
porphyrin substituted nucleotide 34 (12.5 mg, 9.5 µmol, 1 eq) were added. The reaction 
mixture was stirred for 2h without formation of the dimer 44. 
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12.4.3 Synthesis of the (dUZnDPP -dUZnTPP) dimer 
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The porphyrin substituted nucleotide 86 (22 mg, 19 µmol, 1.2 eq) was dissolved in dry DCM 
(1 ml). Then, CEP-Cl (7.3 mg, 31 µmol, 6.9 µl, 2 eq) and DIEA (8 mg, 62 µmol, 10.5 µl,  
4 eq) were added. The reaction mixture was stirred for 2h under argon. Finally, the DPP 
building block 86 (20 mg, 15.5 µmol) and NPhlmT (17 mg, 58 µmol, 3.7 eq) were added. The 
reaction mixture was stirred overnight. The crude product was purified by silica column 
chromatography (DCM/EA, from 10:1 to 1:1) and the dimer was obtained as a purple solid 
(11 mg, 4.2 µmol, 27%). 
 
C134H133N12O26PSi2Zn: 2384.9 g/mol 
 
Maldi-TOF: m/z: 2384.6 [M·]+ 
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13 Synthesis of diadenosine dimer 
13.1 6-N-Benzoyl-2’-deoxyadenosine 50 
 
 
 
2’-deoxyadenosine 49 (1 g, 3.7 mmol) was dried by co-evaporation three times with dry 
pyridine, and resuspended in pyridine (20 ml). Trimethylchlorosilane (2.5 ml, 20 mmol) was 
added and the reaction mixture was stirred for 15 min. Then, benzoylchloride (2.3 ml,  
20 mmol) was added and the reaction was kept at room temperature for 2h. The mixture was 
then cooled in an ice bath, and 5 ml of H2O was added. After 5 min, 5 ml of 32% aqueous 
ammonia was added, and the mixture was stirred at RT for 1h. The reaction was then 
evaporated to near dryness and the residue was dissolved in water( 100 ml). The solution was 
washed once with AcOEt portion (25 ml). Crystallisation began immediately after separation 
of the layers and addition of AcOEt portion (25 ml) to the aqueous phase. After the solution 
was cooled for one night, the filtration gave the 6-N-benzoyl-2’-deoxyadenosine 50 (0.57 g, 
1.6 mmol, 44%) as a white powder. 
 
C17H17N5O4: 355.13 g/mol 
 
Maldi-TOF: m/z: 356.38 [M·]+ 
 
TLC: Rf = 0.46, DCM/MeOH (10:1), turned to yellow when revealed with H2SO4 in MeOH 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 11.1 (-NH, s, 1H), 8.72 (1H, s, H-8); 8.66 (1H, s,  
H-2); 8.01 (2H, m, -CH(o)); 7.6-7.55 (1H, m, -CH(p)); 7.53-7.46 (2H, m, -CH(m)); 6.46 (1H, m, 
H-1’); 5.35 (1H, m, OH-3’); 5.0 (1H, m, OH-5’); 4.43 (1H, m, H-3’); 3.88 (1H, m, H-4’); 
3.62-3.5 (2H, m, H-2’), 2.80-2.76 (1H, m, H-5’); 2;36-2.30 (1H, m, H-5’). 
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13.2 5’-O-DMT-6-N-Benzoyl-2’-deoxyadenosine 51 
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The 6-N-Benzoyl-2’-deoxyadenosine 50 (100 mg, 0.28 mmol, 1 eq.) was dried by  
co-evaporation with dry pyridine (3×1 ml) and kept overnight on the vacuum line, and 
redissolved in pyridine (1 ml) and molecµlar sieves (4 Å). The solution was stirred for one 
hour, TEA (78 µl, 0.56 mmol, 2 eq.) and dimethoxytrityl chloride (105 mg, 0.31 mmol,  
1.1 eq.) were added. The reaction mixture was stirred at RT under Ar overnight, pyridine was 
evaporated, residue freed from pyridine by evaporation of toluene. A column chromatography 
of the remaining oil (CH2Cl2/MeOH from 100:1 to 10:1) gave the 5’-O-DMT-6-N-Benzoyl-
2’-deoxyadenosine 51 (147 mg, 0.22 mmol, 78%) as a yellow foam. 
 
C38H35N5O6: 657.26 g/mol 
 
Maldi-TOF: m/z: 659.07 [M·]+ 
 
TLC: Rf = 0.35, DCM/MeOH (10:1), turn black with H2SO4 in MeOH 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 11.17 (-NH, s, 1H), 8.94 (1H, s, H-8); 8.73 (1H, s, 
H-2); 8.15 (1H, m, Bz-H(p)); 8.02 (2H, m, Bz-H(o)); 7.63-7.59 (2H, m, Bz-H(m)); 7.54-7.39 
((5H, m, Bz-H(DMT))7.25-7.20 (4H, m, m-Bz-H(p)); 6.79 (4H, m, m-Bz-H(o)); 6.49 (1H, m,  
H-1’); 4.73 (1H, m, OH-3’); 4.16 (1H, m, H-3’); 3.75 (1H, m, H-4’); 3.42 (2H, m, H-2’),  
2.92-2.88 (1H, m, H-5’); 2;62-2.55 (1H, m, H-5’); 1.40-1.36 (6H, m, -OCH3). 
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13.3 5’-O-DMT-6-N-Benzoyl-2’-deoxyadenosine dimer 52 
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5’-O-DMT-6-N-Benzoyl-2’-deoxyadenosine 51 (385 mg, 0.57 mmol) was dried by co-
evaporated with pyridine (3 × 2 ml) and kept overnight on the vacuum line, redissolved in 
dioxane (1 ml) with molecµlar sieves and the phosphorylating agent 48 (3.18ml, 1.1 eq.) was 
added. After 15 min, TLC indicated the end of the reaction (Rf = 0). 
6-N-Benzoyl-2’-deoxyadenosine 50 (305 mg, 0.86 mmol, 1.5 eq) was dried by evaporation of 
pyridine (3×2 ml) and kept overnight on the vacuum line, redissolved in dioxane (1.5 ml) with 
molecular sieves. The reaction mixture was stirred for 1h at RT under Argon and filtered over 
celite. The organic phase was washed with triethylamonium Buffer (first 1M , then 0.1M), 
dried over Na2SO4 and evaporated. A column chromatography (CH2Cl2/MeOH, from 1 % to  
7 %) gave the 5’-O-DMT-6-N-Benzoyl-2’-deoxyadenosine dimer 52 (585 mg, 0.49 mmol,  
87 %) as yellow oil. 
 
C61H54ClN10O11P: 1168.34 g/mol 
 
Maldi-TOF: m/z: 1169.3 [M·]+ 
 
TLC: Rf = 0.35, DCM/MeOH, (10:1) 
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 11.1 (2H, s, -NH), 8.69-8.57 (2H, m, H-8); 8.31-8.24 
(2H, m, H-2); 7.95-7.91 (6H, m, Bz-H(p+o)); 7.55-7.04 (17H, m, Bz-H(m) + m-Bz-H(o) +  
Bz-H(DMT) + Cl-C6H4); 7.85-7.71 (4H, m, m-Bz-H(m)); 6.45-6.41 (2H, m, H-1’); 4.50-4.42 
(2H, m, H-3’); 4.32-4.25 (2H, m, H-4’); 3.76-3.60 (6H, m, -OCH3); 3.38-3.29 (4H, m, H-2’), 
2.90-2.75 (2H, m, H-5’); 2;57-2.53 (2H, m, H-5’). 
 
 
31P-NMR (Hz, CDCl3, ppm): -10.9 (s). 
 
 
Preparation of stocks of phosphorylation reagent 48 solution 0.2 M: 
 
 
P
O
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O
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N
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N N
N
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N
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O O
+
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4887
88  
 
 
2-chlorophenylposphorodichloridate 88 (3.1 mmol, 1 eq., 0.5 ml) in 3 ml dioxane was added 
dropwise to a solution of 1-hydroxy-6-trifluoromethyl-benzotriazotes 87 (2.03 eq., 1.27 g) in 
dioxane (12.5 ml) and pyridine (0.5 ml, 1.02 eq.). The reaction mixture was then stirred for 
1h, and filtered via canula under inert atmosphere. The yellow solution of phosphorylation 
reagent 48 was stored in the fridge under Argon. 
 
C20H10ClF6N6O4P: 578.01 g/mol 
 
Maldi-TOF: m/z: 578.75 [M·]+ 
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13.4 2’-deoxyadenosine dimer 53 
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To a solution of 5’-O-DMT-6-N-Benzoyl-2’-deoxyadenosine dimer 52 (585 mg, 0.49 mmol, 
1 eq) in CH2Cl2 (5ml), 0.5 ml of dichloroacetic acid were added and the mixture was stirred in 
an ice bath for 10 min. The solution was washed with NaHCO3 and dried over Na2SO4. After 
removal of all volatiles under reduced pressure, flash chromatography (CH2Cl2/MeOH from 
100:1 to 10:1) gave the 6-N-Benzoyl-2’-deoxyadenosine dimer (248 mg, 0.28 mmol, 57 %) as 
yellow oil. 
 
To cleave the chlorophenyl, the product (238 mg, 0.27mmol) was dissolved in pyridine (10 
ml). Then syn-2-pyridine-2-calboxaldoxime (1.32 mg, 10.8 mmol) and tetramethylguanidine 
(1.22 ml, 9.64 mmol) were added. The reaction mixture was stirred for 20h at 25°C.  
 
To deprotect the dimer from the benzoyl group, a solution of ammoniac 32% (20 ml) was 
added to the mixture and stirred for 2h at 50°C. The reaction mixture was concentrated to 
about 10 ml under reduced pressure, washed with Et2O, and evaporated. The yellow oil was 
kept at the vacuum line for one day. After purification by HPLC, we obtained the  
2’-deoxyadenosine dimer 53 (220 mg, 0.39 mmol, 80%) as white oil. 
 
C20H25N10O8P: 564.16 g/mol 
 
Maldi-TOF: m/z: 566.50 [M·]+ 
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14 Manual PNA Fmoc-synthesis 
 
14.1 Solutions for PNA synthesis: 
 
These  solutions were prepared  in small glass vials. 
 
Monomer Solutions.  
 
Monomers were dissolved in NMP at a concentration of 0.3M. This solution provided the 
base that was necessary for activation on the PNA monomer with HATU prior to coupling. 
 
? A (725 g/mol)  
? C (701 g/mol) 
 
_ 321 mg (0.9 mmol, 3 eq) Base A was dissolved in 3 ml NMP. (V=0.370 ml for each 
couplage) 
_ 315 mg (0.45 mmol, 3 eq) Base C was dissolved in 1.5 ml NMP. (V=0.185 ml for each 
couplage) 
 
DIPEA solution (1.5 ml DMF): (V=0.185 ml for each couplage) 
 
_ 0.6 M DIEA in DMF: 154 µl DIEA was mixed in 1.5 ml  
_ 0.9 M 2,6-lutidine in DMF: 156 µl 2,6-lutidine mixed in 1.5 ml  
 
Capping Mix (10 ml DMF): (V=0.185 ml for each couplage) 
 
_ 5% acetic anhydride: 500 µl in 10 ml 
_ 6% 2,6-lutidine: 600 µl in 10 ml  
 
20 % piperidine in DMF.  
 
2 ml piperidine was mixed with 8 ml of DMF (dimethylformamide) and stored in an amber 
bottle in the hood. 
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0.6M HATU in DMF.  
 
0.844 g (3 eq) HATU (Applied Biosystem) was dissolved in DMF to give a total volume of 
3ml. This solution was stored in a glass vial wrapped in aluminium foil in the hood. This 
reagent crystallised overnight, thus fresh solution was prepared everyday. V=0.185 ml for 
each couplage 
 
 
14.2 Manual synthesis 
 
The PNA molecules were synthesized on Rink Amide MBHA resin under argon. 
 
14.2.1 Swelling the resin 
 
50 mg (37 µmol, 1 eq) MBHA resin was placed in a small Merrifield vessel and washed three 
times with DMF for 1 min. The resin was then suspended in a small amount of DMF (4 ml) 
and was shaken for 1h. The solvent was then drained and the resin was washed twice with 
DMF. Finally, a few resin beads were sampled to a small glass tube for the Kaiser test. 
(Qualitative test for the absence or presence of free amino groups) 
 
14.2.2 Fmoc-deprotection 
 
The coupling cycle was started with the cleavage of the Fmoc protecting group. The 
deprotection was achieved by two successive incubation in piperidine. The resin was shaken 
with a mixture of 20% piperidine in DMF (4 ml) for 1 min and then 4 min. The solvent was 
drained and the Fmoc groups and piperidine were washed away five times with DMF during  
1 min. At the end of this step, a Kaiser test was performed to check the successful Fmoc 
deprotection. If the Kaiser test was positive (blue colour), the Fmoc protecting groups were 
removed and the next amino acid was coupled. And if the Kaiser test was negative (white 
colour), the coupling was repeated until the entire amino group was deprotected.  
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14.2.3 Coupling reaction 
 
The deprotection step was followed by a double coupling of the monomer (base A or C). 
0.185 ml of the first monomer C, 0.185 ml of HATU solution and 0.185 ml of base Mix 
DIPEA were added, and the mixture was shaken twice for 45 min. The resin was washed 
thrice with DMF after the second coupling step.  
 
14.2.4 Free amine acetylation 
After the coupling reaction, we need to capp all the unreacted amino groups as acetamides by 
adding 1.5 ml of capping Mix. The mixture was shaken for 5 min, and the resin was washed 
three times with DMF. Then, a Kaiser test was performed to check the successful protection 
of the free position. The white colour confirmed the completion of the reaction. 
 
 
Finally, the cycle was repeated from 2.2 to 2.4 until the synthesis of the desired PNA 63 was 
completed. During the night, the Merrifield vessel with the resin was stored in the fridge 
under Ar. 
 
The terminal Fmoc was removed as described above (II) and the free NH2 was acetylated 
(IV). The resin was washed another 5 times with DMF and 2 times with DCM. 
 
After Synthesis, the final PNA molecule was cleaved from the dried resin. 
 
14.2.5 Cleavage of the side chain protecting groups and from MBHA Resin 
 
6 ml of a solution TFA/TIS (95:5) was added, and the mixture was shaken two times for 2h to 
cleave the resin and the Boc protecting group from the side chain. The solution was drained in 
a conical glass centrifuge tube, and added 5-fold excess of cold dry ether. The solution was 
mixed, placed in an ice bath for 10 min, and centrifuged in good for 5 min. The supernatant 
was poured off carefully, and this step was repeated four times with the following dry ice 
incubation: 5 min, 2min, 0 min, 0 min. Finally, the supernatants were mixed together and 
evaporated to dryness. The PNA was stored under Ar at -4°C before purification. 
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14.2.6 Purification and characterisation of PNA 
 
14.2.6.1 Purification 
 
The PNA was precipitated in acetonitrile and the first purification of the PNA strand was 
done on sephadex LH 20 column (DCM/MeOH, 1:1), but gave no pure material. A second 
purification on semi-prep HPLC gave pure material (22.6 mg, 13.6 µmol, 37%). 
 
HPLC: from 2% to 11% in 35 min 
 
Temperature: 55°C 
λ= 260 nm 
Column semi-preparative: RP-18e HPLC LiChrospher  
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HPLC: Crude Product after synthesis  
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14.2.6.2 Characterisation 
 
Quality Control of synthesised PNA was done by MALDI-TOF mass spectrometry. 
 
C66H83N39O15: 1661.69  
 
MALDI-TOF: m/z: 1661.1 [M·]+ 
 
The UV-visible spectra showed an absorption maximum at 260 nm in water. Using different 
concentration from a 0.33 mM solution and the Beer-Lambert equation, we calculated the 
extinction coefficient of the PNA strand. The measurements were performed in water at 80°C. 
We obtained: ε260 = 63 344, compared to normal DNA strand εcalcd. = 66 920. 
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Kaiser Test. 
 
The “Kaiser Test” is a colorimetric test for the presence of amino groups; we use it to make 
sure that each coupling step in PNA synthesis goes to completion. It is based on the reaction 
of ninhydrin with amino groups to form a blue adduct. Therefore, an incomplete coupling 
cycle will lead to a positive Kaiser test, demonstrated by the development of a blue colour, 
while coupling to completion will yield a negative (yellow) test. 
 
The following solutions were prepared: 
 
A. Dissolved 8 g phenol in 2 ml absolute ethanol. The solution was warmed to completely 
dissolve the phenol.  
 
B. Dissolved 13 mg KCN in 20 ml water. Transferred the DCN into a tarred vial in the hood, 
then it was carried to the balance with the cap on. 
 
C. Diluted 20 μl of aqueous KCN solution with 980 μl pyridine then added to 100 μl of the 
phenol/ethanol solution. This was the Kaiser (A) solution. 
 
D. Dissolved 1.0 g ninhydrin in 20 ml absolute ethanol. This was the Kaiser (B) solution 
 
E. Stored Kaiser (A) and (B) solutions in amber dripper bottles. 
 
Once the solutions were prepared, the following procedure was performed: 
 
Set a heating block to 100 °C and removed a small amount of resin from the reactor and 
placed it in a microcentrifuge tube. Then, added two drops each of Kaiser (A) and (B) 
solutions; placed the tube in the heat block for two minutes. Finally, removed and observed 
the color: Blue = positive (i.e. amino groups present); Yellow = negative (i.e. no amino 
groups present). 
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15 Synthesis of oligonucleotides  
15.1 Principle of the Automated DNA Solid-Phase Synthesis 
 
Synthetic oligonucleotides were usually built up in 3’ to 5’ direction and the first building 
block was covalently bound to the solid phase via a base-labile succinyl linker. The 
connection to the solid phase was via an amide bond and the 5’ hydroxyl group was protected 
by acid-labile DMT ether. For this work, only 1 µmol and 15 µmol synthesis scale were used.  
The monomeric nucleotide building blocks carry a temporary protecting group (DMT), which 
get cleaved before each coupling step. They also contain permanent protecting groups for the 
amino functions of A, C and G, as well as for the phosphate function, which are only cleaved 
after completion of the oligonucleotide synthesis. The DMT group was used for the protection 
of all 5’ hydroxyl groups. The amino groups of A, C, and G were protected as amides or 
amidines, and the phosphates are protected by the 2-cyanoethyl group.  
The first step of oligonucleotide synthesis was the deprotection of the terminal DMT group by 
2% trichloroacetic acid. The following, tetrazole activated nucleotide then couples with this 
free hydroxyl group. In the next step, unreacted 5’ hydroxyl groups were capped in a fast and 
quantitative reaction as acetate, in order to terminate any further synthesis of fault sequences. 
The subsequent oxidation of the labile P(III) compound to the phosphate was achieved by 
reaction with iodine/water/pyridine mixture. With the cleavage of the DMT group the next 
synthesis cycle starts. Upon completion of the synthesis, the oligonucleotide was manually 
cleaved off the solid phase by treatment with 25 % aqueous ammonia solution at 55°C 
overnight. All permanent protection groups are also cleaved in this step with exception of the 
terminal DMT group (scheme 31). 
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Scheme 31: the synthesis cycle of the Phosphoramidite method. 
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15.2 Incorporation of the Building Block 
 
Freshly-prepared the DMTdUZnDPP phosphoramidite was dried under high vacuum overnight 
and was dissolved in anhydrous DCM under argon to give a 17 mM solution. The sequence 
was synthesised on the 1 µmol or 15 µmol scales using Trityl-on or Trityl-off procedure. 
Solution of DMT-CE phosphoramidite bases (0.1 M) in acetonitrile was then prepared and 
used in the DNA synthesizer. The program was started under standard mode until the desired 
column length was completed. For the ODN 5-7, the last base added was the F-DMT-dC-CE 
nucleotide. A 0.1 M solution of F-DMT-CE phosphoramidite in acetonitrile was then 
preparated and used in the DNA synthesizer. Upon completion of the syntheses, the columns 
were dried in an argon flow and were incubated by 25% ammonium hydroxide and methanol 
(or dioxane) (1:1) at 55°C overnight to release the DNA strand. The solution was centrifuged 
and the supernatant was separated from the solid support. The resin was washed twice with 
DCM/MeOH (or dioxane) (1:1) and the obtained solution were centrifuged. The supernatants 
were collected, combined and the thus obtained solution was lyophilized. (In presence of 
dioxane, the residue was re dissolved in ethanol and lyophilized again) 
 
The purification was dependant of the oligonucleotide length and the amount of porphyrins. 
 
 
15.3 DNA Melting Temperatures 
 
Prior to the DNA melting temperature (Tm) measurements, the desired two complementary 
strands were dissolved in 1.0 ml buffer solution (pH 7.0, 50 mM KHPO4, 500 mM NaCl) and 
annealed according the procedure described in chapter 5. 
Tm measurements were carried out at 260 nm, 280 nm, 410 nm, and at temperature gradient of 
1°C min-1. The measurements were performed two times and the values given were the mean 
of the heating and cooling cycles. 
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15.4 Data for the synthesized Oligonucleotides 
 
The identity of all oligonucleotides was verified by MALDI-TOF MS using the appropriate 
Matrix. 
 
 
15.5 Synthesis 
15.5.1 Dimer 47 
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The standard procedure was used to synthesise a dimer 47 starting from the building block 40. 
The purification was achieved by preparative TLC using DCM/MeOH (10:1) as eluent to 
obtain the pure material with 5 % yield. 
 
C147H142N12O30PZn: 2649.9 g/mol 
 
MALDI-TOF: m/z: 2648. 6 [M·]+ 
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15.5.2 Trimer 57 
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The standard procedure was used to synthesise a trimer with one central modification. This 
trimer 57 was purified on a sephadex LH20 column (l = 2.5 m, Ø = 3.5 cm) and the product 
was eluted with DCM/MeOH (1:1) as eluent (1 second per drop). 
 
C119H141N14O21P3Zn4-: 2258,89 g/mol 
 
MALDI-TOF: m/z: 2259. 2 [M·]+ 
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15.5.3 Tetramers 
 
 
O
O
NDMTO
HN
O
O
Zn
O
O
NDMTO
HN
O
O
R R
R R
Zn
P
N
O CN P O
N
CN
SPS
30-45%
dU
dT
DMTdT
dU
dU
dT
DMTdT
dU
R R
R R
dU
dT
DMTdT
dU
R R
42 45
54 55 56
tBu
tBu
tBu
tBu
tBu
tBu
tBu
tBu
R = C6H13
M
M
M
M
M
M
 
 
Using the same standard procedure, two homo-porphyrin 54 and 56 were synthesized using 
the building blocks 42 and 45 respectively. Then the hetero-porphyrin 55 was synthesised. 
For solubility reason, the DMT group was left on the last position. These tetramers were 
purified on a sephadex LH20 column (l=2.5m, Ø=3.5 cm) and the products were eluted with 
DCM/MeOH (1:1) as eluent. (1 seconds per drop) 
 
C199H250N16O28P3- (54): 3407.1 g/mol 
 
MALDI-TOF (54): m/z: 3407.2 [M·]+ 
 
C175H186N16O28P3- (55): 3052.2 g/mol 
 
MALDI-TOF(55): m/z: 3051.0 [M·]+ 
 
C151H122N16O28P3- (56): 2699.7 g/mol 
 
MALDI-TOF(56): m/z: 2700.5 [M·]+ 
 ε 410 / [M-1 cm-1] 
54 - 
Zn-54 208 916 
55 56 704 
Zn-55 58 392 
56 244 152 
Zn-56 300 664 
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15.5.4 21mer oligonucleotides 
15.5.4.1 Modified oligonucleotides (ODN) 
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The same procedure was used to synthesis longer modified oligonucleotides with different 
amounts of porphyrins as shown in the table infra. The building blocks 41 or 42 were used. 
The extinction coefficient was determinated in PTT buffer. 
 
 Name Sequence 5’ → 3’ DMT ε 260 / [M-1 cm-1] 
1 ODN 64 ATG CTA AGC TPT GAT CGA TGC ON 198 904 
2 ODN 65 ATG CTA AGC PTP GAT CGA TGC ON 195 708 
3 ODN 66 ATG CTA AGC PPP GAT CGA TGC ON 193 112 
4 ODN 67 TTT TTT PPP PPT TTT TT ON 122 320 
5 ODN 68 ATG CTA AGC TPT GAT CGA TGCC OFF 204 404 
6 ODN 69 ATG CTA AGC PTP GAT CGA TGCC OFF 201 208 
7 ODN 70 ATG CTA AGC PPP GAT CGA TGCC OFF 198 612 
 
 
Name MW calcd. MW found. 
ODN 64 7755.59 7855.0 
ODN 65 8731.22 8789.0 
ODN 66 9706.0 9786 
ODN 67 10 043.25 10 075 
ODN 68 8 110.2  
ODN 69 9141.24  
ODN 70 10 177.9  
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15.5.4.2 Oligonucleotide synthesis (ON) 
 
Using the same standard procedure on CPG support, we synthesised different non modified 
oligonucleotides as shown infra. 
 
 
 Name Sequence DMT ε 260 / [M-1 cm-1] 
1 ON 61 AAA A ON 55 400 (MeOH) 
2 ON 62 TTT T ON 33 000 (MeOH) 
 
 
15.5.4.3 Purification  
 
The purification of these DNA strands was done with two different methods: 
 
? Method A: Affinity Chromatography 
 
We synthesized the complementary strand of ODN on PS solid support, and then we purified 
these strands by affinity recognition.  
 
Duplex formation: 
 
200 µl of PTT buffer was added to the DNA strand, and heated at 50°C overnight in the 
thermomixer. The solution was filtered, added to the appropriated solid support and heated at 
60°C in the thermomixer for 10 min. Then, the suspension was cooled down slowly to 25°C 
and left in the fridge for one and half hours. The solid support was filtered, suspended in 0.1 
M TEAA Buffer (100 µl), and left again in the fridge for 1h30. The buffer containing the 
failure sequences was filtered off. 
 
 
 
 
 
Synthesis of Oligonucleotides  211 
Cleavage: 
 
The solid support was suspended in 200 µl of MeOH/H2O (9:1), heated at 60°C for 5 min 
filtered and the liquid was collected in an eppendorf (1.5 ml). This last step was repeated 
twice, and then the solutions were collected, and combined. Water (500 µl) was added and the 
obtained solution was lyophilized up to a 250 µl volume reduction. The liquid was co-
evaporated thrice with water to obtain the pure ODN. The solid support was washed several 
times with water and used again for other purifications. 
 
 Name Sequence 5’ → 3’ DMT 
4 ON 4 TAC GAT TCG AAA CTA GCT AGC TTT TA OFF 
5 ON 5 TGG TTA AAA AAA AAA AAA AAA TTG A OFF 
 
 
? Method B: fluorous affinity purification: 
 
The last step of the fully automated synthesis was the addition of the F-DMT-dC-CE 
nucleotide 89. This fluorous tag will be selectively retained on the Fluoro-PakTM column. We 
applied this method for the ODN 5-7. 
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Sample preparation 
 
Without removing the ammonia and dioxane used in the deblocking step, the solid was 
filtered support over filter and the crude was diluted with an equal volume of lading buffer. 
The final sample volume was 4 ml. 
 
Conditioning the column 
 
In order to prepare the Fluoro-Pak™ column, MeCN (2 ml), 0.1 M aqueous TEAA (2 ml) and 
loading buffer (2 ml) were passed, at a flow rate of 2 seconds per drop. The first 2-3 drops of 
MeCN was discoloured. 
 
Loading the FDMT-on oligonucleotide 
 
The sample prepared in 4.2 above was passed through the pre-conditioned column at a flow 
rate of 5 seconds per drop, these conditions that allow one-pass loading. The loading buffer 
was used and a slow loading rate was employed. 
 
Eluting remaining failure sequences 
 
Then, 10% MeCN (2 ml) in 0.1 M aqueous TEAA and water (2 ml) were passed at a flow rate 
of 2 seconds per drop. The acetonitrile/TEAA solution selectively washed the remaining non-
fluorous compounds (failure sequences) from the resin, and left the FDMT-on oligonucleotide 
bound and the water washed the buffer out of the resin prior to the acid-catalyzed detritylation 
in the next step. 
 
On-column detritylation 
 
3% aqueous TFA (3 ml), 0.1 M aqueous TEAA (1 ml) and water (1 ml) were passed at a flow 
rate of 2 seconds per drop. The TFA cleaved the FDMT group from the full-length 
oligonucleotide. A faint yellow colour was appeared on the column due to the trityl cation. 
The TEAA wash neutralized the residual TFA and ensured that the detritylated 
oligonucleotide had lipophilic triethylammonium counterions and was thus, retained on the 
support during the subsequent water wash, which removed excess TEAA buffer. 
Synthesis of Oligonucleotides  213 
Elution of the final detritylated oligonucleotide 
 
Finally, 20% acetonitrile (1 ml) in water was passed at 2 seconds per drop and collected the 
eluate in an appropriate sample tube. A further 1 mol 20% acetonitrile was collected at higher 
concentration of acetonitrile (e.g. 50-100 %). 
 
Fluoro-Pak™ II Columns: Each column contains 150 mg of adsorbent, and are designed for 1 
micromole purifications. 
 
Figure 1: Introducing a solution to the 
column. Use a Syringe with needle to pass 
the solution through the hole in the luer 
adaptor. 
Figure 2: With the desired solution already 
present in the column, use a syringe to 
pressurize the column with air, thereby 
eluting the solution. 
 
 
Remarks: use here one column for 2* 1 µmol (reactions yield was low) 
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